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Abstract 
To investigate the clinical and fiscal feasibility of administering a pre-treatment, 
dimensional personality assessment to clients seeking treatment at university-based 
counseling centers, a multi-phase study was conducted. This study sought to replicate the 
results of a recent study conducted by Ryder, Costa Jr., and Bagby (2007) regarding the 
validity of the DSM-IV-TR PD symptoms and their relationship to nonnal personality traits. 
This study also investigated the clinical utility of providing pre-treatment personality 
information to therapists, as assessed by a dimensional measure of normal personality the 
NEO-PI-R. Impact on treatment outcome was evaluated. After completing a pre-treatment 
assessment battery, university-affiliated clinic clients were randomly assigned to treatment 
condition (therapist received results of NEO-Pl-R assessment or therapist did not receive 
results). Client treatment outcome data were collected for the first six sessions of therapy. 
Results from both phases of the study were mixed, indicating that additional research on both 
topics is warranted. Replication analyses generally supported the results of Ryder et al. 
(2007); however, more research needs to be conducted before the generalizability of the 
results can be adequately addressed. Likewise, access to pre-treatment personality assessment 
results appeared to be beneficial from a preventive medicine perspective; however, more 
methodologically rigorous investigations need to be conducted before anything definitive can 
be deduced. 
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Statement of the Problem 
Aided by the passage of the Health Maintenance Organization (HMO) Act in 1973, 
managed care organizations have dominated the health care scene since the 1990s. The 
primary purpose of these organizations is to stem the rising cost of health care, including 
behavioral/mental health care. Since the late 1990s, l-IMOs and their behavioral/mental 
health care subcontractors (managed behavioral health organizations; MBI-!Os) have been 
credited with subduing rising medical costs. They accomplished this by implementing cost 
containment strategies that reduced unnecessary hospitalizations, lowered provider fees, and 
limited assessment and therapy services (Frank & Garfield, 2007; Meyer eta!., 2001). 
A particular cost containment strategy employed by MBHOs is to limit the number of 
psychotherapy sessions a client may obtain during a specific time frame, typically 6 to 20 
sessions per calendar year. Interestingly, researchers (Anderson & Lambert, 2001; Lambert, 
Hansen, & Finch, 2001) have detennined that 50% of therapy clients required II to 21 
sessions of treatment before they met criteria for clinically significant therapeutic 
improvement. Clinically significant improvement was defined as a 14-point decrease in a 
total symptom score on a measure of symptom distress [Outcome Questionnaire 45.2 
(OQ45.2); Lambert eta!., 1996] when the initial total symptom score is in the dysfunctional 
range (above 63 on the OQ 45.2). 
Not only is it interesting to note that this research suggested the number of sessions 
needed to effect change may be greater than the typically allotted 6 to 20, it begs the 
questions, "What is the treatment status of the other 50% of the clients?" and "What factors 
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impede or facilitate therapeutic effectiveness?" According to the psychotherapy literature, 
two of the major impediments to effective therapeutic outcomes arc poor therapeutic alliance 
(e.g., Klein et al., 2003; Kopta, Lueger, Saunders, & Howard, 1999) and comorbid 
personality disorder (PD) symptomology (e.g., Chiesa, Fonagy, Holmes, Drahorad, & 
Harrison-Hall, 2002). Unfortunately, third party payers are reluctant to approve payment for 
services related to personality assessment (e.g., Mariush, 2004; Meyer et al., 2001). They 
contend that there is no empirical evidence to suggest personality assessment, in particular, is 
useful in the context of cunent treatment protocols. They also maintain that personality 
assessment procedures significantly deplete limited psychotherapy funds, thereby decreasing 
the number of sessions a client is eligible to receive (e.g., Eisman eta!., 2000; Kubiszyn et 
a!., 2000). 
In light of data suggesting the most effective therapy experience could entail more 
sessions than third-party payers are willing to reimburse, it has become imperative that 
providers be able to quickly identify potential obstacles to effective treatment outcome so 
that clients' concerns can be better addressed in the insurance-coverage allocated time 
fi·ames. The development of a time and cost effective pre-treatment protocol that enhances 
the therapeutic alliance, facilitates clinically significant therapeutic change, and is deemed 
acceptable for routine reimbursement by third-party payers is sorely needed. Since 
therapeutic alliance and comorbid PD symptomology have been identified as major 
impediments to therapeutic change, any pre-treatment behavioral health care protocol should 
include measures of these moderators. 
However, thwarting the development of an empirically validated pre-treatment 
assessment protocol that would include measures of personality assessment is a literature full 
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of experimental studies questioning the clinical validity of the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-IV-TR; American Psychiallic Association, 2000), 
especially the personality disorder categories. The DSM-IV-TR Axis Il personality disorder 
categorical system is often utilized as the basis for many personality assessment instruments. 
Critics note the system has excessive within-disorder diagnostic heterogeneity, high rates of 
between-disorder diagnostic overlap, and poor correlation with fi.mctional impairment (e.g., 
Grilo eta!., 2001; Widiger & Frances, 2002). 
Thus, there are two issues that need to be addressed when considering the feasibility 
of behavioral health care pre-treatment assessment for personality disordered symptomology 
and therapeutic alliance: (1) will the chosen measure for personality assessment be clinically 
valid and useful, and (2) will the pre-treatment assessment battery yield results that arc cost-
effective in terms of reduced symptom distress and subsequent reduction in utilization of 
services, so that third-party payers will reimburse the cost of the assessment services? The 
answers to these questions will provide behavioral/mentalliealth practitioners with 
information that may promote reimbursement for services that identify known impediments 
to effective therapeutic outcomes. 
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Overview of the Behavioral Health Care System and Issues Impacting the Delivery of 
Therapeutic Treatment 
"All modern societies use varying types and intensities of health care rationing 
simply because there are not enough resources to meet the need and demand" (Cummings, 
Budman, & Thomas, 1998, p. 460). 
At one point in the not-so-distant past, assessment was a major component of the 
services offered by psychologists. Testing services were justified as being a means to 
improve diagnosis, improve treatment outcomes, and shorten treatment (Ambrose, 1997). 
However, with the advent of managed behavioral health care, the autonomy of many 
psychologists, with regard to deciding when and how to best assess and treat clients, has been 
significantly curtailed (Maruish, 2004). Why? According to numerous authors (e.g., 
Cummings, O'Donohue, & Cummings, 2009; Frank & Garfield, 2007; Maruish, 2004), the 
two main reasons for the development of managed behavioral care oversight were "runaway" 
costs and lack of empirical evidence to justify expenditures. 
Runaway Costs 
In the 1980s, three events in behavioral health care converged to set the stage for 
runaway costs: 
I) In an effort to slow Medicare and Medicaid spending, the United States Congress 
enacted diagnosis related groups (DRGs). DRGs defined the maximum number of 
hospital days for which the federal govemment would pay. However, Congress 
was unable to write DRGs for psychiatry, leaving hospital stays for this service up 
to the discretion ofthe practitioner (Cummings et al., 2009). 1 
1 According to English, Sharfstein, Scher!, Astrachan, and Muszynski (1986), DRGs for psychiatry were 
inappropriate due to evidence that suggested DRGs were poor predictors of resource utilization; and, since 
hospitals treat more severe cases, they would be at financial risk if payment fOr services was based on DRGs. 
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2) Most states repealed ce1iificate-of-need legislation for in-patient behavioral health 
care. Thus, to address the Joss of revenue from DRGs for medical 
hospitalizations, hospitals doubled the number of beds available for psychiatric 
in-patient hospitalizations. The increase in beds was accompanied by an increase 
in spending- from $3 50 million in 1980 to $1.2 billion in 1990 (Frank & 
Garfield, 2007). 
3) From the 1960s through the 1980s, indemnity plans (fee for service plans) 
allowed psychotherapy clients to obtain psychotherapy services for as long as the 
client and/or therapist felt the services were justified. Evidence from national 
surveys in the 1970s and 1980s indicated that 80% ofthose seeking 
psychotherapy services under indemnity plans utilized 18 or fewer sessions of 
treatment (e.g., Cummings, 1977; Wright, 1991, 1992). This suggested that 20% 
of those seeking psychotherapy services needed long-tem1 treatment. Research 
conducted by Cummings and VandenBos during that time colJaborated these 
survey results (Cummings, 1977; Cummings & VandenBos, 1979, !981 ). Their 
findings indicated that 85% of therapy clients responded to treatment in 15 
sessions or less, while another 10% needed "and should receive" Jong-tenn 
therapy, with an additional 5% being interminable (Cummings, Budman, & 
Thomas, 1998). These authors noted, whether by design and or a consequence of 
circumstance, from the 1960s until the 1980s, many solo-practice therapists 
eventually acquired a caseload of those 15-20% long-term clients. Thus, 
according to Cummings, Budman, and Thomas (1998, p. 463), "During the 
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heyday of indemnity-reimbursed solo practice, 20% of the patients could absorb 
70% of the expenditures." 
Unable to control the rapidly escalating behavior health care costs, Congress tumed 
the problem over to the private sector, and managed health organizations (l-IMOs) and their 
subcontractors, managed behavioral health organizations (MBHOs), came into being. 
Cummings et al. (2009, p. 33) pmirayed the situation succinctly: 
The Golden Age of psychotherapy was over by the mid-1990s, done in by our 
insistence on long tenn (largely psychoanalytically oriented) psychotherapy, 
as well as the profession's refusal to address out of control mental health costs 
that exceeded tor a time a 16% inflation rate. Controls were foisted upon the 
economically helpless psychotherapy practitioners, oflen arbitrarily, but ever 
so drastically. 
The main cost containment strategies employed by MBHOs were lower 
reimbursement tor services, significant curtailment of inpatient care, denial or significant 
cmiailment of assessments, and limitation of the number of therapy sessions available per 
year per client (Frank & Garfield, 2007; Meyer et al., 2001). These strategies continue to be 
the major cost containment techniques utilized by MBHOs to date. 
Lack of Evidence to Justify Expenditures 
What enabled MBHOs to control utilization of inpatient care, deny reimbursement f(Jr 
most psychological assessment, and dictate to psychotherapists how many sessions they have 
to address a client's distress-related symptomology? According to these arbitrators of care, 
the psychological literature. 
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For instance, MBHOs often deny reimbursement for personality assessment on the 
basis that "there is no conclusive, unequivocal research that demonstrates that objective 
personality assessment in and of itself' improves diagnosis, improves treatment outcomes, or 
shmiens treatment (Ambrose, 1997, p. 66). Moreover, third-party payers have used the DSM 
to justify nonpayment for personality assessment services: 
One provider manual states: However ... [the MCO] cannot suppmi the use 
of tests for behavioral health diagnostic purposes since the DSM-IV ... makes 
no reference to psychological or neurological testing for diagnostic purposes. 
Instead to make behavioral health diagnoses the DSM-IV emphasizes clinical 
interviews and obtaining infonnation from persons who have observed the 
patient. (Eisman eta!., 2000, p. 132). 
With regard to dictating the number of allowable therapy sessions, MBHOs rely on 
national survey figures, such as those from the 1970s and 1980s mentioned previously, that 
indicate typical psychotherapy services range from 1-2 sessions for 40% of clients, less than 
10 sessions for 60% of clients, and less than 18 sessions for 80% of clients (Wright, 1991, 
1992). 
Notably, there is a growing literature that indicates treatment for personality disorder 
symptomology has significant cost reduction benefits with regard to health care utilization 
following treatment (e.g., Maruish, 2004). However, as mentioned above, personality 
assessment, in and of itself, has not been empirically validated as a means to realizing 
behavioral health cost reductions (e.g., Ambrose, 1997; Jones, Amaddeo, Barbui, & Tansella, 
2007). So, the MBHOs may be justified in using this rationale for denial of assessment. 
However, using national survey utilization data to justify limiting the number of available 
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sessions is not justifiable, given that the reason for leaving therapy in these surveys is 
unclear. In fact, Hennessy and Green-Hennessy (1997) cite several studies that indicate client 
preferences regarding number of sessions of psychotherapy are influenced by levels of cost-
sharing and out-of-pocket expenses associated with services- not recovery from 
symptomology. 
Empirical Evidence Regarding Number of Sessions Needed to Evidence 
Psychotherapeutic Recovery 
An administrative requirement imposed upon practitioners, which MBJ-!Os utilize 
under the rubric of containing eosts, is the provision that behavioral health care providers 
supply documentation that demonstrates the effectiveness of treatments offered to clients. A 
client self-report questionnaire developed specifically for outpatient psychotherapy 
assessment is typically utilized (e.g., OQ 45.2, Lambert eta!., 1996; Treatment Outcome 
Package, Kraus, Jordan, & Horan, 1996; Clinical Outcomes in Routine Evaluation -
Outcome Measure, Evans eta!., 2000). It is interesting to note that Lambert and his 
colleagues have conducted a series of studies that challenge the validity of limiting therapy 
sessions, especially with regard to symptom recovery issues. 
As noted previously, Lambert's research team (Anderson & Lambert, 2001; Lambert, 
Hansen, & Finch, 2001) suggested that only half of those remaining in therapy long enough 
to evidence clinically significant symptom change realize that change in ll to 21 sessions of' 
therapy. In particular, Anderson and Lambert (2001) reported the results of a survival 
analysis utilizing the OQ 45.2 data from clients seen in a training clinic setting. Study 
outcomes indicated that 25% of the 100 clients beginning therapy in the dysfunctional range 
(total symptom distress levels greater than 64) were estimated to reach clinically significant 
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change by the end of session 8, 50% after session 13, and 75% after session 25. When 
analysis was conducted on the group of clients reporting initial levels of distress higher than 
83 .I (n=56), survival analysis results indicated a 25'Yo recovery rate after 10 sessions, a 50% 
recovery rate after 20 sessions, and a 73% recovery rate after 26 sessions. 
Likewise, in the study conducted by Lambert, Hansen, and Finch (2001), utilizing the 
data from 6,072 clients ti:om a variety of employee assistance programs and managed 
behavioral health care programs, survival analyses results suggested that 50% of those who 
begin treatment in the dysfunctional range could be expected to achieve clinically significant 
change after 21 sessions of psychotherapy. If those who terminated therapy early were to be 
included in these analyses, the proportion of clients evidencing significant change in 
symptom distress early in treatment would be lower (Lambert, Hansen, & Finch, 2001). 
Limited Availability of Services Revisited 
Even though research suggests that 50 to 75% of clients need 1 I to 40 sessions of 
therapy to realize clinically significant change in their symptomology, it is doubtful that 
employers and MBHOs will be incorporating approval for extended services into their 
therapy protocols. "The demands of managed mental health care are for. .. time-efficient 
services" (Quirk, Strosahl, Kreilkamp, & Erdberg, 1995, p. 28). Moreover, the maximum 
number of sessions is often limited by contract stipulations between the MBHO and the 
employer purchasing the MBHO services (Howard & Bassos, 2000). 
Thus, a therapist's ability to effectively address a client's presenting problem(s) is 
often hampered by the unwillingness of MBHOs to approve more than six to twenty sessions 
in a given fiscal year. Consequently, if therapists are to be optimally effective in twenty 
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sessions or less, it becomes imperative that the impediments to client change be quickly 
identified and addressed. 
Identifying the Impediments to Therapeutic Change 
Numerous researchers have postulated a variety of predictors of therapeutic change. 
Therapist-client matching (e.g., Calvert, Beutler, & Crago, 1988), client-treatment matching 
(e.g., Conrod, Pihl, Stewart, & Dongier, 2000), severity of symptoms, past use of therapy, 
duration of the problem, treatment expectation (e.g., Lutz, 2002), therapeutic reactance (e.g., 
Arnow eta!., 2003), therapeutic alliance (e.g., Kivlighan & Shaughnessy, 1995; Krupnick et 
a!., 1996), specific personality variables (e.g., Conte, Plutchik, Picard, Karasu, & Vaccaro, 
1988; Conte, Plutchik, Picard, & Karasu, 1991), and comorbid personality disorders (e.g., 
Shea, Widiger, & Klein, 1992; Tyrer, Manley, Van Horn, Leddy, & Okoumunne, 2000) are a 
few of the predictors most often cited in the research literature. Nonetheless, according to 
Orlinksy, Grawe, and Parks (1994), the five variables that have consistently demonstrated 
robust relationships with outcome in the research literature are therapist skill, client openness 
versus defensiveness, client cooperation versus resistance, treatment duration, and overall 
quality of the therapeutic relationship, often referred to as the therapeutic alliance. 
Treatment duration, as noted previously, is highly correlated with the client's ability 
to achieve clinically significant change; however, it is the one variable most easily targeted 
as the venue to control escalating mental health care costs. Therefore, therapist skill, client 
characteristics, and the therapeutic alliance appear to be the most likely candidates lor 
identification and modification with regard to facilitating therapeutic change. 
Therapist skilL There is an extremely large literature addressing the various therapist 
skills and characteristics that can influence the therapeutic process. [n a review of this 
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literature, specifically investigating the therapist characteristics and techniques that 
negatively impact the therapeutic alliance, Ackerman and Hilsenroth (200 I) identified the 
most common attributes impacting the therapeutic relationship as over structuring the 
therapy, failure to structure therapy, inappropriate self-disclosure, criticalness, unyielding 
transference interpretation, inappropriate use of silence, belittling, superficial interventions, 
unwanted advice, misinterpretation, unsupportive confrontation, and doing something the 
client does not want or need. They summarized by noting that these negative attributes may 
weaken the therapeutic alliance and "reduce the opportunity for patient change" (p. 173). 
Overall, their findings suggested that therapist attributes, as well as client attributes and 
process variables, can significantly impact the outcome oftherapy and that this impact is best 
understood in the context of the therapeutic alliance. 
Therapeutic alliance. Kopta eta!. (1999, p. 447) claimed, "Randomized clinical 
trials repeatedly find that a positive alliance is one of the best predictors of outcome." Their 
contention is substantiated by numerous outcome studies. Krupnick et al. (1996) rcpmied 
results from the National Institute of Mental Health Treatment of Depression Collaborative 
Study suggesting that the therapeutic alliance was predictive of treatment success for 225 
patients receiving either interpersonal psychotherapy, cognitive-behavior therapy, 
imipramine with clinical management, or placebo with clinical management. In addition, 
Kivlighan and Shaunghnessy (1995) reported a significant association between therapist 
ratings of the working alliance and therapeutic outcome. 
Klein et al. (2003) investigated the relationship between alliance and symptomo!ogy 
change in a large sample of chronically depressed patients while controlling for (a) early 
change in symptoms, hypothesized to possibly influence subsequent alliance ratings and (b) 
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patient characteristics- gender, severity, comorbid anxiety, substance usc, personality 
disorders, highest level of functioning in last 5 years, and childhood history of abuse and/or 
neglect. The results indicated early alliance predicted change in depressive symptoms, even 
after controlling for early change in symptomology and patient characteristics. Thus, 
empirical research strongly supports the importance of controlling for the strength of the 
therapeutic alliance if identification of other impediments to therapeutic change is the 
objective. 
Client personality characteristics. Although Klein eta!. (2003) results implied that 
client characteristics do not appear to interfere with the ability of the therapeutic alliance to 
predict therapy outcome, the results of other studies suggest that client characteristics can 
significantly influence therapeutic outcome. For instance, comorbid personality disorder has 
been identified as a significant predictor of therapeutic outcome, with researchers contending 
that comorbid personality disorders are associated with a poorer response to treatment for 
depression (e.g., Shea, Widiger, & Klein, 1992), anxiety (e.g., Dressen & Amtz, 1998), and 
substance abuse disorders (e.g., Compton, Cottier, Jacobs, Ben-Abdallah, & Spitznagel, 
2003; Pettinati, Pierce Jr., Belden, & Meyers, 1999). Correspondingly, Tyrer eta!. (2000) 
repmied that the average hospital stay for psychotic patients with comorbid personality 
disorder was 49 days longer than the average hospital stay for psychotic patients without 
personality disorder. 
The prevalence of personality disorders in the clinical setting has been estimated to be 
as high as 78%. Psychiatrists and psychologists responding to a survey (30% response rate) 
reported that 40% of the clients being treated for maladaptive personality characteristics had 
a diagnosable DSM-IV Axis II disorder (Westen & Arkowitz-Weslen, 1998). Likewise, an 
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analysis of epidemiological studies of psychiatric disorders conducted by Zimmerman, 
Chelminski, and Young (2008) indicated that 33 to 50% of patients in psychiatric settings 
had a personality disorder, as indicated by semi-structured interviews. Notably, results from 
the Collaborative Longitudinal Personality Disorder Study (Shea, Stout, Yen, et al., 2004) 
indicated that 78% of the individuals diagnosed with major depressive disorder had one of 
four co-occurring personality disorders (schizotypal, borderline, avoidant or obsessive-
compulsive). Therefore, comorbid personality disorder symptomology appears to be 
pervasive among clients seeking psychotherapy. 
However, client personality characteristics do not have to be "disordered" or 
maladaptive to negatively or positively influence therapy outcome. For example, Calvert, 
Beutler, and Crago (1988) investigated the assumption that matching psychotherapy to 
patient characteristics would result in improved treatment outcome. Their results suggested 
that patients repmiing an internalizing defensive style achieved greater symptom relief with 
insight/awareness-focused therapies, whereas, externally defended patients achieved greater 
symptom relief with behaviorally oriented treatments. 
Likewise, Conrod, Stewart, Phil, Cote, Fontaine, and Congier (2000) conducted a 
study investigating the utility of motivation-matched treatments for female substance 
abusers. Motivation was assessed utilizing a composite of subscalcs from various empirically 
validated personality and psychopathology measures [e.g., all NEO-PI-R subscales (Costa & 
McCrae, 1992); the Trait Anxiety subscale of the State-Trait Anxiety Inventory (Spielberger, 
Gorsuch, Lushene, Vagg, & Jacobs, 1983); etc.]; results from these subsca1es were then 
categorized into five personality-specific motivation types (anxiety sensitive, hopeless-
introverted, sensation seeking, impulsive, and low personality risk; Conrad, Pihl, Stewart, & 
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Dongier, 2000). The study had three conditions: ( 1) a motivation-matched intervention in 
which participants with anxiety-related symptoms were assigned to a cognitive restructuring 
training developed for anxiety disorders, pmiicipants with depression-related symptomology 
were assigned to a cognitive restructuring training for depression, and participants with 
impulsive and sensation-seeking tendencies were assigned to a cognitive restructuring 
training that addressed these symptomologies; (2) a motivation film (control) intervention; 
and (3) a motivation-mismatched intervention. The investigators reported that only the 
participants in the matched intervention reported reduced frequency and severity of 
problematic alcohol m1d drug use. These two studies arc just a sample of those that establish 
the correlation between client personality characteristics and treatment outcome (e.g., Karno. 
Beutler, & Harwood, 2002; McKnight, Nelson, Hayes, & Jarrett, 1984; Trower, Yardley, 
Bryant, & Shaw, 1978). Thus, it appears to be important to also identify client personality 
characteristics--nonnal or disordered--that may be impediments to therapeutic effectiveness. 
In summary, the research literature intimates that identification of client personality 
characteristics and strength of therapeutic allia11ce (which inherently incorporates therapist 
characteristics), combined with effective therapy techniques, ca11 significa11tly impact 
therapeutic outcomes. Given that third-party payers are reluctant to approve more than 6 to 
20 sessions without sufficient justification, the timing of the identification of possible 
impediments to therapeutic change is crucial. 
Pre-treatment Assessment 
Haynes, Leisen, and Blaine (1997) have identified the conditions under which pre-
treatment assessment is likely to have the greatest utility, one in particular being ''when there 
is a body of knowledge linking treatment methods to client characteristics" (p. 335). The 
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treatment matching literature, exemplified by the Conrad, Stewart, Pihl, et a!. (2000) study, 
appears to be providing the body of knowledge that links client characteristics to treatment 
methods. Moreover, a literature base that portends the therapeutic utility of pre-treatment 
assessment is beginning to develop. Finn and Tonsager (1997) have delineated the benefits of 
pre-treatment assessment, highlighting results from various studies investigating its utility. 
The studies in their review indicated that assessment feedback could be utilized as a 
therapeutic intervention that facilitates the therapeutic alliance. 
In one such study, Newman and Greenway (1997) investigated the impact of MMPI-2 
feedback for clients seeking therapy at a university counseling center. All participants were 
administered the MMPI-2 and then randomly assigned to one of two groups: test feedback 
(experimental condition) or attention-only with delayed feedback (control condition). 
Results indicated that participants who received MMPI-2 feedback demonstrated a 
significant decline in self-reported symptom distress levels compared to the attention-only 
group. Thus, it appears that pre-treatment personality assessment may, in fact, positively 
impact treatment outcome. However, the positive impact seems to be contingent upon 
whether or not the results are utilized to detennine appropriate treatment (e.g., Conrad, 
Stewart, Pihl, 2000) or whether the results of the assessment are reviewed with the client 
(e.g., Finn & Tonsager, 1997; Newman & Greenway, 1997). 
Benefits of personality assessment in a clinical setting 
Regarding the issue of the validity of psychological testing and assessment in general, 
several authors (e.g., Finn & Tonsager, 1997; Haynes et al., 1997; Meyer eta!., 2001) have 
identified the primary purposes of assessment2 Summarized, they are to: 
2Testing is defined as the administration, scoring, and interpretation of a psychological test; whereas, 
assessment is a broader concept and refers to "the scientific and professional activity of collecting, evaluating, 
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(a) describe current functioning, including cognitive abilities, severity of disturbance, 
and capacity for independent living, through the simultaneous measurement of a potentially 
large number of personality, cognitive, or neuropsychological characteristics, 
(b) confirm, refute, or modify the impressions forrned by clinicians through their less 
structured interactions with patients, 
(c) identify therapeutic needs, highlight issues likely to emerge in treatment, offer 
guidance about likely outcomes, and recommend fon11S of intervention (especially when 
there are a variety of treatment approaches to choose fi·om, when there is empirically 
validated support for matching treatment to client characteristics, or when the client is 
experiencing a multiple problems and treatment foci need to be prioritized), 
(d) aid in the differential diagnosis of emotional, behavioral, and cognitive disorders, 
(e) monitor treatment over time so that successful interventions (or lack thereof) can 
be evaluated or to identify new issues that may require attention as original concerns are 
resolved, 
(f) manage risk, including minimization of potential legal liabilities and identification 
of problematic treatment reactions, and 
(g) provide the information necessary to give skilled, empathic assessment feedback 
as a therapeutic intervention in itself. 
All of these functions can be ascribed to personality assessment in particular. 
Personality assessment infonnation, if used appropriately, can decrease the number of 
therapy sessions needed to obtain beneficial results (Quirk ct al., 1995) and/or can increase 
the effectiveness of the chosen treatment (e.g., Barkman, Stiles, & Shapiro, 1993; Conrod, 
and integrating information about a subject using, whenever possible, different sources of information" 
(Fernandez-Ballesteros eta!., 2001, p. 188). 
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Stewart, Pihl, et al., 2000; Piper, Joyce, McCallum, Azim, & Ogrodnicznk, 2002). Results 
from a meta-analysis (Perry, Banon, & Ianni, I 999), conducted to investigate the utility of 
psychotherapy for personality disorder symptomology, indicated that 52% of patients 
remaining in therapy recovered (no longer met full criteria for personality disorder). In 
addition, the investigators reported, "A heuristic model based on these findings estimated that 
25.8% of personality disorder patients recovered per year of therapy, a rate sevenfold larger 
than that in a published model of the natural history of borderline personality disorder (3.7% 
recovered per year, with recovery of 50% of patients requiring I 0.5 years of naturalistic 
follow-up)" (p. 1312). 
Perhaps more importantly, personality assessment infonnation has been shown to 
improve diagnostic accuracy. For example, in a study examining the incremental validity of 
MMPI profile information for diagnostic purposes, six psychiatry or neurology residents 
were given case history infom1ation, physical exam information, and medical test data for 
thirteen patients (Schwartz & Wiedel, 1981 ). In half of the cases, they were also given MMPI 
profiles and automated interpretations. Results indicated that diagnostic decisions based on 
information that included the MMPI profiles were significantly more accurate than diagnoses 
made without benefit of MMPI profile interpretations. 
Numerous studies (e.g., Fennig, Craig, Lavelle, Kovasznay, & Bromet, 1994; Shear et 
al., 2000, Jensen-Doss & Weisz, 2008) have been conducted unequivocally indicating that 
diagnoses based on an unstructured interview and clinical judgment alone are inaccurate 
more often than accurate. This, in combination with MBHOs reluctance to reimburse 
personality assessments, prompted the American Psychological Association to commission a 
study (e.g., Meyer et al., 2001, p. 128) to evaluate contemporary threats to psychological 
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assessment and to assemble evidence of the efficacy of assessment in clinical practice. 
According to Meyer and colleagues (2001 ), disagreements between unstructured interview 
diagnoses and structured interview diagnoses in general psychotherapy clinical practice are 
pronounced. However, they contend, "Even more drastic errors have been found for 
personality disorders .... Across studies, there was a meager correspondence between the 
diagnoses derived from a single clinician using the single method of assessment and the 
diagnoses derived from the multimethod evaluations (K ~" .28, N = 218, ... " (p. 151 ). They 
went on to state that, after correcting for agreements due to chance, about 70% of the 
interview diagnoses were in error. "By necessity then, the research findings indicate that 
many patients may be misunderstood or improperly treated when they do not receive 
thorough assessment. Errors ofmisappraisal and mistreatment are most likely when 
administrative efforts to save money restrict clinicians to very brief and circumscribed 
evaluations" (Meyer et al., 2001, p. 151). 
Haynes, Spain, and Oliveira (1993, p. 281) summarized the previous findings 
succinctly: "Because of the difficulties of relying on psychiatric diagnosis and subjective 
judgment to identify the causes of a client's behavior problems, pretreatment psychological 
assessment is pivotal to deriving valid causal inferences." Moreover, according to Harkness 
and Lilienfeld (1997, p. 349), the American Psychological Association's Ethics Code (2002) 
and the individual differences research literature necessitate inclusion of personality trait 
assessment for the "construction and implementation of any treatment plan that would lay 
claim to scientific status." Harkness and Lilienfeld support their contention with quotes from 
the Ethics Code, Standard 2.04, "Psychologists' work is based upon established scientific and 
professional knowledge of the discipline" (p.5). l-Ienee, from an ethical as well as diagnostic 
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perspective, personality assessment appears to enhance all aspects of the therapeutic 
endeavor. 
Summary 
Despite high clinical prevalence rates and compromised therapeutic recovery for 
individuals with comorbid personality disorders, as well as the noted advantages of 
perfonning this type of evaluation, personality assessment is rarely conducted as a routine 
part of a clinical intake protocol. Clinicians often cite lack of appropriate reimbursement as 
the culprit, whereas inefficient use of time and lack of cost-effectiveness are reasons cited by 
MHBOs (e.g., Eisman eta!., 2000; Kubiszyn et al., 2000). However, the current literature 
suggests personality assessment has the potential to significantly improve the therapeutic 
process and perhaps shorten a treatment protocol. So the challenge becomes: how can 
clinicians convince MHBOs to reimburse this valuable therapeutic tool? 
Dorfinan (2000) suggested that clinicians, when requesting authorization for 
assessment--personality or otherwise--be prepared to answer the following questions: 
1. Will the assessment render a more valid clinical diagnosis that leads to shorter 
treatment duration with greater effectiveness? 
2. How will the assessment save time and money over the course of treatment and 
thereafter? 
3. If other psychologists routinely make diagnoses and are able to provide effective 
treatment without objective assessment, why should this service be covered? 
4. Can you back up your assertions with support from the research literature? 
Payment-justification support for questions 1 and 3 has been provided in this 
discourse. However, empirical supp01i for question 2 is sparse; and the ability to provide 
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definitive support with regard to personality assessment for question 4 is contingent upon the 
assessment instrument utilized. In the following sections, identification of an empirically 
validated, clinically useful personality assessment instrument will be explored in the context 
of a discussion regarding the validity of the DSM PD diagnostic taxonomy and a review of 
the available assessment instruments. 
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The Classification of Personality Disorders -A Taxonomy in Turmoil 
"171e categories and criteria proposed in DSM were never more than arbitrary ideas 
based on expert opinion. The fact thatfundamental revision is now required attests to the 
success of DSM-111 in stimulating research and promoting personality as an integral part o( 
the diagnostic process" (Lives ley, 2003, p. 153). 
What role does the Diagnostic and Statistical Manual: Mental Disorders [DSM, 
DSM-I, DSM-II, DSM-Ill, DSM-III-R, DSM-IV, DSM-IV-TR (TR =text revision); 
American Psychiatric Association, 1952, 1968, 1980, 1987, 1994, 2000] play in this 
reimbursement dilemma plaguing personality assessment? Currently, DSM-IV-TR 
(American Psychiatric Association, 2000) is recognized as the definitive diagnostic 
nomenclature for personality disorders. However, since the introduction of the DSM in 1952, 
practitioners have lambasted the DSM PD classification system for lacking diagnostic and 
statistical validity and reliability, as well as diagnostic comprehensiveness. 
Personality Disorder History in the Evolution of the DSM 
With each revision of the DSM, serious efforts were made to address these concerns. 
The PD classification system in the original DSM (DSM-l; American Psychiatric 
Association, 1952) was strongly influenced by psychoanalytically trained psychiatrists (First 
et al., 2002). It included five PD subclasses, ranging fi·om those considered deep-rooted and 
relatively unaffected by therapy to those that were situationally transient. There were two 
major concerns with the DSM-I classification system: (1) the requirement that a choice be 
made between a neurotic disorder and personality disorder when both were present and (2) 
the unclear diagnostic criteria. The attempt to address these concerns in DSM-II (American 
Psychiatric Association, 1968) included dropping the distinction between personality trait 
and personality pattern disturbances~ both were grouped under one heading "personality 
disorders" - adding and dropping disorders, requiring that impaired functioning and 
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personally experienced distress were needed for diagnosis, and separating sexual deviations 
and alcoholism from personality disorders (Millon & Davis, 1995). In addition, the revision 
committee made a distinct effort to avoid terms that implied acceptance of a particular 
theoretical viewpoint, especially "where matters of causality were notably controversial" 
(Millon & Davis, 1995, p. 15). 
It was the introduction ofDSM-III (American Psychiatric Association, 1980), 
however, that had the most profound effect on the current status of personality disorder 
assessment, diagnosis, and research. Theoretical references regarding the nature or etiology 
of mental disorders were "actively" expunged from this version of the manual (Millon & 
Davis, 1995, p. 16). In addition, more specific and explicit diagnostic criteria (essentially 
behavioral in nature) were included for the personality disorders, "with the hope that 
[personality disorders] would then be diagnosed reliably in general clinical practice" 
(Widiger, 2001, p. 64). Moreover, personality disorders were placed on a separate axis, 
eliminating the need to choose between a personality or symptom syndrome when both were 
present. The separate axis also allowed "practitioners to place the clinical syndromes of Axis 
I within the context of the individual's lifelong and pervasive style of functioning recorded 
on Axis II" (Millon & Davis, 1995, p. 17). Accordingly, if a personality disorder was not 
diagnosed but dysfunctional personality traits were identified, it was recommended that these 
traits be listed under Axis II. Many investigators credit the establishment of a separate axis 
for personality disorders, the detailed criteria sets, and the subsequent development of PD 
symptomology assessment instruments for the fluny of personality-related research that 
followed (e.g., Livesley, 2001; Morey, 1997; Widiger, 2001). 
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It was the notable increase in PD research that highlighted the systematic diagnostic 
enors resulting from unclear, inconsistent, and contradictory DSM-lll (American Psychiattic 
Association, 1980) PD criteria (Widiger, 2001 ). This, in turn, instigated substantial revisions 
to the PD criteria sets in DSM-III-R (American Psychiatric Association, 1987). In addition, a 
general revision was made to four disorders (schizoid, avoidant, dependent, and compulsive), 
changing the monothetic diagnostic requirements (all criteria must be met) to polythetic 
diagnostic standards (only a subset of criteria are required for diat,YJ1osis; Widiger, 2001 ). 
However, the reliability and validity of the criteria sets for PDs remained controversial. 
Specifically, the rate of diagnostic overlap (typically 3 to 4 PDs per individual; Widiger & 
Rogers, 1989) forced researchers to question the qualitative distinctiveness of the PD criteria 
In an effort to further address the problematic overlapping criteria between the PD 
disorders, revisions in the DSM-IV (American Psychiatric Association, 1994) PD 
classification system were again substantial. Of the 21 criteria that were listed for more than 
one disorder, 12 were eliminated and 9 were reworded so that the criteria reflected the 
motivational aspects associated with a particular disordered behavior (Widiger, 2001). For 
example, the DSM-Ill-R (American Psychiatric Association, 1987) criteria "avoidance of 
close relationships" for avoidant and schizoid disorders were qualified in DSM-IV with "is 
unwilling to get involved with people unless certain of being liked" for avoidant personality 
disorder (p. 665) and "neither desires nor enjoys close relationships, including being part of a 
family" (p. 641) for schizoid personality disorder. Regarding diagnostic comprehensiveness, 
3 According to Livesley (200 I, p. 18), "Overlap is otten misleadingly referred to as comorbidity. However 
comorbidity refers to the co-occurrence of distinct diagnoses, and there is no evidence that personality 
diagnoses are distinct in this sense. When applied to personality disorder, the term 'comorbidity' simply 
obscures a fundamental flaw in the system." 
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DSM-IV experienced modifications to the number of PO disorders as did the previous 
editions. 
Thus, substantial efforts bave been made to provide mental/behavioral health 
practitioners with a taxonomy for personality disorders that has acceptable reliability and 
validity. However, many acknowledge that the current taxonomy of personality disorders in 
DSM-IV-TR (American Psychiatric Association, 2000) "remains a troublesome area" in the 
classification of mental disorders (Livesley, 2003, p. 153). Some of the identified problems 
include (1) the atheoretical approach of the system, (2) the lack of reliability and validity for 
the categorical structures as evidenced by the lack of multivariate statistical support for the 
categories, (3) the confusion regarding the distinction between axis I and axis II disorders, ( 4) 
the excessive overlap among the DSM-IV-TR PDs, (5) the arbitrary distinction between 
nonnal and abnormal personality, ( 6) limited disorder coverage, and (7) the lack of empirical 
documentation for the clinical utility of treatment decisions for most of the personality 
disorders (e.g., Liveslcy, 2001, 2003; Westen & Arkowitz-Westen, 1998). 
Noted Problems with the Current Categorical System 
The a theoretical approach of the system. As mentioned above, the DSM revision 
committees deliberately sought to make personality disorder criteria atheoretical in 
description due to the limited empirical support for etiological speculations. The descriptions 
of the crite1ia may be atheoretical, but the origins remain theoretically diverse (Livcslcy, 
2001). For example, the criteria for histrionic personality disorder have theoretical origins in 
psychoanalytic and phenomenologic principles, and the criteria for avoidant personality 
disorder have theoretical origins in social learning principles. Livesley (200 I) argues that this 
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lack of a coherent theoretical basis for the personality disorders results in diagnostic overlap 
and poor reliability. 
However, as also noted by Livesley (200 I), a unified theory of personality that 
incorporates all identified dimensions of normal and abnonnal personality is not yet available 
and may never be. As elucidated by Millon and Davis ( 1995), " ... the substantive and 
professional character of mental health would be simply too multidimensional in structure 
and too multivariate in function ever to lend itself to a single, fully satisfactory system" (p. 
16). They continued by noting that, if and when a unified theory is developed, it would need 
a consensus endorsement before being accepted as the basis of the DSM taxonomy, which, 
given the current theoretical diversity among the "experts," would probably be slow in 
coming. Therefore, a solution to the concern that the DSM personality disorder classification 
system is atheoretical does not appear to be forthcoming in the near future. 
Moreover, there is some question regarding whether or not the DSM is tmly 
atheoretical, especially pertaining to personality disorders. Follette and Houts (1996) 
presented a convincing case suggesting the DSM is theoretically based on the medical model, 
which is evolving into a biological model. They cited the DSM requirement for most 
disorders to detennine that the problem is not due to "the direct physiologic effects of a 
substance (e.g., a drug of abuse, a medication) or a general medical condition" as evidence of 
this evolution. Likewise, within the DSM-IV -TR (Ameli can Psychiatric Association, 2000), 
inferences are made indicating the suppmi of a biopsychosocial model for the 
conceptualization of disorders: "Judgments about personality functioning must take into 
account the individual's ethnic, cultural, and social background" (p. 687). The 
biopsychosocial model provides a venue whereby biological, cognitive, systemic, or other 
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explanations for maladaptive personality symptomology can be explored and comparatively 
assessed regarding their utility in the identification and treatment of tbese symptoms. 
Therefore, it would seem that systematic adoption of this model would ensure the continued 
progression of science and perhaps avoid the controversy and difficulty that would be 
associated with comparing the utility of specific etiology models. 
The lack of reliability and validity for the categorical structures. When 
personality-disordered symptomology has been assessed using more than one form of 
measurement, research indicated that there is only a modest convergence regarding 
diagnostic results. In a review conducted by Clark, Livesley, and Morey (1997), median 
kappa values between structured interviews ranged from .35 to .50; median kappa values 
between questionnaires and interviews ranged from .08 to .42; median correlation values 
between questionnaires and interviews ranged from .19 to .54; and median correlation values 
between different questionnaires ranged from .39 to .68. In a review of personality 
assessment instruments, Clark and Harrison (2001) reported that structured interviews 
evidenced test-retest (average 2 months apari) kappa values for diagnoses ranging between 
.36 for the Structured Clinical Interview for DSM-111-R Personality Disorders (SCID-11) and 
.48 for the Structured Interview for DSM-IV Personality (SIDP); they intimated that 
personality disorder diagnosis, via these instruments, is unstable. However, the test-retest 
reliability estimates for self-report inventories were higher (.41 to .91). 
Notably, most of this research was conducted using instnnnents based on DSM Ill or 
DSM-III-R criteria. Yet these poor convergent validity and reliability results suggest that the 
conceptual adequacy of the personality disorder constructs and the operationalization of these 
constructs in the criterion sets are critical issues for both assessment and diagnosis (Clark & 
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Harrison, 2001). Unfortunately, research investigating these issues using DSM-IV-TR 
criteria is sparse (e.g., Ryder eta!., 2007, Grilo eta!., 2001, & McGlashan eta!., 2000). The 
general consensus of these authors is that the DSM-IV-TR personality disorder symptoms 
have good convergent validity; conversely, there are mixed opinions regarding the divergent 
validity of the DSM PD categories. Grilo eta!. (2001) reported that the PD categories have 
"some discriminant validity" (p. 264), while Ryder et al. (2007) stated that the general lack of 
divergent (discriminant) validity of the PD categories is "problematic" (p. 631 ). However, 
with the advent of confirmatory factor analytic techniques, investigators are beginning to 
present evidence that perhaps the criterion sets of the PDs are adequate representations of 
these disorders (e.g., Amtz, 1999; Sanislow eta!., 2002). 
Excessive diagnostic overlap among the DSM-IV-TR personality disorders. 
Results from the Collaborative Longitudinal Personality Disorders Study, a repeated-
measures study of a clinical sample of four DSM-IV personality disorders (schizotypal, 
borderline, avoidant, and obsessive-compulsive, and major depressive disorder, without a 
comorbid personality disorder, serving as a control group) evidenced a mean of 1.4 (SD-1.6; 
median= 1) additional personality disorders among the participants meeting criteria for the 
study disorders (McGlashan eta!., 2000). This level of axis II overlap matched studies 
investigating personality-disorder diagnosis overlap utilizing DSM-Ill-R c1iteria (1.8 in 
Oldham eta!., 1995 and 1.7 in Stuart, Klimidis, & Minas, 1998). According to Clark and 
Harrison (200 1 ), diagnostic overlap is problematic for several reasons; it is indicative of (1) 
inadequate conceptualization of the basic constructs, (2) a failure of the DSM criteria to 
represent the underlying constructs adequately, and/or (3) a failure of existing assessment 
devices to reflect the criteria accurately. 
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It is noteworthy that the number of multiple personality disorders has dropped from a 
co-occurrence rate of3-4 per individual using DSM Ill or DSM-lll-R criteria (Widiger & 
Rogers, 1989; Skodol, Rosnick, Kellman, Oldham, & Hyler, 1990, as cited in Widiger & 
Sanderson, 1995) to approximately 1.5 per individual using DSM-IV criteria (McGlashan et 
al., 2000). Although it remains somewhat of a problem, it appears that the DSM-IV axis II 
criteria revisions have begun to affect the personality disorder diagnostic overlap concerns of 
practitioners. However, the rate of overlap suggests the categorization method may not be the 
best taxonomy for identifying and classifying maladaptive personality symptomology. 
Confusion regarding the distinction between Axis I and Axis II disorders. First 
et al. (2002) presented a cogent synopsis of the mental disorders literature that argues in 
favor of personality disorders as spectrum conditions of axis I disorders. They cited 
phenomenological, genetic, and biological research that suggests (1) schizo typal personality 
disorder symptomology is on a continuum with schizophrenia symptomology (e.g. Stein, 
1992, as cited in Widiger & Shea, 1991 ), (2) avoidant personality disorder symptomology is 
on the same continuum as social phobia symptomology (e.g. Reich et al., 1989, as cited in 
Widiger & Shea, 1991), and (3) cluster B personality disorder symptomology is on a 
continuum with the affective instability symptomology associated with the mood disorders 
(e.g. Pinto & Akiskal, 1998, as cited in Widiger & Shea, 1991)4 In fact, the spectrum 
concept may account f(n· the relatively high comorbidity rates between axis I and axis 11 
diagnoses in clinical samples. For example, McGlashan et al. (2000), again reporting results 
from the Collaborative Longitudinal Personality Disorders Study, stated patients in all groups 
were assigned a mean of3.4 (SD=l.7; median= 3.0, range 0-9) lifetime axis I diagnoses. 
4The reader is also referred to Widiger and Shea (1991) for a more detailed account regarding the differentiation 
of axis I and axis II disorders, accompanied by DSM revision suggestions to resolve this dilemma, 
PD Pre-Treatment Assessment 29 
Thus, the diagnostic dilemma becomes how to conceptualize symptomology (both Axis I 
clinical disorders and Axis II development/personality disorders)- as a continuum 
underlying psychopathological syndrome (state)/personality (trait) processes or as distinct 
dimensions that interact in clinically significant ways (First et al., 2002). 
The arbitrary distinction between normal and abnormal personality. According 
to Livesley (2001), research suggests that the features of normal personality and personality 
disorder are continuous, regardless of sample characteristics (patient or nonpatient) or feature 
description (diagnostic criteria or traits), and that it is not possible to identifY distributions in 
either description that suggest a discontinuity. Eysenck (1994), in pruiicular, empirically 
validated this claim using correlational and factor-analytic techniques to test a continuity 
hypothesis for psychoticism. Moreover, Walton, Robert, I<rueger, Blonigen, and Hicks 
(2008) utilized Item Response Theory in an effort to replicate Eysenck's findings; they 
reported, "the primary conclusion based on these findings suggests that measures of normal 
range personality capture much of the infmmation obtained with a 'direct' measure of 
psychopathy" (p. !640). Other researchers echo Livesley's and Eysenck's contention (e.g., 
Lynam & Widiger, 2001; O'Connor & Dyce, 1998), providing evidence that nonnal 
personality trait measures and their relationship to abnormality may in fact account tor the 
overlap problem currently plaguing the DSM PD categorical system. 
Limited Disorder Coverage. Westen & Arkowitz-Westen (1998) conducted a study 
in which randomly selected clinicians were asked to describe their last three non psychotic 
adult clients who were being treated with psychotherapy for "enduring patterns of thought, 
feeling, motivation, or behavior that are dysfunctional or lead to distress. Their personality 
problems may or may not be serious enough to qualify for a personality disorder diagnosis" 
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(p. 1768). Of the 714 patient profiles that were submitted for the study, only 39.4% were 
diagnosed with personality disorders. This diagnosis proportion did not vary by clinician 
degree (M.D. 35.2% or Ph.D. 38.3%), nor by theoretical orientation (psychodynamic 42.4%, 
cognitive-behavior 32.5%, and eclectic 35.4%). According to the investigators, comorbid 
axis I disorders (38%- 42%, depending on category- mood, anxiety, substance abuse, or 
adjustment) could not account for "the roughly one-half of patients with personality 
pathology who cannot be diagnosed on axis II" (p. 1768). As a result, Westen and Arkowitz-
Westen were led to the conclusion that "the majority of patients with personality pathology 
significant enough to warrant clinical psychotherapeutic attention (60.6%) arc currently 
undiagnosable on axis II" (p. 1769). These findings corroborated Millon's (1991) contention 
that "not only are there problems in assigning many patients to the limited categories 
available, but clinicians often claim that the more they know patients, the greater the 
difficulty they have in fitting them into a category" (p. 255). 
The lack of empirical documentation for the clinical utility of treatment 
decisions for most ofthe personality disorders. This assertion is typically substantiated by 
the literature addressing psychopharmacology or psychosocial interventions. These 
interventions usually address a specific feature of a disorder or a cluster of related features 
(i.e., anxiousness, self-mutilation behavior, suicidal ideation; Livesley, 2001 ). Moreover, 
rarely if ever is a categorical diagnosis used to plan treatment strategies. Widiger and Lowe 
(2008, p. 374) succinctly delineate this concern: 
As expressed by the chair ofDSM-V, for the existing diagnostic categories, "lack of 
treatment specificity is the rule rather than the exception" (Kupfer, 2002). It is telling 
that it has been over 10 years since the American Psychiatric Association began 
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publishing practice guidelines for the diagnostic categories ofDSM-IV-TR and, as 
yet, treatment guidelines have been developed for only 1 ofthe 10 personality 
disorder diagnostic categories. , , , However, what is also evident .. is that treatment 
does not address or focus on the entire personality structure. 
Widiger and Lowe (2008) then note that dialectical behavior therapy (DBT), utilized 
with borderline personality disordered clients and the most researched treatment modality for 
a personality disorder, "is an effective treatment for many of the components of this 
personality disorder, but it is evident to even the proponents of this clinical approach that the 
treatment is not entirely comprehensive in its effectiveness" (p. 375). 
Summary. As is evident from the above discussion, there are legitimate concerns 
regarding the clinical utility of the DSM personality disorder categories, making it difficult 
for practitioners to accurately classify their patients' symptomology and diftlcult for 
managed care companies to justify payment tor services that address dysfunction described 
as "pervasive, inflexible, and stable over time" (DSM-IV-TR; American Psychiatric 
Association, 2000, p. 685). The time has come for a major change to the fom1at of the DSM 
PD classification system. Although task force teams have worked diligently in the past to 
improve the categorization system, major revisions need to be accomplished so that 
practitioners who utilize the DSM in treatment delivery have a resource that will guide and 
support the correct classification, assessment, treatment, and reimbursement for services that 
target PD symptomology. 
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The Exploration of the Clinical Utility and Diagnostic Feasibility of a Dimensional 
System of Classification 
As noted, a substantial literature has developed regarding the shortcomings of the 
DSM personality disorder categorical system. More impmiant, however, is the 
acknowledgement by the American Psychiatric Association that the current categorical 
system is no longer feasible and that a research agenda is needed to explore the clinical utility 
of a dimensional model of classification (e.g., Bagby, Sellbom, Costa Jr., & Widiger, 200B; 
Widiger and Lowe, 2008). Typically, dimensional models of maladaptive personality 
symptomology define symptomology as extremes of nonnal personality traits or variations 
on a continuum of a measure of a maladaptive trait (e.g., low, moderate, or high levels of 
distress). 
Since 1994, many researchers have developed alternative models to the current 
categ01ical system for personality disorders (the reader is referred to a listing provided by 
Bagby, Costa Jr., Widiger, Ryder, & Marshall, 2005, p. 308). One popular alternative is to 
conceptualize personality disordered symptoms as extremes (high or low) of normal 
personality traits as measured by a five-factor model (FFM) of personality [e.g., NEO 
Personality Inventory Revised (NEO-PI-R), Costa and McCrae, 1992]. The FFM of 
personality has a substantial research base validating the factor structure in a variety of 
language and cultural settings (e.g., McCrae and Costa, 1997). It also has a substantial 
research base validating its usef\Jlness as a diagnostic tool (e.g., Huprich, 2003; Rossier & 
Rigozzi, 2008; Shea et al., 2004; Sher, Bartholow, & Wood, 2000; Soldz and Vaillant, 1999). 
In a recent article, Krueger, Markon, Patrick, Benning, and Kramer (2007) stated that 
dimensional representations of personality pathology are "better predictors of functional 
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impainnent when compared with categorical representations ofDSM-IV-TR PDs in 
treatment seeking patients" (p. S65). Moreover, Widigcr and Lowe (2008) outlined the 
clinical and diagnostic advantages of the integrative five factor model, noting that the model 
would provide a theoretically unifonn classification of normal and abnormal personality 
functioning, giving clinicians the ability to address both strengths and weaknesses. They 
reported the model has an extensive scientific foundation, in behavior genetics, molecular 
genetics, childhood antecedents, and universality [see Widiger and Lowe (2008) for listing of 
research]. These authors argued that the theoretical basis of the five-factor model, in 
conjunction with the extensive scientific research support, provides a constmct validity that 
has been lacking with the current DSM-IV-TR categories of PD. 
Although adapting a dimensional model of personality classification appears to be the 
prefened method for addressing the current DSM's clinical validity issues, the chances of it 
being incorporated into the upcoming revision of the DSM (DSM V) are slim. The 
substantial research support needed to justify this type of radical change in the diagnostic 
system is not yet available. Notably, in an effort toward establishing the evidence needed to 
make this change, Ryder, Costa Jr., and Bagby (2007) attempted to simultaneously 
investigate the validity of the DSM categorical system for PDs and the clinical validity of a 
dimensional representation of personality by evaluating the DSM-IV-TR PD symptoms, as 
represented by the Structured Clinical Interview for DSM-IV Personality Disorders (SCID-!1; 
First, Gibbon, Spitzer, Williams, & Benjamin, 1997), with respect to convergent validity 
(symptom to disorder coherence within a PD to address validity ofDSM categorical system), 
divergent validity (distinctiveness of each PD symptom relative to other PDs, again to 
address validity ofDSM categorical system), relation to general personality traits 
PD Pre-Treatment Assessment 34 
(comparison with NEO-PI-R results), and association with functional impairment 
(comparison with DSM-IV-TR Global Assessment of Functioning scores). Based on the 
results of their analyses, the authors make two general suggestions regarding the cunent 
categorical system: (1) where necessary, add, rewrite, or eliminate PD disorder items to 
ensure that each PD encompasses a "coherent and relatively nonoverlapping set of 
symptoms" or (2) "abandon the effort to relate PD traits to the existing I 0 disorders ... and 
generate a set of more coherent PDs to facilitate categorical diagnosis" (Ryder eta!., 2007, p. 
631). 
Conclusion 
As described above, the validity of the current DSM categorical system for 
personality disorders is questionable at best. However, the American Psychiatric Association 
is making a concerted effort to address this weakness of the DSM. Investigation is ongoing 
regarding the clinical and diagnostic utility of dimensional models of personality and 
personality pathology. Unfortunately, it is unlikely that the empirically validated evidence 
based on DSM related research needed hy third party payers to justify treatment and payment 
for personality disordered diagnoses will be forthcoming in the near future. 
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Is There a Gold Standard for Maladaptive Personality Assessment? 
", , , psychological tests act like some of our best psychotherapy supervisors; they 
alternately help us grasp our clients' inner worlds and then retain a grounded nomothetic 
perspective on the clients' problems" (Finn & Tonsager, 1997), 
Despite the tum1oil associated with the DSM diagnostic system, personality 
assessment can be an integral, informative component of case conceptualization and 
therapeutic treatment planning, The issue in this circumstance is how to choose an 
appropriate assessment instnunent that is both clinically informative, as well as cost efficient, 
thereby facilitating the oppmiunity to realize reimbursement from third-party payers? 
Considerations When Choosing a Personality Assessment Instrument 
When deciding which personality assessment instrument will be most appropriate for 
use in a clinical setting, client preferences and abilities, clinician preferences and abilities, 
measurement device psychometric properties, and clinical utility issues should all be 
considered (e.g., Maruish, 1999; Rubio-Stipec, Hicks, & Tsuang, 2000; Zarin, 2000; see 
Appendix A, page 126, for a consolidated list), Important client factors worthy of 
consideration include (I) the likelihood of omitting important sources of assessment 
infom1ation (i.e., in what circumstances is the behavior or trait most likely to occur, etc.); (2) 
the ethnic and cultural appropriateness of the instrument; (3) the cost in terms of effort, time, 
and additional expense; and (4) the potential emotional and psychological impact that 
completing the instrument may have on respondent 
Clinician preferences and abilities that should be considered when choosing a 
personality assessment device include (I) the potential impact on initiation or maintenance of 
rapp01i, (2) usefulness in guiding treatment decisions, (3) amount of training required to 
obtain mastery with the instrument, ( 4) costs in terms of time and money to administer, score, 
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interpret, and present results, and (5) the tendency to become over-reliant on standardized 
assessments to the point of exclusion of other clinically rei evant infonnation. 
A clinician must also be concerned with the psychometric properties and clinical 
utility of the assessment device. Are the psychometric properties (e.g., reliability, construct 
validity, discriminative validity, positive predictive power, negative predictive power, etc.) 
acceptable? Is the reading level appropriate for all manner of clientele? Is the length and 
level of comprehensiveness appropriate for all parties concerned (e.g., client, agency, third-
party payer, etc.)? Is the instrument validated for the populations of interest? Is the empirical 
support for the instrument sufficient and methodologically sound? Is the method for 
determining categorization of symptoms [e.g., a scale score or the Diagnostic and Statistical 
Manual: Mental Disorders, Fourth Edition (DSM-IV; American Psychiatric Association, 
1994)] psychometrically validated? In addition, the clinician must also determine the 
appropriate use of the measure (e.g., screening, diagnostic, prognosis, etc.), the degree to 
which clinical decision making is enhanced by use of the particular instrument, and whether 
or not the instrnment is the most appropriate means of obtaining the desired infonnation 
(e.g., client vs. informant, interview vs. questionnaire). Serious deliberation of these issues, 
when determining the appropriateness or utility of an assessment instrument, can minimize 
treatment failnre (e.g., Finn & Tonsager, 1997; Kubiszyn eta!., 2000; Quirk eta!., 1995). 
In order to maximize the potential of the clinician's review, the issues listed above 
should be considered within the context of the current debates in the personality assessment 
field. Erdberg (2004) has suggested each assessment approach accounts for some of the 
unique aspects of the variance in personality. While this idea may have some merit, its 
implementation is compromised by the lack of a gold standard by which to judge the utility 
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and validity of personality measures. Although clinical interviews have been touted as the 
gold standard for diagnosing personality disorders (e.g., Clark & Harrison, 2001; Kaye & 
Shea, 2000), this assertion has been called into question due to the inadequate 
operationalizations of the DSM-IV Axis II criterion sets (e.g., Clark, Livesley, & Morey, 
1997). 
A second point of contention is the notable lack of situation-specific behavior 
assessment in most personality measures. Mischel (1968) and others have suggested that the 
situation is a stronger determinant of behavior than personality dispositions or traits; 
therefore, it should not be assumed that individuals behave consistently across diverse 
situations. 
A third debated issue is the degree to which impression management (e.g., fake good, 
fake bad, etc.) is assessed in the various personality assessment measures and the impact of 
social desirability on the accuracy of the responses (e.g., Morey, 1997). Finally, a fourth 
concern is that individuals suffering from personality disorder symptomology may not 
possess the insight to accurately self-report their symptoms (e.g., Westen & Shedler, 1999). 
Therefore, despite the well-documented need for personality assessment in clinical settings, 
significant confounds limit the degree to which clinicians can have confidence in the 
reliability, validity, and clinical utility of any given assessment. 
Personality Assessment Instruments 
Currently, there are more than seventy-five empirically validated comprehensive 
personality assessment instruments. If instruments that measure only one, two, or some small 
portion of the facets of personality are included, this number increases exponentially, well 
into the hundreds. Of the seventy-five comprehensive instruments, many address only 
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selective aspects of personality (i.e., Defense Style Questionnaire, Bond & Wesley, 1996; 
Diagnostic Interview for Borderline Patients, Gunderson, Kolb, & Austin, 1981; Hare 
Psychopathy Checklist Revised, Hare, 1991; etc.). These assessment instruments are 
administered in one of two formats: clinician-administered or self-report. Each format has 
distinct advantages and disadvantages. 
Clinician-administered questionnaires. A clinician-administered structured 
interview based on the DSM-IV-TR personality category symptomology is considered the 
gold standard for personality assessment. Clinician-administered personality-assessment 
interviews [e.g., Structured Clinical Interview for DSM-IV Axis II Personality Disorders 
(SCID-II), First et al., 1995, 1997; Personality Assessment Schedule (PAS), Tyrer & 
Alexander, 1979, 1988] have diagnostic advantages not possessed by self-report inventories, 
such as the ability to immediately ask follow-up questions for clarification or clinician 
support if questions trigger emotional distress in the respondent. However, the administrative 
expenses (e.g., clinician time to administer [typically one to two hours], score, and interpret) 
prohibit cost-effective use of structured or semi-structured interviews as standardized pre-
treatment assessment devices. Moreover, any instrument based on the DSM-IV-TR, as noted 
earlier, has questionable clinical utility, other than diagnostic guidance. Therefore, inclusion 
of most clinician-administered, stmctured interviews in a clinically-valid, cost-effective pre-
treatment assessment battery would not be feasible or easily justifiable. 
Clinically Useful Self-Report Questionnaires. Self-report instruments vary in 
response format (e.g., sentence completion, evoked word response, true/false, Likert scale, 
etc.), length (from 15-30 items on checklists to 500+ items on the MMPI-2), administration 
(paper and pencil, computer generated, etc.), and completion time (anywhere from 5-l 0 
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minutes to 2 or more hours). Some assess DSM-IV Axis I symptomology (e.g., anxiety, 
depression, substance abuse), as well as personality symptomology/traits (e.g., Millon 
Clinical Multiaxial Inventory III [MCMI-III; Millon, Millon, & Davis, 1994), Personality 
Assessment Inventory [PAl; Morey, 1991], Schedule for Nonadaptive and Adaptive 
Personality [SNAP; Clark, 1993]). Many instruments have versions applicable for 
administration to family members or friends [e.g., Adjective Check List (Gough, 1960) 
Personality Research Form (Jackson, 1974, 1977)]. Notably, several have foreign language 
versions, which have been empirically validated (e.g., Eysencyk Personality Questionnaire 
[Eysencyk & Eysencyk, 1964], MCMI-III [Millon et al., 1994], Minnesota Multiphasic 
Personality Inventory znct Version [MMPI-2; Butcher, Dahlstrom, Graham, Tellegen, & 
Kaemmer, 1989], NEO Personality Inventory Revised [NEO-PI-R; Costa & McCrae, 1992]). 
However, researchers from other countries have questioned the validity of translated 
assessments and have instead developed instruments validated and nonned on their 
respective populations (e.g., Freiburg Personality Inventory [Fahrenberg, Hampel, & Self, 
1985]; Karolinska Scales ofpersonality [KSP; afKlintebert, Schalling, & Magnusson, 1986], 
Trier Personality Inventory [TPI; Ellis, Becker, & Kimmel, 1991 ]). 
The main advantages of the self-report fonnat include increased efficiency and 
reduced administration time for clinicians, inclusion of validity items or scales to detect 
response styles that may invalidate the results (i.e., exaggeration, faking, acquiescence, social 
desirability, etc.), and normative data to guide interpretation. The disadvantages of self~rep01i 
instruments include(!) a general lack of ethnic or cultural norms, (2) the possible 
unavailability of a clinician to address negative affect invoked by answering the items on the 
questionnaire, (3) clinician over-reliance on questionnaire data increasing the likelihood of 
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omitting other important domains of assessment information, and (4) the inability to ask 
follow-up questions at the time of administration (Kaye & Shea, 2000). 
Two compilations of self-report personality instruments considered appropriate for 
clinical use are listed in Appendix B, page 127. Based primarily on the work of Kaye and 
Shea (2000) and the American Psychiatric Association's current exploration of dimensional 
representations of personality disorders, discussion will be limited to the four trait-
based/dimensional instmments from this list with the most research support for their utility: 
Inventory of Interpersonal Problems-Personality Disorder Scales (IIP-PD; Pilkonis, Kim, 
Proietti, & Barkham, 1996), Stmctural Analysis of Social Behavior Intrex Questionnaire 
(SASB-IQ; Benjamin, 1996), Tridimensional Personality Questionnaire (TPQ; Cloninger, 
Przybeck, & Svrakic, 1991) or Temperament and Character Inventory (TCI which replaced 
the Tridimensional Personality Questionnaire; Cloninger, Przybeck, Svrakic, & Wetzel, 
1994), and NEO Personality Inventory- Revised (NEO-PI-R; Costa & McCrae, 1992). 
Please see Appendix C, page 128, for an overview of these instmments. 
The IIP-PD is the only trait-based diagnostic self-report inventory recommended for 
clinical use by Kaye and Shea (2000) and Clark and Harrison (200 I). The original version 
was a 127-item instmment with a 5-point response format. A newer shorter version (64 
items) has yet to be empirically validated. Ten-week test-retest reliability coefficients for the 
older version ranged from .80 to .87. Validity coefficients with the Revised Interpersonal 
Adjective Scales (IAS-R) ranged from .36 to .38. Although preliminary studies indicate the 
instrument is useful in treatment development and is sensitive to therapeutic progress, Kaye 
& Shea (2000) noted the clinical utility of this instmment still needs to be established. 
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The SASB-IQ, the first of three trait measures of normal personality, was developed 
to assess an individual's interpersonal and intrapsychic interactions, in order to facilitate the 
psychotherapy process (Kaye & Shea, 2000). The short form consists of 108 items rated on 
an 11-point response format. It is very difficult to hand score due to complex mathematical 
procedures; therefore, computer scoring is highly recommended. The program and 
accompanying forms are available for $50, with a subseqnent $2 cost per administration, 
making this a very affordable means of assessment. However, due to the complexity of the 
model, a significant training investment is required. Test-retest reliability conducted with 
subject samples consisting of20 or less participants yielded coefficients of .80 or better. 
Validity coefficients estimated using scores from the Revised Interpersonal Adjectives Scales 
(Wiggins, Trapnell, & Phillips, 1988) ranged between -0.20 to --0.40, suggesting that 
additional validity research needs to be conducted. Surprisingly, the manual provides norms 
derived from a sample of 80 college students taking abnormal psychology classes. According 
to Kaye and Shea, the average age of the participants was mid-20s, and the volunteers were 
mostly women. Thus, the interpretation of instrument scores for a clinical population is 
suspect. 
The TCI is a 240-item inventory with a yes/no response fonnat; it is based on 
Cloninger's biosocial theory of personality. It measures three dimensions -novelty seeking, 
harm avoidance, and reward dependence. Six-month test-retest reliability coeft]cients ranged 
from .70 to .79 for the three dimensions. Validity coefficients determined using the NEO-Pl-
R and the MCMI-II ranged between -.75 and .71 for specific scales. Costs estimates are 
approximately $4.50 per protocol. Conflicting reports regarding the clinical utility of the 
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instrument (Clark and Harrison, 200 I) suggest that its usefulness in the clinical setting still 
needs to be established. 
Of the three trait-based measures of normal personality, the NEO-PI-R has the most 
empirical support. This 240-item inventory, employing a 5-point response format, assesses 
five major domains (neuroticism, extraversion, openness, conscientiousness, and 
agreeableness) and six facets in each domain, yielding a total of 30 subscales. 11 is available 
in college-age, self-, or other-report formats. Results are obtained by comparing scores with 
those from an appropriate normative group. The norm groups (500 men and 500 women) 
were compiled from participants in a variety of studies (i.e., the normative sample for the 
Augmented Baltimore Longitudinal Study of Aging, participants in a national study ofjob 
performance, spouses and peers; Costa & McCrae, 1992). It provides useful information 
regarding personality strengths and weaknesses associated with the various personality 
disorders (e.g., Huprich, 2003; Trull & Widiger, 1997), has a relatively low administration 
cost (approximately $13 per computer scored protocol -· based on a minimum of I 00 
administrations), and takes the average client approximately 20-40 minutes to complete. 
Test-retest reliability coefficients for a 6-7 year interval ranged !1-om .63 to . 93 on the five 
major domains. Validity coefticients with the Myers-Briggs Type Indicator and the 
Personality Research form range between .49 and .60 (Kaye & Shea, 2000). A research 
database, supporting the clinical utility of the NEO-PI-R, is starting to amass (e.g., Egger, De 
Mey, Derksen, & van der Staak, 2003; Quirk, Christiansen, Wagner, & McNulty, 2003; 
Saulsman & Page, 2003). 
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The Utility ofthe NEO-PI-R in a Clinical Setting 
The clinical utility of the NEO-Pl-R has been empirically substantiated, especially 
with regard to it having a solid theoretical foundation and being a source of identification for 
personality strengths/adaptive traits and personality weaknesses/maladaptive traits. 
Addressing its theoretical roots, it is interesting to note that the NEO-Pl-R (Revised NEO 
Personality Inventory; Costa and McCrae, I 992) was derived originally from studies based 
on a cluster analysis of personality characteristics as measured by the 16 PF. The 16 PF (16 
Personality Factors; Cattell, 1946) was originally developed based on the hypothesis that 
language supplies behavior descriptions and that the analysis oflanguage makes it possible to 
identify personality traits and their organization (Allport & Odbert, 1936, as cited in Rossicr, 
de Stadelhofen, & Berthoud, 2004). This theoretical foundation is also the fundamental 
theoretical basis for the development of the NEO-PI-R (Costa & McCrae, 1992). The NEO-
PI-R has a top-down hierarchal organization; first, five orthogonal higher-level domains were 
identified [neuroticism (N), extraversion (E), openness to experience (0), agreeableness (A), 
and conscientiousness (C)], then six lower level facets were defined for each domain. Thus, 
the development and structure of the NEO-PI-R exemplifies a coherent taxonomy that 
facilitates the understanding of normal personality traits (Miller, Reynolds, & Pilkonis, 
2004). 
Studies validating the clinical utility of the NEO-Pl-R as an identifier of adaptive 
personality traits are numerous. For example, in a study investigating the utility of 
personality assessment in predicting medication compliance in a population suffering from 
psychotic disorder, the NEO-PI-R profiles predicted both insight regarding illness and 
outpatient medication adherence (Wilson, 2003 ). In addition, a study conducted to investigate 
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the predictive utility of the NEO-PI-R for academic examination performance, Chamorro-
Premuzic and Fumham (2003) reported that select NEO-Pl-R domain facets (i.e., 
achievement striving, self-discipline, and activity) accounted for almost 30% of the variance 
in academic examination performance. 
The NEO-PI-R is not limited to assessment of normal/adaptive personality 
characteristics. In a statistical review of data published for 3 7 personality and 
psychopathology inventories, O'Connor (2002, p. 962) found "relatively consistent evidence 
for high levels of similarity between normal and abnormal populations," concluding that "the 
dimensional universes of normality and abnormality are apparently the same." Likewise, in a 
study conducted by Livesley, Jackson, and Schroeder (1991), the scores on 100 scales, 
measuring features of personality disorder, for 274 general population participants and 158 
personality-disordered participants were combined. The results indicated that there was no 
evidence of bimodality or points of rarity that would suggest nom1al and abnonnal 
personality characteristics are categorically separate. 
Based on these findings, researchers began to explore the relationship between the 
NEO-Pl-R domain and facet scales and the DSM personality disorder criteria. In a study 
designed to evaluate Trull and Widiger's (1997, as cited in Huprich, 2003) five-factor-model 
predictions ofDSM-IV personality disorders, Huprich (2003, p. 33) reported that "facets 
hypothesized to be associated with a given personality disorder were able to predict variance 
in their respective SCID-II personality disorder scores for seven often personality disorders.'· 
Similarly, in a study that compared results from a structured interview for DSM-IV 
personality with results from the NEO-PI-R and the SNAP (a true/false self report inventory 
of nonadaptive and adaptive personality; Clark, 1993), the NEO-PI-R, at the facet level, out-
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performed the SNAP for predicting interview-based personality disorder ratings. 
Remarkably, the facets significantly predicted 12 ofihe !3 disorders (Reynolds & Clark, 
2001). Moreover, Widiger and Mullins-Stewart (2009, p. 199) noted that the "FFM 
descriptions include the DSM-IV-TR personality disorder features and go beyond the 
criterion sets to provide fuller, more comprehensive descriptions of each personality 
disorder." 
In addition, results of a study conducted by Miller, Reynolds, and Pilkonis (2004, p. 
317) indicated that the "experts were able to use the five-factor-model facets to describe PDs 
in an accurate manner." These studies, in conjunction with studies that substantiate the 
incremental validity of the NEO-PI-R when added to batteries utilizing the MMPI, MMPI-2 
PSY 5, and TCI (e.g., Ball, Tennen, Poling, Kranzler, & Rounsaville, 1997; Quirk eta!., 
1995; Sharpe & Desai, 2001), suggest that, when the five-factor-model facet scores are 
utilized, meaningful relationships between dimensional personality characteristics and 
psychopathology can be established. This implies that assessments such as the NEO-Pl-R 
may have clinical utility. 
For example, in a study investigating the incremental validity of the NEO-PI-R in the 
prediction of social and vocational adjustment for hospitalized female patients with a clinical 
diagnosis of borderline personality disorder (Clarkin, Hull, Cantor, & Sanderson, 1993, p. 
476), the authors noted that the DSM criteria in combination with the NEO-Pl traits made a 
unique contribution to the prediction of social and vocational adjustment; the fact that both 
"in combination predict an important variable such as social functioning better than either 
alone" suggests the importance of both sources of information. In a study investigating the 
utility of the NEO-PI-R in predicting treatment responsiveness in an outpatient drug-
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rehabilitation population (Piedmont & Ciarrocchi, 1999, p. 224), the authors noted that the 
results of their study support "our contention that broad-based personality inventories may be 
useful for identifying motivational patterns that are consistent with the demands of certain 
treatment modalities. Tests that measure only emotional adaptation or symptomology may 
miss these broader motivational links with treatment responsiveness." 
Beyond being a valid measure of adaptive personality characteristics and possessing 
the potential to identify maladaptive personality characteristics, the NEO-PI-R has many 
administration advantages as a pre-treatment assessment device. It has 240 statements for 
which respondents rate their level of agreement on a 5-point Likert scale, requiring 
approximately 30 to 40 minutes to complete. Thus, the instrument is comprehensive, yet does 
not require an exorbitant amount of time to answer. As noted previously, the cost is 
approximately $13 for 100 paper and pencil administrations that are computer scored. As 
such, the instrument is relatively inexpensive. The computer-scored version provides a 
profile that is easily interpreted by the therapist, thus minimizing sc01ing and interpretation 
time requirements. 
Because the NEO-PI-R profile highlights personal strengths and potential 
weaknesses, its developers portend that it may provide the clinician with information that can 
assist in the rapid development of empathy (Costa & McCrae, 1992). In addition, the 
computer-generated summary provides non-technical and non-threatening feedback of 
results. If used appropriately, the NEO-PI-R results may allow the therapist to provide a 
client with personalized feedback; such feedback has been shown empirically to aid in the 
establishment of rapport (Allen, Montgomery, Tubman, Frazier, & Escovar, 2003) and to 
enhance the therapeutic alliance (Hilsenroth, Peters, & Ackennan, 2004). In addition, the 
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developers provide empirical support suggesting that the NEO-PI-R can aid the therapist in 
anticipating the course of therapy and selecting optimal treatments (Costa & McCrae, 1992). 
Moreover, due to its substantial research support for identifying adaptive and 
maladaptive personality characteristics, the NEO-PI-R may be the needed bridge to aid 
behavioral/mental health practitioners through the transition from a categorical to a 
dimensional diagnostic classification system. 
Thus, this measure has strong empirical support for its clinical utility. This suggests 
that the NEO-PI-R has the potential to yield clinically-relevant infonnation and more valid 
clinical diagnoses, which in turn may yield shorter treatment duration with greater 
effectiveness, ultimately saving time and money. Therefore, if proven as an effective pre-
treatment assessment protocol, the potential to convince third-party payers to approve 
reimbursement for its administration, scoring, and interpretation may exist. 
Conclusions 
Relative to semi-structured/stmctured interviews, self-report measures of trait-based 
and diagnostic-based personality characteristics appear to have adequate reliability and 
validity psychometric properties, with a few notable exceptions (e.g., SASB-IQ). They are 
also cost effective to administer. However, due to high sensitivity, coupled with the inability 
to ask follow-up questions for positive responses, most self-report, diagnostic-based 
inventories yield high false-positive rates (Guthrie & Mobley, 1994). This has prompted 
researchers to recommend that these instmments be used as screening devices only. Due to 
limited correspondence with DSM-IV personality disorders, researchers also suggest that the 
SASB-IQ and TPI not be used for clinical purposes until additional research supports this 
venue. 
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Notably, the NEO-PI-R has been empirically proven to be useful in a clinical setting 
and is one of the most economically feasible instruments to administer. In addition, it 
provides information on nonnal and abnom1al aspects of personality, allowing the clinician 
to assess both strengths and weaknesses of a client, as opposed to popular assessments such 
as the MMPI-2, which offers little with regard to identifying personality strengths. Moreover, 
the NEO-PI-R is comprehensive with regard to assessing the various aspects of normal 
personality and identifying constellations of normal personality trait variants that are 
reflective of personal disordered symptomology. These attributes, in combination with the 
NEO-PI-R's dimensional basis of assessment, make it the most easily justifiable measure of 
personality evaluation. However, a research base establishing the cost-effectiveness, in terms 
of facilitating shorter treatment duration and greater therapeutic effectiveness, of utilizing the 
NEO-PI-R as a pre-assessment measure needs to be established. 
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Purpose of the Study and Hypotheses 
Purpose 
The purpose of this study was twofold. The first objective was to replicate the 
analyses conducted by Ryder, Costa Jr., and Bagby (2007) utilizing a distinctively different 
client population. The Ryder et al. analyses were conducted on a sample consisting of 
inpatients and outpatients being seen for treatment at a medical-school affiliated, psychiatric 
facility. The sample utilized for this study consisted of clients being seen at university-based 
outpatient training clinics. Results could be used to address the generalizability of the Ryder 
and colleagues' results with regard to the clinical validity of the DSM PD categorical system. 
The second objective was to determine the impact of pre-treatment personality 
assessment, as well as therapeutic alliance, on treatment outcome during the first six sessions 
of therapy for clients receiving services at university-based psychology training clinics. 
Personality was assessed utilizing the NEO-PI-R (Costa Jr. & McCrae, 1992). Treatment 
outcome was measured utilizing the total symptom score from the Outcome Questionnaire 
(OQ45.2; Lambert, Hansen, Umpress, et al., 2001 ). Therapeutic alliance was assessed 
utilizing the Working Alliance Inventory- Short Fonn (W AI-S; Tracey & Kokotovic, 1989). 
Hypotheses 
The study tested the following hypotheses: 
a. Hypothesis 1: It was hypothesized that replication analyses to determine the 
symptom-to-disorder diagnostic validity of the DSM-IV-TR personality disorder 
criteria! traits in terms of (a) convergent validity, (b) divergent validity, and (c) 
association with the Five Factor Model personality traits would yield results 
similar to those of Ryder, Costa Jr., and Bagby (2007). 
PD Pre-Treatment Assessment 50 
b. Hypothesis 2: It was hypothesized that ratings of functional impainnent. as 
measured by the OQ 45.2, would be more strongly associated with impainnent as 
measured by the SCID-II-SR than the Global Assessment of Functioning (GAF) 
scores utilized in the Ryder et al analyses. 
c. Hypothesis 3: It was hypothesized that more clients whose therapists received 
NEO-PI-R reports would report clinically significant change in OQ 45.2 total 
symptom scores by session 6 than clients whose therapists did not receive NEO-
Pl-R reports. 
d. Hypothesis 4: It was hypothesized that there would be a significant difference in 
OQ 45.2 change scores between experimental groups (main effect for feedback). 
e. Hypothesis 5: It was hypothesized that the therapeutic alliance would be rated 
higher by clients whose therapists received NEO-PI-R reports than by clients 
whose therapists did not receive these reports. 
f. Hypothesis 6: It was hypothesized that there would be no interaction between the 
feedback condition and the strength of the therapeutic alliance on OQ 45 change 
scores. 
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Method 
The aim of this dissertation was to explore psychotherapy outcome as a function of 
practicum therapists' access to pre-treatment client personality information. Thus, practicum 
therapists, their supervisors, and potential therapy clients were recruited for participation in 
the investigation. This multilevel recruitment process, in conjunction with the dual-nature of 
the inquiry (parallel studies: one systems oriented, the other treatment-outcome oriented), 
made it necessary to implement the dissertation in a series of phases: 
I. Therapist and Supervisor Recruitment, 
2. Client Recruitment and Baseline Assessment, and 
3. Treatment Outcome. 
The following describes the methodology utilized to execute each of these phases. 
Phase 1: Therapist and Supervisor Recruitment 
When the dissertation was initially proposed, the Eastern Michigan University 
Psychology Clinic (EMU PC) was designated as the primary data collection site. This clinic 
is the training facility for students in the EMU doctoral clinical psychology program. 
Clientele seen at the EMU PC consisted primarily of referrals from health care practitioners 
and clinics in the local geographical area. A substantial number of the clients were unable to 
qualify for services at the local Community Mental Health clinic and were unable to aJiord 
private-practice services. Thus, to accommodate this population, the clinic utilized a sliding 
fee payment plan based on income. 
As a means of introducing the studies to EMU PC therapists and supervisors, a 
training workshop to facilitate mastery of the NEO-PI-R (a measure of normal personality 
characteristics described in greater detail in the Phase I section) was conducted. All therapists 
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scheduled to see clients at the EMU PC, in addition to all supervisors, were invited to 
participate in the workshop. The workshop was designed to familiarize attendees with the 
utility of the NEO-PI-R and to provide a feedback protocol that would facilitate clients' 
understanding and utility of the questionnaire results. Before the start and upon completion of 
the workshop, therapists and supervisors were asked to complete questionnaires (See 
Appendices K and L, pages 136-137). These questionnaires were developed to assess 
participants' self-efficacy regarding NEO-PI-R assessment and interpretation and to assess 
the quality of the presentation. 
Following the workshop, therapists and supervisors were provided with an outline of 
the project. Therapists interested in participating were then asked to complete a consent form 
(see Appendix N, pages 139-140) and Therapist Demographics questionnaire (see Appendix 
G, page 132). The Therapist Demographies questionnaire included questions about age, 
gender, etlmicity, and primary theoretical orientation, as well as therapy, assessment, and 
assessment feedback experience. Supervisors interested in pmiicipating were also asked to 
complete a consent form (see Appendix P, page 143). 
At the time of the proposal, data collection, based on previous therapists' case load 
assignments, was estimated to take approximately one year. However, due to unexpected 
administrative anomalies, such as reduced therapist case load, and increasing number of 
transfer clients, data collection proved to be more difticult than originally anticipated. 
Consequently, practicum therapists and supervisors from two additional independent clinics 
were approached to participate in the studies; the clinics included the EMU Counseling and 
Psychological Services (CAPS; students receive free counseling services at this facility) and 
Wentworth and Associates, a private practice located in Utica, Michigan. Due to clinic-
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affiliated time constraints, an abridged version of the training workshop was conducted at the 
respective staff meetings. The pre- and post-workshop questionnaires (described above) were 
not administered at these presentations. Supervisor and therapist consent forms and Therapist 
Demographic questionnaires were distributed at the CAPS presentation. However, due to 
therapist time and caseload constraints, consent to participate and data were unable to be 
collected at the Wentworth and Associates clinic (see appendices N through Q, pages 139-
148). 
Moreover, as a result of the extended time frame associated with data collection (25 
non-consecutive months due to intemship interruptions), new practicum therapists and 
supervisors joining staff at the participating clinics were approached individually, via 
telephone/email and recruitment flier, to participate in the project (see Appendix M, page 
138). One-on-one training sessions were conducted with those who agreed to participate after 
receiving a description of the study. 
In summary, all student therapists completing practica at the two EMU clinics, in 
addition to all clinic supervisors, were asked to participate in the dissertation protocol, via a 
recruitment flier, training involvement, and consent fonn. Participation was predicated on the 
following therapist and supervisor inclusion criteria: 
• Signed a written consent form, which included paperwork completion 
requirements (two questionnaires per client for therapists, one questionnaire per 
client for supervisors; questionnaires described in the Treatment Outcome 
section). 
• Attended a training presentation/in-service to develop the skills necessary to 
interpret the results of the NEO-PI-R, had previous NEO-PI-R 
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training/experience, or were briefed individually regarding the skills necessary to 
utilize the results of the NEO-Pl-R. 
Therapists and supervisors refi.tsing to participate or unwilling to sign the informed 
consent form were not included in the project. 
Phase 2: Client Recruitment and Baseline Assessment 
Client-participant recruitment and assessment procedures. Therapy clients 
considered for recruitment in the study included individuals 18 years or older seeking 
treatment at the EMU Psychology Clinic (EMU PC) or EMU Counseling and Psychological 
Services (CAPS). 
Clients from EMU PC and CAPS were asked to participate in the one or both phases 
of the project in accordance with the inclusion criteria below: 
• Signed a written consent form, which included paperwork completion 
requirements (several questionnaires through the course of treatment, if the 
participant was eligible for inclusion in that phase of the project; questionnaires 
are described in the Treatment Outcome section). 
• Were willing to complete the baseline assessment battery before being seen for a 
second treatment session at the clinic. 
• Had the cognitive capability and willingness to complete all routine clinic 
paperwork. 
Clients were excluded from participation based on the following criteria: 
• Had cognitive impainnents that impeded the ability to provide valid data, as noted 
in the initial clinic paperwork (i.e., initial contact fonn) or via therapist report. 
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• Were deaf or blind; exclusion was dictated by the lack ofNEO-PI-R questionnaire 
validity studies for these populations. 
Client-participant recruitment. When potential clients were contacted by a member 
of the clinic staff to complete a phone intake interview (EMU PC) or during the in-person 
intake (CAPS), the interviewer asked the client if he/she would be willing to be contacted 
regarding possible participation in a study. If the potential client agreed to be called, either 
orally or by completing an interest form, the interviewer recorded the name and phone 
number in the appropriate study-specified data fields on the intake form. 
Potential client-participant contact. Therapy clients who expressed an interest in 
project participation were contacted by a research assistant (see Appendix R, page 147, for 
contact protocol). An overview of the project was given, and the potential participant was 
asked if he/she would like to schedule an appointment with a research team member before 
his/her second therapy appointment to complete the baseline assessment. This assessment 
consisted of a review and signage of a consent form (see Appendices S through U, pages 
149-152) and completion of a questionnaire battery (which included a demographics form, 
NEO-PI-R, SCID-II-SR, and OQ45.2 described below in the Measures section). In addition, 
the research assistant infonned the potential participant at the time of the recruitment phone 
call whether or not he/she met inclusion criteria for the project and, if eligible, what form of 
compensation he/she would receive for participation. If eligible and the client chose to 
participate in the study, he/she was given $10 cash (CAPS) or a $10 credit to his/her clinic 
account (EMU PC) upon completion of the questionnaire battery. 
Potential participants were also told that the project protocol included the possibility 
of some pmiicipants being contacted, following termination of therapy, to complete of a 
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follow-up questionnaire battery. If the participant was contacted to complete the follow-up 
questionnaires, he/she was informed that, upon receipt (at the EMU PC) of the completed 
questionnaires (SCID II SR and OQ 45.2 described below in the Measures Section), a 
monetary compensation of $10 would be mailed to him/her for his/her time and effort. 
Personality questionnaire battery completion. If eligible to participate in the study, 
the client was met by a research assistant at a pre-detennined place and time. First, the 
consent form was reviewed with the participant Upon completion of the consent form, the 
assistant explained the directions for completing the questionnaire battery. The participant 
was then left alone in a private space to complete the paperwork. If the participant had any 
questions, the research assistant was available to answer them. Upon completion of the 
questionnaire battery, the research assistant compensated the participant as previously 
outlined, placed the completed questionnaires in an envelope, and deposited the envelope in 
the principal investigator's mailbox at the EMU PC. 
Measures. The following measures were included in the questionnaire battery. 
Client demographics questionnaire. Salient client characteristics were identified via 
queries about age, gender, ethnicity, marital status, annual household income, and so on (see 
Appendix F, page 131). 
NEO Personality Inventory Revised (NEO-PI-R; Costa & McCrae, 1992). This is a 
240-item questionnaire designed to provide a summary of individual's personality 
characteristics. It was developed using rational and factor analytic methods to determine five 
major factors of personality: Neuroticism (N), Extraversion (E), Openness to Experience (0), 
Agreeableness (A), and Conscientiousness (C). For each factor, there are six facet scales, 
which are designed to capture more specific traits. Items are answered using a 5-point 
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response format, ranging from ]-strongly agree to 5-strongly disagree. The items are simple 
statements describing general tendencies (e.g., "I am efficient and effective in my work"). 
There are two versions of this measure: the self-report fonn and the observer rating form. 
The self-report form was utilized in this study. 
Reliability. In an employment sample utilizing the self-report version (Costa & 
McCrae, 1992), intemal consistencies (coefficient alpha) for the individual facet scales 
ranged from .56 to .81; the factor scales had coefficient alphas ranging from .86 to .95. 
Similar values were repmied for a clinical sample (Fagan et al., 1991 ). Test-retest reliability 
scores for a small sample (31 men and women) ranged from .66 to .92 for the facet scales and 
from .86 to .91 for theN, E, & 0 factors. 
Validity. The developers of the measure provide multiple examples of convergent and 
discriminant validity for all of the facets and factors (Costa & McCrae, 1992). 
Appropriate populations. The NEO-PI-R has been validated for use with individuals 
who are 17 years or older and is available in a wide variety of languages. It is recommended 
that individuals suffering from a disorder that may affect their ability to complete the 
measure (e.g., dementia, psychosis, etc.) should not be administered the instrument. 
Scoring. If 41 or more responses are missing, it is recommended that the protocol not 
be scored. Iff'ewer than 41 items are missing, and the respondent is not available to answer 
questions, it is recommended that the missing items be scored as if the "neutral" response 
option was selected. If more than 3 responses are missing on any particular facet scale, the 
developers recommend that scale be interpreted with caution. The NEO-PI-R contains six 
validity checks: honesty and accuracy, completeness, acquiescence, nay-saying, and random 
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responding. Following the manual recommendations, T scores above 55 were considered 
high, and scores below 45 were considered low. 
For purposes of this investigation, the computer scoring software, purchased with the 
inventory, was utilized to provide the therapists with a standardized feedback report on their 
client's results. Standardized feedback was provided, when applicable (Phase 3), in two 
formats: a client summary (a brief summarization of the respondent's profile with regard to 
the five factors) and an interpretive report (a comprehensive report that details factor and 
facet scores and provides a clinical hypotheses section which lists possible DSM-IV-TR Axis 
II disorders the client may be experiencing). It should be noted that the NEO-PI-R 
interpretive report only listed PDs for which the participant scored 90% or higher than the 
nonnative sample. 
Structured Clinical Interview for DSM-IV Axis II Disorders Self'Report 
Questionnaire (SCID-II-SR; First et al., 1997). The SCID-II-SR is a 119-item questionnaire 
(see Appendix X, pages 157-162).ltems are answered in a yes/no format. The SCID-II-SR 
was developed as a screening questionnaire for the clinician-administered Structured Clinical 
Interview for DSM-IV Axis II Disorders. The questionnaire is scored for the number of 
endorsed criteria for each personality disorder. It is recommended that a follow-up interview 
be conducted to verify the presence of any disorder for which a minimum number of criteria 
were endorsed on the questionnaire. For the purposes this investigation, a follow-up 
interview was not conducted, and the questionnaire was modified to included an additional 
21 items associated with Antisocial Personality Disorder. 
Reliability and Validity. The developers direct users to the research literature that 
established reliability and validity for the DSM-III-R version of the SCID-!1-SR (e.g., 
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Ekselius, Lindstrom, von Knorring, Bodlund, & Kullgren, 1994). Currently, there is a paucity 
of reliability or validity data for the self-report version of the SCID-II, DSM-!V version; and 
no reliability or validity data have been obtained for the modified version utilized in this 
investigation. 
Outcome Questionnaire 45 (OQ 45.2; Lambert, Hansen, Umpress, et al., 2001). The 
OQ 45.2 is a 45 item self-report inventory that measures client progress in therapy. It is 
designed to be repeatedly administered during the course of treatment, in addition to being 
used as a baseline-screening instrument to aid with treatment decisions. The developers 
stress that it was not designed for client diagnosis. The questimmaire has tlu·ee subscales: 
symptom distress, interpersonal relationships, and social role performance. The utilization 
advantages of the OQ 45.2 include low cost, sensitivity to change over short periods of time, 
and brevity, while maintaining high levels of reliability and validity. 
Reliability. In university student and employee assistant program samples (Lambert, 
Hansen, Umpress, eta!., 2001), internal consistencies (coefficient alpha) for the subscales 
ranged from .70 to .92; the total scale score had coefficient alphas of. 93 for both samples. 
Test-retest reliability scores ranged fi·om .78 to .82 for the subscales and .84 for the total 
score, with the college sample. 
Validity. Constrnct validity coefficients were computed using scores from the 
Symptom Checklist 90 Revised Global Severity Index subscale score (SCL-90-R; Derogatis, 
1977), Inventory of Interpersonal Problems total scale score (liP; Horowitz, Rosenberg, 
Baer, Urena, & Villasenor, 1988), and Social Adjush11ent Scale total scale score (SAS; 
Weissman & Bothwell, 1976), and ranged fi·om .45 to .92. 
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Scoring. Scale items are totaled to yield 4 scores: Total Scale (all items), Symptom 
Distress (25 items), Interpersonal Relationship (II items), and Social Roles (9 items). If an 
item is left blank, the subscale mean item score is inserted for that item. Total Scale scores 
above 63 are considered in the clinical range. Total Scale scores that are originally above 63 
and decrease by 14 points are indicative of clinically significant change. 
Summary. In this phase of the investigation, clients were recruited from each of the 
previously-listed participating clinics. If they met inclusion criteria, they were asked to 
complete the pre-therapy questionnaire battery consisting of four measures: demographics 
form, NEO-PI-R, SCID-II-SR, and OQ 45.2. All the infonnation collected in this phase was 
utilized in the data base for Study I; portions of this information provided data for Study 2. 
Phase 3: Treatment Outcome 
Participant recruitment. Clients who completed the pre-treatment questionnaire 
battery before the second session of therapy and were assigned to practicum therapists at the 
respective clinics were included in this phase of the investigation. Thus client exclusion 
criteria for this phase included: 
• Inability to complete the questionnaire battery before the second therapy session. 
• Receiving treatment from a non-practicum therapist. 
Protocol. The study protocol for this phase of the project is described below. 
Study design and experimental condition assignment. A quasi-experimental design 
was utilized in this phase. Upon completion of the pre-treatment questionnaire battery, the 
participants were randomly assigned to treatment condition via a random numbers table. An 
exception to the random assignment protocol was made if the therapist's supervisor declined 
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to participate in the study; clients in this situation were automatically assigned to the control 
group. 
In the experimental condition, the therapist and the therapist's supervisor received a 
narrative report of the NEO-PI-R results (TR); in the control condition, the therapist did not 
have access to the NEO-PI-R results (NR). For participants in the experimental condition, 
copies of the NEO-PI-R results and narrative reports were placed in a sealed envelopes and 
deposited in the therapist's and supervisor's mailbox at the respective clinic before the 
participant's second therapy appointment. Note: Participating clients, therapists, and 
supervisors were told orally, and in writing via the informed consent, that the NEO-PI-R 
results would be available for control-condition clients after their sixth session of therapy, if 
requested. 
Study protocol during treatment. During the course of treatment, all participants 
completed the OQ 45.2 just prior to each session, as part of the routine clinical procedure 
(see Table 1, p. 65, for a time table). At the EMU PC, therapists entered the OQ 45.2 data 
into a computer scoring program and received a cumulative t,>raphic representation of the 
participant's progress. For clients participating in treatment at CAPS, OQ45.2 fonns were 
regularly collected by a research assistant, scored, graphed, and returned to the clinic for 
distribution to the therapist before the next therapy session with the respective client. 
Regarding review of the OQ 45.2 results with the client, therapists were highly encouraged, 
as part of the clinic procedure, to review the OQ 45.2 at the beginning of the session with a 
client and to attend to critical items (e.g., suicide ideation, drug use, etc.) during the session. 
Just prior to the fourth scheduled appointment, a W AI-S was provided for completion 
by both the therapist and the client (see the Working Alliance Inventory section below for 
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description of the WAI-S). Therapists were given the therapist version (WAI-S-T), while 
client-participants were provided the client version (W AI-S-C). 
At the time of each client's sixth session, therapists were asked to complete the 
Therapist Questimmaire (E or C form as appropriate). In addition, supervisors of the 
therapists, if participating in the study, were asked to complete a Supervisor Questionnaire. 
Post treatment study protocol. The project protocol included a follow-up to he 
conducted three months after the participant's last therapy session or upon termination of the 
study. Participants were asked, via mail, to complete a follow-up questionnaire battery 
consisting of the SCID-II-SR and the OQ 45.2. A cover letter was included in the mailing, 
explaining the compensation procedure for completion of battery (see Appendix V, page 
155). Participants who returned the completed questionnaires, in the provided stamped, 
addressed envelope, received a $10 compensation for their effort upon receipt at the EMU 
Psychology Clinic of the completed questionnaires. 
Measures. Additional measures for this phase of the project arc listed below. 
Working Alliance Inventory- therapist and client versions (WAf; Horvath & 
Greenberg, 1989). The Working Alliance Inventory is a 36-item, 3-subscale measure of the 
therapist-client alliance. It has two versions: client and therapist. Numerous empirical studies 
have shown the W AI scores to be predictive of psychotherapy outcome (e.g., Constantino, 
Castonguay, & Schut, 2002; Martin, Garske, & Davis, 2000). An abbreviated version of the 
WAI (12-items, WAI-S; see Appendices D and E, pages 129 and 130) was developed by 
Tracey and Kokotovic ( 1989) using confirmatory factor analysis. The original three subscales 
(Goal- extent to which therapy goals are mutual, important, and capable of being 
accomplished; Task--- agreement about steps taken to improve the presenting problem; and 
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Bond - measures empathy, mutual attachment, and comfort exploring intimate issues) were 
preserved; however, the number of items for each was reduced from 12 to 4, with each of the 
4 items being the highest that loaded on their respective factors. 
The Working Alliance Inventory long (WAI) and short (WAI-S) versions have 
comparable internal consistencies (.95 long, .91 sho1i), predictive validity (e.g., for 
improvement: client long version had a .36 correlation coefficient, client short version .34), 
and subscale intercorrelations (Busseri & Tyler, 2003). Therefore, for the purposes of this 
investigation, theW AI-S was utilized. 
Reliability. Based on an initial validation sample (Tracey & Kokotovic, 1989), total 
score internal consistency reliability coefficient estimates were .98 (client version) and .95 
(therapist version). For the three subscalc scores, internal consistency estimates ranged from 
.90 to .92 for the client version and .83 to .91 for the therapist version. 
Validity. Validity for the short version of the WAI was established with signitlcant 
correlations between W Al-S ratings and client characteristics (Kokotovic & Tracey, 1990). 
Scoring. Each subscale is scored on a 7 -point Likert response format ranging from l 
(never) to 7 (always). Subscale scores can range from 4 to 18 and can be summed for a total 
score. Higher scores reflect more positive ratings of the alliance. 
Therapist Questionnaire- E Form. A therapist questionnaire (see Appendix H, page 
133) was developed for this investigation to assess the therapists' perceptions regarding the 
usefulness of the NEO-Pl-R narrative report in the development of their case formulations. 
The questionnaire consists of one 11-point Likert format response item and eight open-ended 
response format questions. This particular questionnaire was given only to therapists whose 
clients were in the experimental condition (TR). 
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Therapist Questionnaire- C Form. A therapist questionnaire (see Appendix I, page 
134), was developed for this investigation to assess whether or not the NEO-PI-R training 
influenced therapists' case fonnulations for clients in the control condition (NR). This 
questionnaire consisted of one !!-point Likert format response item and three open-ended 
response format questions. 
Supervisor Questionnaire. A supervisor questionnaire (see Appendix J, page 135) 
was developed for this investigation to assess whether or not the NEO-PI-R training 
influenced supervisors' case fommlations and assessment recommendations for their 
supervisees' clients. This questionnaire consisted of one !!-point Likert fonnat response item 
and four open-ended response fonnat questions. 
Summary. In this phase of the investigation, eligible participating clients were asked 
to complete six pre-session OQ45.2 questionnaires and a WAI-S Client Version 
questionnaire before the fourth session of therapy. Participating practicum therapists were 
asked to complete a W AI-S Therapist Version questionnaire and a post sixth-session 
questionnaire. Participating supervisors were also asked to complete a post sixth-session 
questionnaire. (Please see the Table 1, p. 65, for a timeline depiction of data collection for the 
project.) Data collected in this phase of the investigation were combined with portions of the 
data collected in phase I (demographics, NEO-PI-R, and OQ45.2 data) for analysis purposes. 
Human Subjects Approval 
Human subjects approval was obtained for all modifications and time extensions 
associated with this study. Please see appendices Y through AC, pages 163-167. 
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Table 1 
Assessment Timeline 
Measure Time of Assessment' 1 
Pre- lst 2nu 3"' 
Tx Session Session Session 
SCID-II PQ c 
NEO-PI-R c 
NEO 
Narrative T Report to 
Therapist 
Working 
Alliance 
Inventory 
Therapist 
Demographics T 
Questionnaire 
Post 
Treatment 
Questionnaire 
OQ45.2 c c c c 
a Data w1ll be collected before the start of the sesswn 
b Data will be collected 3 months after treatment ends 
C = Client; T =Therapist; S = Supervisor 
4th 5" 6'" - --Post-
Session Session Session Txb 
c 
T&C 
I 
T&S 
I 
c c c c 
Results 
Phase 1: Therapist and Supervisor Recruitment 
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Seventeen therapists and four supervisors participated in the NEO-PI-R workshop and 
completed workshop questionnaires. A year later, when the CAPS administration agreed to 
participate in the study, an abridged version of the workshop was offered during a staff 
meeting at that facility; six therapists and three supervisors participated, with only the 
therapists completing questionnaires. 
Responses for the questionnaire items, as reported by therapists from each clinic and 
EMU Psychology Clinic supervisors, are listed in Table 2 below. Yes/No responses are 
reported in proportions. Eleven-point Likert scale responses (from 0 for "no confidence," 
"not useful," or "no expertise" ratings to I 0 for "extremely confident," "extremely useful," or 
"expert" ratings) are reported in averages (mean scores). 
Aggregated results indicated therapists averaged 1 year of clinical experience, while 
supervisors averaged 19.75 years. Responses on the questionnaire administered before the 
workshop indicated therapists felt they possessed little or no NEO-Pl-R expertise (M ~' 0.65), 
while supervisors felt they possessed a moderate level ofNEO-PI-R expertise (M = 4.75). 
Responses on the questionnaire administered following the workshop revealed supervisors 
felt confident about giving clients feedback regarding NEO-PI-R results (M = 8.0), while 
therapists reported feeling moderately confident (M = 6.27). Both groups reported similar 
confidence levels regarding perceived clinical utility of the NEO-PI-R (M = 6.75 for 
supervisors; M = 6.5 for therapists). 
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Table 2 
Workshop Questionnaire Results 
Question EMU PC Supervisors EMU PC Therapists CAPS Therapists N=4 N= 17 N=6 
Years of clinical M=I9.75(SD=7.2) M= 0.88 (SD = 0.99) M= 1.33 (SD=0.86) 
ex enence 
Expertise with M = 8.25 (SD = 2.2) M= 3.59 (SD = 2.24) M= 3.5 (SD = 2.7) 
assessment feedback 
Expertise with NEO- M = 4.75 (SD = 3.7) M= 0.29 (SD = 0.77) M = 1.67 (SD = 1.97) PI-R 
Expertise using 
NEO-Pl-R with M = 4.25 (SD = 3.8) M=0.18(SD=0.73) M = 1.0 (SD = 1.27) 
clinical rormlation 
Usefulness of M= 9.0 (SD = .81) M = 7.82 (SD = 2.79) M= 6.4 (SD= 3.36) 
workshOJ:l material 
·----
Received enough 
information about Yes= 100% Yes= 64% (n = 14) Yes=83%(n=5) 
NEO-PI-R 
Confidence giving 
feedback on NEO- M = 8.0 (SD = 2.5) M = 6.06 (SD =! .85) M= 7.0 (SD = 123) 
Pl-R results 
------
ConJidence about 
clinical utility of M= 6.75 (SD = 3.4) M = 6.53 (SD = 1.80) M= 6.4 (SD= 3.13) 
NEO-P1-R results 
Enough to Yes= 100% Yes= 100% Yes= 83% (n = 5) discuss issues 
Therapists and supervisors who did not attend one of the two workshops, due to the 
timing of the start of practica or supervision, were provided workshop materials and, if 
requested, given an overview of the workshop. These therapists and supervisors were not 
asked to complete workshop-related questionnaires. 
Phase 2: Client Recruitment and Baseline Assessment 
Over 250 individuals seeking therapy services at the two university-based clinics 
were contacted to participate in the study. Of those who responded (n = 78), 77 completed 
the baseline assessment battery; one respondent was excluded due to cognitive impainnent 
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and subsequent inability to complete the questionnaire battery. In addition, one of the 
batteries (1 .3%) was not included in the analyses due to sizeable amounts of missing data 
(the battery had a page of missing data in the SCID-II-SR questionnaire). For batteries that 
had incomplete item responses, the items were addressed according to the guidelines listed in 
the respective questionnaire scoring manual. 
Demographic data. The 76 therapy clients included in the final analyses for this 
phase of the study were primarily Caucasian, single, and enrolled in university classes. The 
mean age was 28 years, with 36.8% of participating clients being male and 63.2% being 
female. Demographic data are presented in Table 3. SCID-11-SR responses indicated an 
average of3.05 (SD = 1.99) PDs per client for this population (range 0 to 7), with 7 clients 
not meeting screening criteria for a PD, whereas, the NEO-PI-R responses indicated an 
average of2.28 (SD = 1.82) PDs per client (range 0 to 7), with 16 clients not meeting 
screening criteria for a PD5 
Hypothesis testing. The following are the results associated with hypotheses linked 
to the Phase 2 ofthe study. 
Hypothesis 1. Hypothesis 1 stated that replication analyses to determine the 
symptom-to-disorder diagnostic validity of the DSM-IV-TR personality disorder cliteria in 
terms of(a) convergent validity, (b) divergent validity, and (c) association with the Five 
Factor Model personality traits would yield results similar to those of Ryder, Costa Jr., and 
Bagby (2007). Boot-strapping analyses, a nonparametric technique for setting approximate 
5 As mentioned in the introduction, the NEO-PI-R and the SCID-11-SR arc only screening instruments for 
personality disorder symptomology and diagnosis. Any personality disorder identified by these instruments 
should be, at the very ieast, verified with a therapist follow-up interview before being given as an official 
diagnosis. 
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confidence intervals for a calculated value, were conducted to determine if the proportion of 
SCID-11-SR symptoms that met a pre-determined correlation-coefficient standard for an 
Table 3 
Demographic Characteristics of Phase 2 Participating Clients 
Variable Mean and (SD; Mode) 
or Proportions 
-~~-----------------::--c--:::-::--:-:c::----:-c:-:---::-:c--· 
Age M=28(SD=I0.1;23) 
Gender - Male 36.8% (n = 28) 
Years of College 
0 
I 
2 
3 
4 or more 
Marital Status 
Married/Live with Partner 
Single/Separated/Divorced 
Widowed/Other 
Ethnicity 
European-American 
Black or African-American 
Other 
Employment 
Employed 
Unemployed 
Student' 
Income 
> 150k 
50k-150k 
I Ok-50k 
< IOk 
Don't Know/Missing 
18.4% (n = 14) 
6.6% (n = 5) 
15.8% (n = 12) 
18.4% (n = 14) 
39.4% (n = 30) 
27.6%(n=21) 
68.4% (n = 52) 
4.0% (n = 3) 
65.8% (n = 50) 
7.9% (n = 6) 
26.3% (n = 9) 
30.3% (n = 23) 
26.3% (n = 20) 
43.4% (n = 33) 
3.9% (n = 3) 
11.8% (n = 9) 
31.6% (n = 24) 
28.9% (n = 22) 
23.7% (n = 18) 
Range 
18 to 59 
-~~--~---~··:----~----=-:--------=----:--:----::--:--~··-~·---· 
"It should be noted that if a participant was a student and checked more than one employment 
option, "student" was entered as the primary option for this question. 
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identified criterion (criteria listed below) in this study was significantly different from the 
proportion obtained by Ryder and colleagues. 
Criterion I. The first criterion analyzed determined whether or not a DSM-IV-TR 
symptom of a PD was coherent within that particular disorder (convergent validity). This was 
determined by correlating the symptom score with the total score of the remaining symptoms 
in that particular disorder (i.e., the corrected item-total r). Ryder and colleagues utilized 
correlation coefficients 2": .20 as indication of coherence based on recommendations made by 
Nunnally and Bemstein (1994, as cited in Ryder et al., 2007, p. 629). Results from this study 
are listed in Table 4 below. The first two columns in the table indicate the propmiion of 
symptoms for the pmiicular disorder that met the .20 or above correlation coefficient cutoff 
for each respective study. The third column is the estimated bootstrap 95% confidence 
interval for the present study, calculated by taking 500 (of76 from ann of76, with 
replacement) samples from the present study data set and eliminating the extreme 2.5% from 
each end of the value range. The fourth column indicates whether or not the Ryder and 
colleagues' proportion is significantly different from this study's estimated confidence 
interval values (i.e., if the Ryder and colleagues value is not contained within the confidence 
interval, their value is significantly different fi"om the value obtained in this study). 
Ryder et al. (2007) reported that 70.6% (approximately 74 of I 04) of the SCID-!1-SR 
symptoms met the standard for item-corrected correlation coefficients with their own PD of 
0.20 or higher. Results from this study indicated that 69.2% (72 of 104) of the symptoms 
met the standard. A chi-square analysis of the results from these studies is nonsignificant 
[x2(1, N = 1 04) = 0.092, p = 0. 76]. Thus, this replication analysis corroborated Ryder and 
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colleagues' results, namely that most of the PD traits were found to be related to their parent 
disorder, thereby supporting the generalizability of this contention. 
Table 4 
Criterion 1: PD Symptom Convergent Validity 
Personality Disorder Ryder & Present 95% Confidence Significantly 
(number of items) Colleagues Study Interval Different? 
Antisocial (15) 0.730 (II) 0.867 (13) (0.67, 1.00) No 
Avoidant (7) 0.571 (4) 1.000 (7) (0.86, 1.00) Yes 
Borderline (15) 0.800 (12) 0.533 (8) (0.27, 0.87) No 
Dependent (8) 0.625 (5) 0.500 (4) (0.00, 0.75) No 
Histrionic (7) 0.429 (3) 0.857 (6) (0.428, 0.86) No 
Narcissistic (17) 0.649 (II) 0.588 (1 0) (0.29, 0.71) No 
Obsessive-Compulsive (9) 1.000 (9) 0.143 (1) (0.00, 0.71) Yes 
Paranoid (8) 0.625 (5) 1.000 (8) (0.00, 0.71) No 
Schizoid (7) 1.000 (7) 0.714 (5) (0.29, 0.86) Yes 
Schizotypal (11) 0.636 (7) 0.909 (1 0) (0.55, 1.00) No 
The most notable difference between the two analyses is the proportion of obsessive-
compulsive symptoms that correlated with the parent PD; all of the symptoms in the Ryder 
and colleague sample met the criterion, while only one item in the present sample met this 
criterion. In addition, the Ryder and colleagues' sample had two PDs (histrionic and 
avoidant) evidencing less than 60% of the items meeting the correlation criterion for 
significance, while this study had three (borderline, narcissistic, and obsessive-compulsive). 
Significant differences between study results were evident for three PDs (i.e., avoidant, 
obsessive-compulsive, and schizoid); namely, the Ryder and colleagues' values for these PDs 
were outside the confidence interval range calculated with this study's data. 
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Criterion II. The second criterion analyzed detennined whether or not a DSM-IV-TR 
PD symptom of a disorder was distinctive relative to other disorders (divergent validity). 
This was determined by comparing the corrected item-total correlation value calculated in 
Criterion I with the correlation between the symptom and other PD total symptom scores. 
"Symptoms correlating more highly (absolute value) with their own PD as compared with 
other PDs were considered sufficiently discriminating" (Ryder et al., 2007, p. 629). Results 
are listed in Table 5 below. Again, the first two columns in the table indicate the proportion 
of symptoms for the particular disorder that met the above correlation requirement for each 
respective study. The third column is the estimated bootstrap confidence interval for the 
present study proportions, calculated by taking 500 (of76 from ann of76, with replacement) 
samples from the present study data set. The fourth column indicates whether or not the 
Ryder and colleagues' proportion is significantly different from this study's estimated 
confidence interval values (i.e., if the Ryder and colleagues' value is not contained within the 
confidence interval, their value is significantly different from the value obtained in this 
study). 
Ryder et al. (2007) reported that 53.2% (approximately 54 of 104) of the SCID-1!-SR 
symptoms met the standard for item-corrected correlation coet1icients, with their own PD 
being higher than the symptom correlation coefficient with other PDs. Results fTOm this 
study indicated that 33.6% (35 of 104) of the symptoms met the standard. A chi-square 
analysis of the results from these studies is significant [x2(1, N = I 04) = 7.09, p = 0.008]. 
Although the chi-square is significant, because fewer of the symptoms in this study 
correlated more highly with their own PD than with other PDs, these results corroborate the 
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results of the Ryder et al. study with regard to the lack of divergent validity for PD 
symptoms. 
Table 5 
Criterion II: PD Symptom Divergent Validity 
Personality Disorder Ryder & Present 95% Confidence Significantly 
(number of items) Colleagues Study Interval Different? 
Antisocial ( 15) 0.600 (9) 0.533 (8) (0.33, 0.67) No 
Avoidant (7) 0.571 (4) 0.857 (6) (0.29, 1 .00) No 
Borderline ( 15) 0.467 (7) 0.133(2) (0.00, 0.28) Yes 
Dependent (8) 0.500 (4) 0.125(1) (0.00, 0.38) Yes 
Histrionic (7) 0.286 (2) 0.571 (7) (0.00, 0.71) No 
Narcissistic (17) 0.355 (6) 0.176 (3) (0.00, 0.29) Yes 
Obsessive-Compulsive (9) 1.000 (9) 0.000 (0) All estimates were 0 NA 
Paranoid (8) 0.375 (3) 0.500 (4) (0.00, 0.75) No 
Schizoid (7) 0.714 (5) 0.286 (2) (0.00, 0.43) Yes 
Schizo typal (11) 0.454 (5) 0.182 (2) (0.00, 0.27) Yes 
Again, the most notable difference between the two analyses was the number of 
obsessive-compulsive symptoms meeting the criterion; all of the symptoms in the Ryder and 
colleague sample met the criterion, while none of the items in the present sample met this 
criterion. Also, Ryder et al. reported that two PDs (obsessive-compulsive and schizoid) 
showed divergent validity for more than 60% of the constituent items, while only one PD in 
this study (avoidant) showed a similar level of divergent validity for its constituent items. 
Similar to Criterion I, significant differences between study results were evident for a number 
of PDs for this criterion (borderline, dependent, narcissistic, schizoid, and schizotypal). 
Criterion III. The third criterion analyzed determined the relation of each DSM-IV-
TR PD symptom to one or more personality dimensions of the Five Factor Model as 
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measured by the NEO-PI-R (relation to general personality traits). This was detennined by 
correlating each PD symptom with each of the 30 facets of the NEO-Pl-R. "Symptoms that 
correlated significantly [Bonferroni corrected (.05/30; p < .002)] with one or more facets 
were considered adequately related to the universe of general personality traits" (Ryder eta!., 
2007, p. 630). Results are listed in Table 6 below. Again, the first two columns in the table 
indicate the proportion of symptoms for the particular disorder that met the above correlation 
requirement for each respective study. The third column is the estimated bootstrap 
confidence interval for the present study proportions, calculated by taking 500 (of 76 from an 
n of76, with replacement) samples from the present study data set. The fomih column 
indicates whether or not the Ryder and colleagues' proportion is significantly different from 
the confidence interval values. 
Table 6 
Criterion III: Proportion of PD Symptoms Related to NEO-PI-R Personality Traits 
Personality Disorder Ryder & Present 95% Confidence Significantly 
(number of items) Colleagues Study Interval Different? 
Antisocial (15) 0.467 (7) 0.000 (0) (0.13, 0.87) No 
Avoidant (7) 0.857 (6) 1.000 (7) (0.857, 1.00) No 
Borderline ( 15) 0.800 (12) 0.600 (9) (0.67, 1.00) No 
Dependent (8) 0.625 (5) 0.375 (3) (0.38, 1.00) No 
Histrionic (7) 0.857 (6) 0.286 (2) (0.28, 1.00) No 
Narcissistic (17) 0.706 (12) 0.176 (3) (0.35, 0.88) No 
Obsessive-Compulsive (9) 0.444 ( 4) 0.429(4) (0.428, 1.00) No 
Paranoid (8) 0.500 (4) 0.750 (6) (0.63, 1.00) Yes 
Schizoid (7) 0.286 (2) 0.571 (4) (0.43, 1.00) Yes 
Schizo typal ( ll) 0.182 (2) 0.273 (3) (0.182, 0.91) No 
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Ryder et al. reported that 57.2% (60 of 1 04) of the SCID-II symptoms met the 
standard of correlating at a significance level ofless than .002 with NEO-PI-R facets. 
Conversely, results from this study's sample indicated that only 39.4% ( 41 of 1 04) of the PD 
symptoms were significantly related at the p < .002level. Chi-Square analysis of this 
difference in total symptoms reaching correlational significance is significant [l(l, N= 104) 
= 6.95,p = .008]. Thus, this analysis would not support the generalizability of Ryder and 
colleagues' results. 
It is noteworthy that, for the Ryder et al. (2007) results, 5 of the PDs (antisocial, 
obsessive-compulsive, paranoid, schizoid, schizotypal) had fewer than 60% of the symptoms 
associated with NEO-Pl-R facets, whereas, for this study, 7 of the PDs had fewer than 60% 
of the symptoms evidencing an association. However, it should be acknowledged that a 
significance level less than .002 is very conservative. Moreover, the Ryder and colleague 
sample size was 203, suggesting a moderate correlation would be significant, whereas this 
study sample size was 76, suggesting a strong conelation was needed for significance. 
Hypothesis 2. Hypothesis 2 stated that ratings of functional impainnent, as measured 
by the OQ 45.2, would be more strongly associated with impairment as measured by the 
SCID-Il-SR than the Global Assessment of Functioning (GAF) scores utilized in the Ryder 
and colleagues' analyses (their Criterion IV). Boot-strapping analyses were again conducted 
to detennine if the proportions ofSCID-Il-SR symptoms per PD that significantly correlated 
with OQ45.2 total symptom scores were significantly different from the proportions obtained 
by Ryder and colleagues utilizing GAF scores. Results are listed in Table 7 below. Again, the 
first two columns in the table indicate the propmiion of symptoms for the particular disorder 
that met the above correlation requirement for each respective study. The third column is the 
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estimated bootstrap confidence interval for the present study proportions, calculated by 
taking 500 (of76 from ann of76, with replacement) samples from the present study data set. 
The fourth column indicates whether or not the Ryder and colleagues' proportion is 
significantly different from the confidence interval values. 
Table 7 
Criterion IV: Proportion ofPD Symptoms Significantly Correlated with Functional 
Impairment Scores 
Personality Disorder Ryder & Present 95% Confidence Significantly 
(number of items) Colleagues Study Interval Different? 
Antisocial (15) 0.133 (2) 0.067 (1) (0.00, 0.33) No 
Avoidant (7) 0.286 (2) 1.000 (7) (0.57, 1.00) Yes 
Borderline ( 15) 0.600 (9) 0.800 (12) (0.40, 0.93) No 
Dependent (8) 0.125 (1) 0.250 (2) (0.125, 0.62) No 
Histrionic (7) 0.000 (0) 0.000 (0) (0.00, 0.43) No 
Narcissistic ( 1 7) 0.118(2) 0.176(3) (0.06, 0.41) No 
Obsessive-Compulsive (9) 0.000 (0) 0.288 (3) (0.14, 0.57) Yes 
Paranoid (8) 0.125 (1) 0.875 (7) (0.38, 0.88) Yes 
Schizoid (7) 0.429 (3) 0.143 (!) (0.14, 0.86) No 
Schizotypal (11) 0.364 (4) 0.273 (3) (0.09, 0.55) No 
-··----------~~·--·---·-~·------
Ryder et al. reported that 21.8% of the SCID-!1-SR symptoms met the correlation 
significance standard set for GAF measures of fi.mctional impairment. This proportion does 
not appear to accurately reflect what would be expected for their estimated number of 
symptoms (25 of 104, calculated 24%); the proportion difference (21.8% vs. 24%) equates to 
approximately 2-3 items. However, the Ryder and colleagues' item total as reported here 
matches the item total listed in the appendix of their article, suggesting that the reported 
proportion is incorrect. 
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Notably, 37.5% (39 of 104) of the SCID-II-SR symptoms endorsed in this study 
significantly correlated with OQ45.2 measures offunctional impairment, suggesting a 
stronger association as hypothesized. A Chi-square analysis for this difference was 
significant, x2(1, N= 104) = 4.42,p = .035, supporting this contention. 
Summary Phase 2 hypotheses results. In summary, Hypothesis I was partially 
supported in this analysis as evidenced by a (a) nonsignificant chi-square for Criterion I, (b) 
fewer symptoms in this study correlating more highly with their own PD as opposed to other 
PDs for critelion II, and (c) II out of20 bootstrap analyses being nonsignificant for these 
two Criteria. However, Cliterion III did not yield results suggestive of support for an 
association between PD symptoms and NEO-PI-R facets. Thus, replication analyses of the 
symptom-to-disorder diagnostic validity of the DSM-IV-TR personality disorder criteria! 
traits in terms of (a) convergent validity and (b) divergent validity yielded similar results to 
those of Ryder, Costa Jr., and Bagby (2007), supporting the generalizability of those results. 
However, a significant correlational association between NEO-PI-R facets and PD 
symptomology was not evidenced, thereby not supporting the contention that Criterion III 
would yield results reflective of the Ryder and colleagues' results. 
In addition, Hypothesis 2 was supported. There was a significant chi-square 
difference between the number ofPD symptoms, as measured by the SCID-li-SR inventory, 
correlating with the OQ45.2 total symptom score, as opposed to GAP ratings. 
Phase 2 exploratory analysis. The computer scoring program for the NEO-PI-R 
produced a comprehensive interpretive report (Costa Jr., McCrae, & PAR Staff, 2000) for 
eaeh participant; this report, as mentioned previously, listed potential PDs based on responses 
scoling 90% or higher than the normative sample. Some researchers (e.g., Samuel & 
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Widiger, 2008; Saulsman & Page, 2003) contend that "all ofDSM-IV-TR personality 
disorder symptomatology are readily understood as maladaptive variants of the domains and 
facets of the FFM" (Widiger & Mullins-Stewatt, 2009, p. 199). In addition, as mentioned 
previously, Huprich (2003) stated that facets hypothesized to be associated with a given PD 
predicted variance in seven of the ten PDs. 
To explore the diagnostic agreement between the SCID-11-SR and the NEO-PI-R PD 
screening assessments for this population sample, a kappa statistical analysis was perfom1ed. 
For a detailed description of the calculation of these Kappa values, the reader is referred to 
Viera and Garrett (2005). Results are listed in Table 8 below. 
Table 8 
Comparison of Potential PDs Identified by the NEO-PI-R and SCID-11-SR 
Personality Disorder PDs Identified Kappa Level of 
(PD) NEO-Pl-R SCID-ll-SR by both Coefficient Agreement a 
Antisocial 13 39 6 -0.009 Less than chance 
Avoidant 21 33 17 0.441 Moderate 
,. 
Borderline 37 45 30 0.424 Moderate i 
Dependent 37 5 4 0.084 Slight 
Histrionic 19 2 2 0.150 Slight "!" 
Narcissistic 12 18 7 0.342 Fair 1. 
Obsessive-Compulsive 6 38 5 0.105 Slight 
Paranoid 4 29 3 0.098 Slight 
Schizoid 0 18 0 NA* 
Schizo typal 26 8 3 0.018 Slight 
t indicates a kappa analysis identified approxmiate significance< .05 
'Based on table provided by Landis & Koch (1977) as cited in Viera & Garrett (2005) 
* Kappa value could not be computed; no identified disorders for one of the inventories 
These results were only slightly analogous to those reported in a meta-analysis 
conducted by Samuel and Widiger (2008). Based on effect sizes, these authors declared that a 
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strong confirmation was found to support the FFM conceptualization of the DSM-IV-TR 
personality disorders for borderline, antisocial, and avoidant disorders; the results from this 
analysis would support two of those three assertions (avoidant and borderline). They also 
reported significant correlations for the remainder of the PDs, with the weakest results being 
attributed to histrionic PD; only two of the remaining PDs in this analysis yielded an 
approximate significant agreement (histrionic and narcissistic) 6 
Phase 3: Treatment Outcome 
Originally, the study design for this phase of the project stipulated 36 pmiicipants 
resulting from six therapists treating six clients through six sessions of therapy, so that 
therapist variability could be addressed in statistical data analyses. As mentioned previously, 
various uncontrollable factors prevented the timely implementation of this design. At the 
time of the project termination, 27 participants had completed 6 sessions of therapy. 
However, in an effort to minimize therapist variability in the data, the participant pool for the 
hypotheses' analyses of this phase of the project was limited to one client per therapist, 
resulting in a data set of 18 subjects. Since six therapists had treated more than one 
pmiicipant in this phase of the study, it was detennined that each therapist's first client, 
whom had completed all the study paperwork requirements, would be the client included in 
this subject set. 
With regard to random assignment to condition, there were 6 clients in the group of 
27 6-session eompleters and 4 clients in the final group of 18 pmiicipants that defaulted to 
the control condition. Default to the control group condition occurred when the therapist or 
supervisor was not assigned at the time of the battery administration and, upon assignment, it 
was discovered that the therapist or supervisor opted not to pmiicipate in the study. 
6Significance is listed in the SPSS kappa output as "approximate significance." 
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Demographic data. The demographic data for participating clients and therapists are 
described below. 
Table 9 
Demographic Characteristics of Phase 3 Client Participants 
Variable Mean and (SD) or Proportions 
N=27 N= I8 N=9 
----~----·--~~-
Age M=30.I (SD=I 1.6) M=30.6 (SD=I2.3) M=29.I(SD=I0.6) 
Gender- Male 37.0% (n = IO) 44.4% (n = 8) 22.2% (n = 2) 
Years of College 
0 22.2% (n = 6) 27.8% (n = 5) Il.1%(n=I) 
I 7.4% (n = 2) 5.6%(n=I) I 1.1% (n =I) 
2 I4.8% (n=4) I6.7%(n=3) II.I%(n= 1) 
3 l 1.2% (n = 3) I 1.1% (n = 2) II.1%(n=I) 
4 or more 44.4% (n = I2) 38.8% (n = 7) 55.6% (n = 5) 
Marital Status 
Married/Live with Pminer I8.5% (n = 5) 11.1% (n = 2) 33.3% (n = 3) 
Single/Separated/Divorced 74.0% (n = 20) 77.8%(n=l4) 66.7% (n = 6) 
Widowed/Other 7.5% (n = 2) 11.1% (n = 2) 
Ethnicity 
Europcm1-American 74.1% (n = 20) 77.8% (n = I4) 66.7% (n = 6) 
Black or African-American 3.7% (n -" 1) 5.6% (n = I) ll.l%(n=I) 
Other I 8.5% (n = 5) 16.7% (n = 3) II.I%(n=I) 
Employment 
Employed 29.6% (n = 8) 33.3% (n = 6) 22.2% (n = 2) 
Unemployed 26.0% (n = 7) 27.8% (n = 5) 22.2% (n = 2) 
Student 44.4% (n = 12) 38.9% (n = 7) 55.6% (n = 5) 
Income 
> I50k 3.7%(n=l) 5.6% (n =I) 
50k-150k 7.4% (n = 2) 5.6% (n = I) I1.1%(n=I) 
I Ok-50k 29.6% (n = 8) 33.2% (n = 6) 22.3% (n = 2) 
< 10k 29.7% (n = 8) 27.8% (n = 5) 33.3% (n = 3) 
Don't Know/Missing 29.6% (n = 8) 27.8% (n = 5) 33.3% (n = 3) 
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Participating clients' demographic data. Demographic data are presented in Table 9 
(above); data for all those completing this phase (n = 27), for those utilized in the hypotheses 
analyses 
(n = 18), and for those eliminated from the final hypotheses analyses (n = 9) are listed in the 
table. For this phase, the participants were primarily Euro-American, single, educated, and of 
low socioeconomic status. Chi-square analyses to identify potential demographic ditierences 
between the groups of those included and deleted from the final analyses were nonsignificant 
for all variables; likewise, comparison of participants in this phase of the study (n = 18) with 
the participants completing only phase I (n =58) yielded nonsignificant chi-squares for all 
demographic variables. 
Participating clients' personality assessment results. The NEO-Pl-R results, for the 
group of 18 participants included in the following hypotheses analyses, yielded a total of 41 
possible personality disorders (range 0 to 7), with four participants evidencing no personality 
disorders and one participant evidencing seven. Table 10 lists the number ofPDs identified 
by the NEO-Pl-R. 
Table 10 
Personality Disorders Identified by the NEO-PI-R 
Personality Disorder NEO-PI-R 
Antisocial 2 
Avoidant 7 
Borderline 8 
Dependent 11 
Histrionic 3 
Narcissistic I 
Obsessive-Compulsive I 
Paranoid I 
Schizoid 0 
Schizotypal 7 
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Participating therapists' demographic data. Of the 18 therapists included in this 
phase of the study, 39% were male. The average age was 26.5 years, with a mode of24 years 
old, and a range of22 to 43 years old. The primary ethnicity was Caucasian (94%). 
Primary theoretical orientations for this group of therapists were cognitive-behavioral 
( 40% ), eclectic ( 40% ), and psychodynamic (16% ). Experience data are listed in Table 11. 
Table ll 
Therapy and Assessment Experience Datafor Therapists 
Questionnaire Items Mean Mode 
# of TherapyClients 6 2 to 260 
# of Personality Assessment Clients 0 0 to 3 
#of Asssessment Clients 0 0 to 50 
#of Therapy£ eedback Sessions 3.6 0 0 to 50 
#of Asssessment Feedback Sessions 3.4 0 0 to 37 
Hypothesis testing. The results associated with the hypotheses linked to this phase 
of the study are described below. 
Hypothesis 3. Hypothesis 3 stated that more clients in the TR condition (NEO-PI-R 
results to therapists) would report clinically significant change in OQ 45.2 total symptom 
scores by session 6 than clients in the NR condition (no NEO-Pl-R results to therapists). As 
noted previously, if scores on the OQ45.2 total symptom distress scale decrease by fourteen 
points, the client is considered to have experienced clinically significant change in their 
symptomology. Only four of the eighteen reported clinically significant change in their 
symptomology, two for each condition. Chi-square results were nonsignificant, x2(l, N = 4) 
= 0, p = 1.0. Therefore, Hypothesis 3, that more clients in the TR condition would report 
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clinically significant change in OQ 45.2 total symptom scores by session 6 compared with 
clients in the NR condition, was not supported. 
Hypothesis 4. Hypothesis 4 stated that there would be a significant difference in OQ 
45.2 change scores between experimental groups (main effect for having/not having NEO-PI-
R results). At the time of the initial battery or first session, the TR group evidenced a mean 
OQ45.2 total symptom distress score of74.3 (SD = 22.93), while the NR group evidenced a 
mean of 76.3 (SD = 29.12). At the start of the sixth session of therapy, the TR group 
evidenced a mean OQ 45.2 total symptom distress score of65.6 (SD = 19.07), while the NR 
group evidenced a mean score of 69.3 (SD = 22.93). Repeated measures AN OVA results 
demonstrated nonsignificant effect for session (F (l,s) = 1.675,p = .150, r/p = .095), as well as 
a nonsignificant main effect for group assignment (F (1. 16) = .316, p = .582, 1/P = .0 19). 
Therefore, Hypothesis 4, that there would be a significant difference in OQ45.2 change 
scores between experimental groups, was not supported. 
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Figure I. Baseline through Session 6 OQ45.2 Total Symptom Distress Scores 
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Hypothesis 5. Hypothesis 5 stated that the therapeutic alliance would be rated higher 
by clients in the TR group than by clients in NR group. As mentioned previously, the 
Working Alliance Inventory Short Form Client Version (WAI-S-C) was administered at the 
beginning of the fourth session of therapy. On most occasions, this measure was distributed 
to the client by reception personnel at the respective clinic, with the client being asked to 
return it upon completion to the front desk personnel. Of the fourteen WAI-S-C distributed at 
this collection point, twelve were returned. The mean score (based on a range from 0 to 120) 
for the clients in the TR group was 91.6 (SD = 17.2); the mean for the clients in the NR 
group was 93.8 (SD = 7.6). Results of an independent samples t-test were not significant (/(lo) 
= -.268,p = .794). Therefore, Hypothesis 5, that clients in the TR group would rate the 
working alliance higher than clients in the NR group, was not supported. 
Hypothesis 6. Hypothesis 6 stated that there would be no interaction between the 
feedback condition and the strength of the therapeutic alliance on OQ 45 change scores. A 
factorial ANOV A was conducted. For this analysis, the WAI-S Client Version (W A I-S-C) 
results were grouped into high and low scores. Since the developers of the W AI-S (Tracey & 
Kokotovic, 1989) do not provide cut-off scores, nor is there a definitive study in the literature 
providing this information, a median split for this population was utilized to group scores 
into high and low categories. Thus, W Al-S-C scores of 98 and below were categorized as 
low (n = 7), with scores above 98 categorized as high (n = 5). 
OQ45.2 change score means, standard deviations, and cell counts for this analysis 
were as follows: (a) TRJ!ow alliance M = 18.5 (SD = 12.45), n = 4; (b) NRJ!ow alliance M = 
3.0 (SD = 17.44), n = 3; (c) TR!high alliance M= -1.33 (SD = 7.57), n = 3; and, (d) NR/high 
alliance M= 24.5 (SD = 37.48), n = 2. Again, the experimental group main effect was non-
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significant (F(l. 8) = .233, p = .643, 172p = .028). Likewise, the main effect for the categorized 
working alliance was also non-significant (F(I. s) = .006, p = .940, 172 P = .001 ). Although 
Figure 2 below would suggest otherwise, the statistical analysis indicated that the interaction 
between the feedback condition and the strength of the therapeutic alliance was also non-
significant (F(I. 8) = 3.722, p = .090, 1lp = .318). Thus, Hypothesis 6, that there would be no 
interaction between the feedback condition and the strength of the therapeutic alliance on 
OQ45.2 change scores, was supported . 
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Summary of Phase 3 hypotheses results. In summary, three of the four hypotheses 
for this phase of the study, investigating whether or not therapist access to NEO-PJ-R 
personality assessment information impacted treatment outcome during the first six sessions 
of therapy, were not supported. Results indicated that there were no group ditierences for (a) 
clinically significant change in OQ45.2 Total Symptom Distress scores, (b) general OQ45.2 
Total Symptom Distress change scores, and (c) client rating of the therapeutic alliance. The 
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final hypothesis (Hypothesis 6), that there would be no interaction between feedback 
condition and the strength of the therapeutic alliance on OQ 45.2 change scores, was 
supported, although the graphical representation of the data appears to suggest otherwise. 
Qualitative analyses. A qualitative analysis was conducted utilizing questionnaires 
administered to therapists and supervisors after the client-participants completed six sessions 
of therapy. As noted in the Methods Section, the purpose of the questionnaires was to assess 
the impact ofNEO-Pl-R training and/or NEO-PI-R report information on the therapists' and 
supervisors' case conceptualizations. Of the 18 clients completing 6 sessions of therapy, 14 
clients' therapists, and respective supervisors, received copies of the questionnaires; of those 
14, 5 therapists and 6 supervisors opted not to return the forms. Questionnaires were not 
administered to participating therapists and supervisors for the other 4 clients due to the 
researcher being out of town on internship and research assistance becoming unavailable 
after the researcher's departure. 
Therapist Questionnaires. Those therapists in the NR condition were asked to 
complete the C-Form version of the questionnaire. Those therapists in the TR condition were 
asked to complete theE-Form version ofthe questionnaire. 
C-Form questionnaires. Of the eight clients assigned to the NR condition, three were 
assigned to therapists who did not receive forms. Of the five remaining clients, three 
respective therapists returned questionnaires, resulting in a return rate of 60%. There were 
four questions on the C-Form that these therapists completed; please see Appendix W, page 
156, for a synopsis of the results, including mean, standard deviation, median, mode, and 
range of responses for the first three questions. Note: abbreviated versions of the questions 
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are listed in the table for practicality. Please see Appendix I, page 134, for a full version of 
this questionnaire. 
Question 4 asked the therapist to identify any assessment instruments that the client 
completed, other than the NEO-PI-R and OQ 45.2, during the first six sessions of therapy. 
Of the six, one reported that the Beck Depression Inventory and the Rorschach had been 
administered. 
E-Form questionnaires. Of the ten clients in the TR condition, three were assigned to 
therapists who did not receive forms. Of the seven remaining clients, six respective therapists 
returned questionnaires, resulting in a return rate of 86%. There were eight questions on the 
E-Form that these therapists completed; please see Appendix W, p. 156 for a synopsis of the 
results, including mean, standard deviation, median, mode, and range of responses for 
questions 1, 5 and 6. Note: abbreviated versions of the questions are listed in the table for 
practicality. Please see Appendix H, page 133 for a full version of this questionnaire. 
Question 2 read, "Did you share the results with your client?" Of the six respondents, 
one shared the results with his/her client; the other five chose not to share the results. The 
therapist who shared the results reported giving the client the computer-generated client 
narrative supplied by the researcher (question 3: "If you shared the results, how did you 
present them?). In addition, this therapist felt that sharing the nan·ative results had a very 
positive int1uence (question 7; 5 on a scale of -5 to 5) on the client's response to therapeutic 
intervention. 
Question 4 read, "If you did not share the results with your client, what int1uenced 
your decision?" One therapist opted not to answer this question. One therapist reported that 
it was clinically-contraindicated, stating, "Didn't believe we were at a point where the client 
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could make use of the info." Two therapists felt it was irrelevant to case conceptualization. 
One therapist stated that it was unimportant. The final therapist wrote that he/she has 
difficulty determining "what the NEO-PI-R describes as 'personality' and what actually may 
be more changeable in the client" and noted a reluctance to share information early in 
treatment regarding a characteristic that may be changeable. 
Question 8 asked the therapist to identify any assessment instruments that the client 
completed, other than the NEO-PI-R and OQ 45.2, during the first six sessions of therapy. 
Of the seven, one reported administering the Anxiety Disorder Interview Schedule (ADIS); 
another reported administering the Behavioral Health Questionnaire (BHQ) and the HANDS 
screening tool. 
Supervisor Questionnaire. Supervisor questionnaires were not condition specific. Of 
the twelve questionnaires provided to supervisors, ten were received for a return rate of 83%; 
please see Appendix w, p. !56 for a synopsis of the results, including mean, standard 
deviation, median, mode, and range of responses for the first three questions. Note: 
abbreviated versions of the questions are listed in the table for practicality. Please see 
Appendix J, p. 135 for a full version of this questionnaire. 
Question 4 read, "If your supervisee received NEO-PI-R results for this client, did 
you encourage your supervisee to share the results with their client?" Four responded "yes," 
three responded "no," two responded "not applicable," and one responded that the narrative 
had not yet been read. For the four who did encourage their supervisee to share results with 
the client, one indicated that no specific feedback suggestions were given to the therapist, 
while three recommended that feedback be given as suggested during the training (e.g., share 
a copy of the client narrative and review as desired). Of the three who did not encourage the 
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therapist to share the results, one stated he/she felt the results were irrelevant to the case; 
another stated that "it is not useful given the time constraints of the setting." 
Question 5 asked the supervisor to identify any assessment instruments that the client 
completed, other than the NEO-PI-R and OQ 45.2, during the first six sessions of therapy. 
The results reported by therapists were reported by supervisors (i.e., two Beck Depression 
Inventories, one each of ADIS, BHQ, and HANDS). 
In summary, supervisors reported that the NEO-PI-R training/intervention influenced 
their attention to the impact of the clients' personality traits on therapeutic interventions at a 
slightly higher, but not clinically significant, rate than the responses of the therapists on the 
C-Form (M= 3.90 versus M= 1.67, respectively). Supervisors also reported that the NEO-
PI-R report/training had a modicum of higher influence on their conceptualization of client 
strengths and weaknesses compared to therapists in both treatment conditions (M = I. 7, M = 
1.0, M = 1.0 respectively). With regard to recommendations made to their supervisees, 
supervisors reported that the NEO-PI-R report/training had little influence on 
recommendations (M = 1.4). Moreover, supervisors reported mixed results with regard to 
encouraging their supcrvisees to share the results of the assessment with their clients, 
whereas most therapists who received reports opted not to share the results with their clients. 
Therapists in both groups indicated that the NEO-PI-R training and/or report had little 
influence on their conceptualization of their clients' strengths and weaknesses (M = 1.0 for 
both groups). Conversely, therapists in the TR group indicated that the NEO-PI-R was 
moderately useful in the development of their case conceptualizations (AI= 5.83). 
Follow-up questionnaire analyses. Due to unexpected data collection delays and the 
prolonged data collection period, this portion of the study could not be reliably administered. 
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In addition, follow-up analyses were not included in the hypotheses for this study. For these 
reasons, this portion of the study, although included in the consent form, was deleted. 
Phase 3 exploratory analyses. Two exploratory analyses were conducted with data 
from this phase of the study. 
Exploratory Analysis I. The Working Alliance Inventory Short Form (W Al-S) was 
administered to both therapists (W AI -S-T) and the clients (W AI -S-C). Hypothesis 5 results 
indicated that, for the twelve clients returning WAl-S inventories, there was not a significant 
difference between the two experimental groups for client ratings. At-test was conducted to 
determine if this non-significant group difference held for therapists' ratings of the working 
alliance. Results indicated that, although therapists in the NR group rated the alliance slightly 
higher than therapists in the TR group, the difference was not significant. The mean score for 
the therapists in the TR group was 79.7 (SD = 9.8); the mean for the therapists in the NR 
group was 84.0 (SD = 9.1); l(lo) = -.767, p = .461. 
Exploratory Analysis 2. As noted in the introduction, fifty percent of clients typically 
need eleven to twenty-one sessions of therapy before realizing clinically significant change, 
as reported on a symptom distress measure (Lambert, Hansen, & Finch, 200 I). Therefore, it 
may not be surprising that Hypothesis 3, which stated more clients in the TR group would 
realize clinically significant change by the sixth session than clients in the NR group, was not 
supported. 
In an effort to ascertain if having NEO-PI-R results had any impact on treatment 
outcome, an exploratory analysis was conducted to determine if more clients in the TR group 
reported symptom improvement when compared with clients in the NR group. For this 
analysis, OQ45.2 change scores between session 1 and session 6 were grouped according to 
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total distress score deterioration or improvement (note: there were no clients who reported no 
change in total distress scores). Chi-square results approached significance, lC I, N = 18) = 
3.545,p = 0.059. When all27 clients who completed six sessions of therapy are included in 
the analysis, chi-square results become significant, z2(1, N = 27) = 4.34, p = 0.037. For chi-
square cell counts, see Table 12. 
Table 12 
Clients Reporting OQ 45.2 Total Symptom Score Improvement or Decline by Session 6. 
OQ45.2 Score Group 
OQ45.2 decrease in 
symptom score 
OQ45.2 no change or 
increase in symptom 
score 
n = 18 
NEO-PI-R No NEO-PI-
results to 
therapist 
9 
R results to 
therapist 
4 
4 
n = 27 
NEO-PI-R No NEO-PI-
results to 
therapist 
12 
I 
R results to 
therapist 
8 
6 
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Discussion 
The primary aims of this study were (I) to replicate the analysis conducted by Ryder 
et al. (2007) regarding the clinical validity of the DSM PD categorical system, utilizing 
questionnaire responses from a distinctively different population, and (2) to determine the 
clinical utility of a pre-treatment assessment battery, that included a measure of nonnal 
personality characteristics, on treatment outcome during the first six sessions of therapy. The 
overarching objective was to add to the psychological literature regarding the clinical utility 
of a dimensional assessment of personality, as well as the fiscal feasibility of pre-treatment 
personality assessment, in the context ofMBHOs reluctance to reimburse for personality 
assessment and treatment. 
Discussion of the Replication Analysis Results 
As noted previously, the validity of the current DSM PD categorical diagnostic 
system is questionable, at best. Moreover, the Ame1ican Psychiatric Association has 
acknowledged that this issue needs to be addressed. Although a number of empirical studies 
have shown that a dimensional representation of personality disordered symptomology would 
be an improvement over the current system, more research to support the drastic change from 
a categorical system to a dimensional system is needed. Forefront in this research effort is the 
need to establish the clinical validity of a dimensional PD diagnostic system, especially one 
based on nonnal personality assessment, such as the NEO-PI-R. 
Ryder eta!. (2007) recently conducted a study to add support to the research base that 
indicates the convergent validity ofthe current DSM PD symptoms is well established and 
the divergent validity is problematic compromising the clinical validity of the PD categorical 
system. They also sought to authenticate the correlation between the cunently perceived PD 
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symptomology and the FFM model of dimensional personality (in particular, the NEO-Pl-R) 
and to investigate the relation of individual PD symptoms to impairment in the context of 
clinical utility. Since only one other published study (Bagby, Costa Jr., Widigcr, Ryder, & 
Marshall, 2005) has compared the FFM dimensional assessment system against the SCID-ll-
SR, their study was timely. (Note: Huprich, 2003, compared the NEO-PI-R with the 
structured interview SCID-II.) However, they made recommendations based on results from 
a distinct sample, thus compromising the validity of their recommendations. Data collected in 
this study, employing a characteristically different population, were utilized to replicate 
Ryder and colleagues' results. The purpose of this effort was to address the generalizability 
of their results and thereby possibly add credence to their recommendations. 
Results from this study were mixed. The results of the Ryder et al. (2007) study, 
suggesting (a) the overall convergent validity of the PD symptoms with their own parent 
disorder is empirically established and (b) the divergent validity of the PD symptoms with 
other PD disorders is problematic, were replicated. However, a cursory review of the 
difference between the studies regarding the number of symptoms that met correlation-
coefficient cutoffs for convergent validity for each PD suggests that the characteristics of the 
sample may have some influence on the results of the analysis (as indicated by three PDs 
evidencing significantly different results fi·om the Ryder and colleagues' values). This 
possibility was made more obvious by the difference in results for the divergent validity 
analysis, where five of the ten PDs yielded significantly different results between the two 
studies. It is especially noteworthy that the difference in the obsessive-compulsive PD 
results, for Criterion I and II, is so distinctive with regard to these two dissimilar samples. 
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This will be discussed in more detail later in this section when the results of the exploratory 
analysis are reviewed. 
Regarding the association between the SCID-11-SR PD symptoms and the NEO-PI-R 
facets, Ryder et al. (2007, p. 631) purported "many of the PD traits were related to FFM 
personality traits." They based their conclusion on 60 of the 104 SCID-II-SR symptoms 
meeting the strict 0.002 correlation criterion. The results of this study (only 41 symptoms 
meeting criterion) did not support the Ryder and colleagues' contention; however, this 
difference, in all likelihood, is due to the smaller sample size for this study (n = 76 versus n = 
203). As noted in the Results section, the size of this study's sample would dictate that a 
correlation between two variables would need to be strong for it to have significance at the p 
5 .002 level, whereas it would only need to be moderate for a significant correlation in a 
sample size of203. This in all likelihood attenuated the number of symptoms that correlated 
with one or more facets, thereby affecting the proportion of symptoms per PD that correlated 
with NEO-PI-R facets. 
With regard to the association between SCID-II-SR symptoms and functional 
impairment, Ryder et al. (2007, p. 628) noted that "most, if not all, of the individual PD traits 
are written in such a way to imply maladjustment and clinicians will in pmi decide whether a 
trait should be recorded as present or absent based on the extent to which it interferes with 
normal functioning." Based on the results of their findings, that "every diagnosis other than 
Borderline PD showed a lack of association with impairment for a majority of its constituent 
items" (p. 630-631 ), the authors claimed that the low number of PDs symptoms related to 
impairment "compromised the clinical utility" ofPD symptoms. Although the results of this 
study revealed a statistically significant difference between the number of PD symptoms that 
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correlated with GAF scores, as compared to those that correlated with OQ45.2 total symptom 
distress scores (with OQ 45.2 results yielding a higher number), 39 of 104 symptoms would 
not be considered clinically significant, if indeed the clinical utility ofPD symptoms should 
be based on the relationship with impainnent. 
Some researchers argue that impairment should not be taken into consideration when 
defining a mental/behavioral disorder (Lehman, Alexopoulos, Goldman, Jeste, & Ustin, 
2002). More importantly, Lenzenweger, Lane, Loranger, and Kessler (2006), reporting on 
results fi·mn the National Comorbidity Survey Replication (NCS-R), stated that tindings 
suggested the associations between PDs and functional impainnent are largely accounted for 
by comorbid Axis I disorders. This contention was supported thusly: 
Functional impairment might influence help-seeking more strongly among 
patients with pure PDs than among those with Axis I disorders (mindful that 
such help-seeking might be prompted by spouses, other family members, or 
employers rather than by the patients themselves), whereas distress affects 
help-seeking more among patients with Axis I disorders than among those 
with pure PDs .... This possibility is indirectly consistent with our finding 
that help-seeking among people with PDs is strongly affected by Axis I 
comorbidity (p. 562). 
Returning to the issue of the noteworthy difference between the studies with regard to 
obsessive-compulsive results for Criterion I and Criterion II, in a study investigating the 
psychometric and diagnostic efficiency properties of the DSM-IV PD criteria as assessed by 
the Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II; First et al., 
1997), Fanner and Chapman (2002) commented that obsessive-compulsive PD criteria, as 
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assessed by the SCID-II, demonstrated low internal consistency. They continued by stating, 
"This finding suggests that the [obsessive-compulsive] concept is essentially a chimera, or 
compromised of a collection of weakly related features that have been melded together to 
form a diagnostic concept" (p. 296). They further maintained that obsessive-compulsive PO 
has typically performed different than other POs, citing literature to support this contention 
and noting that in factor analyses it loads mostly highly on a factor defined by it alone. They 
summarized their discourse of the validity of the obsessive-compulsive PO syrnptomology by 
stating that the disorder "may well benefit from additional conceptual, theoretical, and 
empirical development" (p. 297). This could account for the vastly different results obtained 
in this study. 
It is interesting to note that when addressing the clinical utility of the NEO-PI-R, via 
studies investigating its capability to conceptualize OSM-IV-TR POs utilizing Widiger and 
colleagues' FFM descriptions of prototypic PDs, researchers tend to attribute the FFM's 
weaker predictive ability for obsessive-compulsive PD and dependent PO to shortcomings in 
the NEO-PI-R (e.g., Miller eta!., 2004; Rossier & Rigozzi, 2008). However, the above 
citation would suggest that the shortcomings may be associated with the OSM 
conceptualizations, not NEO-Pl-R conceptualizations. Another rarely cited reason for the 
poor conceptualization issue being more associated with the OSM rather than with the NEO-
PI-R, that was mentioned previously, is the fact that "the FFM descriptions include OSM-IV-
TR personality disorder features and go beyond the criterion sets to provide fuller, more 
comprehensive descriptions of each personality disorder" (Widiger & Mullins-Stewart, 2009; 
p. 199). 
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These conceptualization issues may also, in part, account for the notable differences 
in identified PDs between the NEO-PI-R and SCID-II-SR listed in Table 8 (p. 78) of the 
phase 2 exploratory analysis. However, any suppositions regarding this issue must be made 
cautiously given the SCID-II-SR's empirically demonstrated production of high rates of 
false-positive PD diagnoses relative to SCID-II findings (i.e., 67% as noted in Fam1er & 
Chapman, 2002, p. 295). 
Upon reviewing the overall results from Phase 2 of this study, it is remarkable that 
Ryder et a!. (2007) doubted that a set of more coherent PDs to facilitate categorical diagnosis 
could be generated, given the results of just their analyses. Results from this study's analyses 
suggest that the Ryder and colleagues' results need to be replicated with a variety of 
populations before total abandonment of the current diagnostic system is suggested. 
However, the problematic divergent validity of the current system will definitely have to be 
addressed if reimbursement from MBHOs for personality assessment is a goal. 
Moreover, the clinical utility of a dimensional PD diagnostic system, as assessed by 
the statistical procedures utilized in the Ryder and colleagues study, was not clearly 
established in this study. More investigations with larger and more diverse sample 
populations will need to be conducted to justify their assertions that "most PDs are composed 
of symptoms that reflect personality," that qualitative differences exist between some PDs 
and normal personality "raising the possibility that they should be moved to Axis I," and that 
a symptom's relation to impairment does in fact compromise its clinical validity (2007, p. 
631). 
It appears that the Personality and Personality Disorder Work Group of the American 
Psychiatric Association concurs with these assertions. In an editorial by Skodol and Bender 
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(2009), the authors stated, "The challenge of the work group is to formulate a system that 
allows for meaningful representation of a patient's personality characteristics and 
psychopathology most pertinent for clinical care, while not taxing the clinician with an 
excessively complicated or burdensome assessment that would inhibit its use" (p. 390). 7 
These authors also noted that the current proposal under consideration by the work group 
consists of five parts, which in essence is a combination of the current system with a 
personality trait assessment "on which the prototypes are based but that can also be used to 
describe major personality characteristics of patients who either do not have a personality 
disorder or have a personality disorder that does not conform to one of the prototypes" (p. 
390). 
Discussion of the Utility of Pre-Treatment Personality Assessment on Treatment 
Outcome 
Although it could be fiscally feasible to administer the NEO-PI-R on a regular basis 
(less than $13.00 based on parameters previously listed), the results from this study suggest 
that more investigation is needed before it can be definitively determined whether or not 
administration of a pre-treatment dimensional measure of normal personality has any clinical 
validity with regard to facilitating therapeutic change in client distress symptomology. The 
most telling outcome warranting the additional research on this topic is the notable effect 
sizes associated with results of two of the hypotheses. 
In particular, Hypothesis 4, regarding OQ45.2 change scores differences between 
groups, was not supported; however, the partial eta squared (112r) efJect size for the repeated 
7This comment was made by Skodol and Bender (2009) in reference to a recent article by Rottman, Aim, 
Sanislow, and Kim (2009) in which these authors stated that clinical psychologists, psychiatrists, and clinical 
social workers, when presented with case profiles based on symptom formats from the PFM, had difficulty 
identifYing correct diagnoses from FFM profiles. 
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measures AN OVA was 0.019, suggesting a moderate relationship between the variables, one 
that may become more evident with a larger sample size. In addition, the large effect size (Y)2p 
= .318) associated with the nonsi1,,>11ificant factorial ANOV A assessing the interaction 
between the feedback condition and the strength of the therapeutic alliance on treatment 
outcome scores also implies that the sample size was not large enough to detect a significant 
interaction. 
As will be discussed in greater detail in the limitations of the study section of this 
discourse, there were a number of uncontrolled variables that may have negatively influenced 
this outcome. However, the most influential study characteristic that may have had the 
strongest effect on the ability to detetmine if the intervention was clinically significant, other 
than sample size, was the relatively short treatment outcome assessment period. As 
previously noted in the introduction, Lambert and colleagues (2001 studies) have discovered 
that 50% of clients do not evidence clinically significant decreases in symptom distress until 
the 11'11 to 20111 session of treatment. The fact that only 22% of this study sample evidenced 
clinically significant decreases in symptom distress by the sixth session is commensurate 
with their findings. 
The working alliance, which has been shown to rate positively with therapy outcome, 
was also investigated in this study with regard to its influence, or lack thereof, on 
experimental group differences. Study findings indicated that there were no significant group 
differences with regard to the clients' or the therapists' rating of the alliance. In addition, the 
twelve and ten point di±Ierences between the client [91.6 (no results) and 93.8 (results)] and 
therapist (79.7 and 84.0, respectively) ratings of the working alliance are not unusual. 
According Tryon, Blackwell, and Hammel (2007) who conducted the meta analysis 
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investigating client-therapist perspectives of the working alliance that produced the above 
results, clients' ratings of the alliance were typically found to be higher than ratings by their 
therapists (d = .63, SD = .42; p. 629). 
What is unusual about the present study's therapist-client dyad population is the 
correlation between the client-therapist alliance ratings. In the Tryon eta!. meta-analysis 
(2007), the correlation between these ratings was found to be moderate (r = .36), whereas the 
significant correlation for the ratings in this study was relatively large (r = .714, p = .009). 
One reason for this difference may be the fact that alliance ratings were solicited at the 
beginning of the fomih session of treatment. In all probability, dyads with lower alliances 
would have already terminated therapy, given the fact that 76 clients began therapy in this 
study and only 27 made it through six sessions. Another possibility for this correlation 
difference could be the relative lack of experience ofthe therapists' regarding their ability to 
accurately judge the alliance. Tyron and colleat,'Ues (2007) list a number of articles that 
repmied clients generally giving higher alliance ratings than practiced therapists. 
With regard to therapists' and supervisors' post-sixth-session questionnaire 
responses, it is interesting to note that therapists rated the personality assessment results as 
being moderately useful in the development of case fonnulation (mean of 6 on a scale of 0 to 
1 0), yet tended to repmi the results were "unimportant" or "inc levant to case 
conceptualization" when asked if they shared the results with their clients. Another 
interesting juxtaposition reported by a few therapists who received NEO-PI-R results was 
their rating of the influence of the reports on client interaction as neutral, yet commenting 
that the results prompted them to be "more empathic" with the client. Overall, supervisors 
a.\'ld therapists reported that the NEO-PI-R training/intervention had little influence on the 
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attention they paid to the impact of the client's personality on therapeutic interactions. More 
importantly, however, is the indication that therapists tended not to share the results of the 
assessment, when they received it, with their clients. Since the therapists participating in this 
study were all in training, it could be surmised that the apparent perceived lack of the NEO-
PI-R's clinical utility could stem from lack of familiarity and training with this instrument. 
Again, more investigation would be needed to substantiate this assertion. 
Discussion of the Phase 3 Exploratory Analyses 
The results of the non-parametric analyses of the sixth-session change scores for all 
participants advancing to Phase 3 of the study are noteworthy for two reasons. It appears that 
clients of therapists in training report more improvement in distress symptomology when the 
therapist has access to non-routine personality assessment infonnation. This is not surprising 
given the extensive psychological literature suppmiive of the assertion that access to 
assessment infonnation facilitates improvement in treatment, treatment planning processes 
(e.g., Finn & Tonsager, 1992), and treatment outcome evaluation (e.g., Lambert, Hansen, & 
Finch, 2001; Lambe1i, Whipple, et a!., 2001)- all of which impact the course of therapy. 
A second reason for the noteworthiness of these results is the notion that 
psychologists should "do no hann." If, as suggested by the data presented in Table 12 (p. 91 ), 
approximately half of the clients whose therapists did not receive NEO-PI-R results reported 
an increase in distress by the sixth session, as opposed to relatively few clients whose 
therapists did receive results, psychologists should be advocating for pre-treatment routine 
personality assessment based on the American Psychological Ethics Code (American 
Psychological Association, 2002, p. 3) which states, "Psychologists strive to benefit those 
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with whom they work and take care to do no harm." This would be especially true for 
therapists in training, as this was the context in which these results were acquired. 
To summarize the findings from phase 3 of the study, most hypotheses were not 
supported. However, effect sizes from statistical analyses, in combination with the significant 
chi-square results from the exploratory analyses, suggest that additional investigation needs 
to be done with larger sample sizes before any definitive conclusions can be made. 
Moreover, if a dimensional personality assessment instmment is to be utilized in clinical 
settings, substantial training on how to use and interpret the assessment should be provided to 
therapists. 
Limitations of the Study 
Maruish (2004), in an attempt to answer the question "why has the cost-effectiveness 
of psychological testing never been proven," succinctly stated: 
One reason is the difficulty of implementing the type of methodology that would 
be required- particularly with regard to controlling variables related to the 
psychologists' skill, the patients' symptoms, the instrumentation used, and the 
therapeutic process employed. (p.l4) 
He continued by commenting, "A well controlled study is not impossible, but it would be 
very difficult and quite costly to complete" (p. 14). 
Maruish's contentions were echoed in a recent article by Perepletchikova, Hilt, 
Chereju, & Kazdin (2009). These authors stressed that treatment integrity, detined as the 
implementation of interventions as intended, is critical for experimental validity and drawing 
valid inferences. They reported that, despite the critical significance of treatment integrity, 
less than 4% of a group of evaluated randomized controlled trials adequately implemented 
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treatment integrity procedures (Perepletchikova eta!., 2007, as cited in Perepletchikova eta!., 
2009). The top three barriers to treatment integrity, as identified by treatment outcome 
researchers, were: (1) there is a considerable time requirement in obtaining accurate 
representation of integrity data (collection of data across therapists, situations, cases, and 
sessions, (2) designing and validating integrity measures is labor intensive and time 
consuming, and (3) it is expensive and time consuming to provide direct training of 
therapists. 
Major limitations of this study involved all of the above cited baniers. In particular, 
this study was time and data collection intensive, requiring an average of four to five hours of 
research assistant time per participant. Thus, lack of time and a dedicated research team were 
obstacles to study integrity and timely completion. 
Inadvertently, therapist turnover became an issue impeding data collection. Both data 
collection sites are training clinics, with therapists completing practica lasting from eight to 
twelve months at each site. Transfer clients and client drop out severely curtailed a 
therapist's opportunity to see six study-participating clients through six sessions of therapy, 
in the given time frame of the practicum, as originally intended. 
More than 250 therapy-seeking individuals, who expressed a willingness to be 
contacted to participate in research, were referred to the study. The total number of 
individuals seeking therapy services during the time of the study at the two data collection 
clinics is unknown. Of the 250, 78 completed some portion of the initial assessment battery, 
with only 27 completing six sessions of therapy and 18 included in the final hypotheses 
analysis. Thus, less than ten percent of the individuals seeking psychotherapy services at 
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these clinics are represented in phase 3 of this study, requiring additional studies to be 
conducted before the gencralizability of any results could be established. 
Several other limitations associated with this study include (a) the small 
compensation for participation which may have had a negative impact on the decision to 
participate in the study, (b) the lack of compensation for therapists and clinic staff (who 
played an integral role in the implementation of this study) which also may have influenced 
their decision to participate in the study, (c) the inability to systematically collect post-
treatment follow-up data which thwarted the ability to analyze the long-term effects of the 
intervention, (d) the compromised random assignment to condition that resulted from 
defaulting clients to the control condition which may have impacted outcome results, (e) the 
inability to meet the requirements of the original design ( 6 therapists, seeing 6 clients through 
6 sessions of therapy) which would have allowed statistical analyses that accounted for 
excess variance resulting from therapist differences, and (f) the lack of assessment regarding 
how the knowledge of personality disorder infonnation may have impacted novice therapists' 
confidence in their ability to adequately meet the therapeutic needs of their clients- to name 
a few. 
Needless to say, self-selection bias and client drop out, in addition to the treatment 
integrity issues and other limitations mentioned previously, imply that results should be 
regarded as tenuous. Clearly, additional studies implementing methodologically rigorous 
protocols are needed to give credence to any conclusions that could be drawn from this 
project. 
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Strengths of the Study 
With regm·d to the replication analysis conducted in phase 2, the results from this 
study reiterate the need to replicate any study's findings with diverse populations before 
assertions about the generalizability of findings can be made. In addition, results add to the 
very sparse literature regarding the SCID-II-SR's and NEO-Pl-R's capabilities of correctly 
identifying personality disordered symptomology. Given the American Psychiatric 
Association's working group decision to investigate Axis II revisions that modify the current 
categorical diagnostic system, this study is timely. 
Another major strength of this study was the implementation of the phase 3 protocol 
in clinic settings without any major administrative procedural changes at either of the data 
collection sites. The only administrative procedure change occurred at the CAPS clinic and 
was minimal in nature; a fonn inquiring about willingness to be contacted to participate in 
research was added to the intake protocol. Most administrative staff suppmi was limited to 
responding to participants' requests for study forms left at reception desks and placement of 
reports and treatment outcome charts in therapists' and supervisors' clinic mailboxes. 
Moreover, therapists and supervisors were not required to do anything with any report 
information (NEO-PI-R reports and/or OQ45.2 cumulative result charts) that they were 
provided. The impetus for the "hands off' attitude was the desire to be able to interpret the 
results of the study, regarding the utility of the pre-treatment assessment protocol, in the 
context of business as usual. 
An equally important, but perhaps not as obvious, strength of this study is the hint 
that the key to facilitating pre-treatment personality assessment reimbursement from MBHOs 
may not lie in exploring the intervention's capability to facilitate/speed recovery from 
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symptomology. Rather, it may lie in identifying the preventive medicine effects associated 
with clients'- whose therapists have access to this type of pre-treatment infonnation-
tendencies to show improvement and avoid decline. The implications for decreased 
utilization of additional medical services by these clients are numerous (e.g., Clark, 2007). 
Recommendations for Future Research 
Replications of this study, incorporating treatment integrity adherence checks, are 
required in order to empirically establish the treatment utility and cost effectiveness of pre-
treatment personality assessment in a clinical setting. To case the cost associated with 
implementing these types of treatment outcome studies, study-specific assessment measures 
should be incorporated into the routine administrative protocol ofthe clinics utilized for data 
collection. For example, the personality assessment could become part of the routine intake 
packet, the OQ 45.2 should be completed by clients at the beginning of each session 
regardless of study participation status, and working alliance inventories should be completed 
by clients and therapists on a monthly basis. 
In addition, treatment outcome data (i.e., OQ45.2 results) should be collected as long 
as the client is in treatment. T11is will allow for accountability of any statistical variance in 
treatment outcome associated with weekly feedback to therapists regarding client report of 
distress symptomology. Lambert and colleagues (e.g., Harmon eta!., 2007; Lambert, Hansen, 
& Finch, 200!; Lambert, Whipple, eta!., 2001; Whipple eta!., 2003) have conducted several 
studies that indicated timely feedback of treatment outcome to therapists can improve 
outcomes for clients indicating decline. However, these researchers admitted that 75% of 
nonresponders to treatment remained unchanged or deteriorated when they left treatment 
despite feedback to therapists (Lambert, Hansen, & Finch, 2001 ). Interestingly, as part of the 
PD Pre-Treatment Assessment 107 
protocol for phase 3 of the present study, OQ45.2 feedback was given to therapists in both 
conditions. Since group differences were noted in the exploratory analysis, additional 
information regarding how the therapists utilized the provided OQ45.2 feedback would prove 
beneficial with regard to the influence ofOQ45.2 feedback on treatment outcome. 
Regarding the clinical utility of the NEO-PI-R, as mentioned previously, more 
research needs to be conducted to investigate therapists' and supervisors' perceptions of the 
treatment utility of this measure. A direct comparison of these perceptions with actual 
outcome measures would be beneficial, given that most therapists' and supervisors' in this 
study reported that the NEO-PI-R results had little influence on their interactions with clients 
and case conceptualizations. 
Conclusions 
In summary, the purpose of this study was twofold: first, to replicate the 11ndings of 
Ryder et al. (2007) study, investigating the validity of the DSM PD symptoms and their 
relationship to nmmal personality traits and ratings of impainnent functioning, utilizing 
results for a distinctly different population, so that generalizability of the results could be 
addressed; and second, to investigate the clinical utility of a pre-treatment personality 
assessment with regard to facilitating productive treatment outcome. 
Results from the replication analyses corroborated Ryder and colleagues 11ndings 
regarding the empirically proven convergent validity of the DSM PD symptoms. Results also 
supported their contention that the divergent validity of the symptoms is not suppotied and 
extended that concern to encompass the notion that the divergent validity problems 
associated with DSM PD symptoms may be population specific. In addition, results from this 
phase of the study supported Ryder and colleagues' contention that functional impairment is 
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not clinically associated with cun·cnt PO symptomology (although this study's results were 
statistically different from the Ryder and colieagne results). Conversely, results from this 
study did not support Ryder and colleagues' assertion that many of the OSM PO symptoms 
were related to nonnal personality traits. 
Results from the pre-treatment personality assessment phase of the study indicated 
that therapists' access to personality infonnation early in treatment did not influence 
treatment outcome during the first six sessions as measured by change scores in client report 
of total symptom distress. Moreover, therapists reported that access to personality assessment 
information did not influence their interactions with clients, nor did it appear to have an 
influence on the clients' perception of the therapeutic alliance. 
On a more positive note, results from the replication analysis conducted in phase 2 
will add to a very sparse literature regarding the clinical utility of the SCID-II-SR measure. 
In addition, results from this phase will add to the literature regarding the diagnostic 
differences between the SCID-II-SR and the NEO-PI-R, as well as the screening potential of 
the NEO-PI-R with regard to identifying maladaptive personality symptomology. Moreover, 
a compelling exploratory analysis result from phase 3 could provide a new direction for 
psychology assessment researchers-that of investigating the "preventive medicine" nature of 
the intervention. 
PD Pre-Treatment Assessment 109 
References 
Ackerman, S., & Hilsenroth, M. (2001). A review of therapist characte1istics and techniques 
negatively impacting the therapeutic alliance. Psychotherapy: Theory, Research, 
Practice, Training, 38(2), 171-185. 
afKlentebert, B., Schalling, D., & Magnusson, D. (1986). Selheport assessment of 
personality traits. Data from the KSP inventory on a representative sample of normal 
male and female subjects within a development project. Reports from the Project 
Individual Development and Adjustment, No. 64. Stockholm Sweden: Stockholm 
University, Department of Psychology. 
Allen, A., Montgomery, M., Tubman, J., Frazier, L., & Escovar, L. (2003). The effects of 
assessment feedback on rapport-building and self-enhancement processes. Journal of 
Menta/Health Counseling, 25(3), 165-182. 
Ambrose Jr., P. (1997). Challenges for mental health service providers: The perspective of 
managed care organizations. In J. Butcher (Ed.), Personality assessment in managed 
health care: Using the MMPI-2 in treatment planning, (pp. 61-72). London, England: 
London University Press. 
American Psychiatric Association (AP A). (1952). Diagnostic and statistical manual of 
mental disorders. Washington, DC: Author. 
American Psychiatric Association (APA). (1968). Diagnostic and statistical manual of 
mental disorders (2"d ed.). Washington, DC: Author. 
American Psychiatric Association (APA). (1980). Diagnostic and statistical manual of 
mental disorders (3'd ed.). Washington, DC: Author. 
American Psychiatric Association (AP A). ( 1987). Diagnostic and statistical manual of 
mental disorders (3'd ed., Revised). Washington, DC: Author. 
American Psychiatric Association (APA). (1994). Diagnostic and statistical manual of 
mental disorders (4'" ed.). Washington, DC: Author. 
American Psychiatric Association (APA). (2000). Diagnostic and statistical manual of 
mental disorders (4'" ed., Text Revision). Washington, DC: Author. 
American Psychological Association (APA). (2002). Ethical principals of psychologists and 
code of conduct. Washington, DC: Author. 
American Pscyhologica1 Association (APA). (2002). Ethical Principles of Psychologists and 
Code of Conduct. American Psychologist, 57(12), 1060-1073. 
PD Pre-Treatment Assessment 11 0 
Anderson, E., & Lambert M. (2001). A survival analysis of clinically significant change in 
outpatient psychotherapy. Journal of Clinical Psychology, 57(7), 875-888. 
Arnow, B., Manber, R., Blasey, C., Klein, D., Blalock, J., Markowitz, J., eta!. (2003). 
Therapeutic reactance as a predictor of outcome in the treahnent of chronic depression. 
Journal of Consulting and Clinical Psychology, 71(6), 1025-2035. 
Arntz, A. (1999). Do personality disorders exist? On the validity of the concept and its 
cogntivie-behavioral fonnulation and treatment. Behavior Research and Therapy, 3 7, 97-
134. 
Bagby, R. M., Costa Jr., P., Widiger, T., Ryder, A., & Marshall, M. (2005). DSM-IV 
personality disorders and the five-factor model of personality: A multi-method 
examination of domain- and facet-level predictions. European Journal of Personality, 19, 
307-324. 
Bagby, R. M., Sellbom, M., Costa Jr., P., & Widiger, T. (2008). Predicting Diagnostic and 
Statistical Manual of Mental Disorders-IV personality disorders with the five-factor 
model of personality and the personality psychopathology five. Personality and Mental 
Health, 2, 55-69. 
Ball, S., Te1men, H., Poling, J., Kranzler, H., & Rounsaville, B. (1997). Personality, 
temperament, and character dimensions and the DSM-IV personality disorders in 
substance abusers. Journal of Abnormal P1ychology, 106(4), 545-553. 
Barkman, M., Stiles, W., & Shapiro, D. (1993). The shape of change in psychotherapy: 
Longitudinal assessment of personal problems. Journal of Consulting and Clinical 
Psychology, 61(4), 667-677. 
Benjamin, L. ( 1996). A clinician-friendly version of the interpersonal circumplex: Structural 
Analysis of Social Behavior (SASB). Journal of'Personality Assessment, 66, 248-266. 
Bond, M., & Wesley, S. (1996). Manual for the Defense Style Questionnaire. Montreal, 
Quebec: McGill University. 
Busseri, M., & Tyler, J. (2003). Interchangeability of the Working Alliance Inventory and 
Working Alliance Inventory, Short Form. Psychological Assessment, 15(2), 193-197. 
Butcher, J., Dahlstrom, W., Graham, J., Tellegen, A., & Kaemmer, B. (1989). MMPJ-2: 
Manual of administration and scoling. Minneapolis, MN: University of Minnesota Press. 
Calvert, S., Beutler, L., & Crago, M. (1988). Psychotherapy outcome as a function of 
therapist-patient matching on selected variables. Journal of Social and Clinical 
Psychology, 6(! ), I 04-117. 
PD Pre-Treatment Assessment Ill 
Cattell, R. ( 1946). Description and measurement ofpersonality. Oxford, England: World 
Book Company. 
Chamorro-Premuzic, T., & Furnham, A. (2003). Personality traits and academic examination 
performance. European Journal of Personality, 17(3), 237-250. 
Chiesa, M., Fonagy, P., Holmes, J., Drahorad, C., & Harrison-Hall, A. (2002). Health 
service use costs by personality disorder following specialist and nonspecialist treatment: 
A comparative study. Journal ofPersonality Disorders, 16(2), 160-173. 
Clark, L. (1993). Schedule for nonadaptive and adaptive personality (SNAP). Minneapolis, 
MN: University of Minnesota Press. 
Clark, L. (2007). Assessment and diagnosis of personality disorder: Perennial issues and an 
emerging reconceptualization. Annual Review of Psychology, 58,227-257. 
Clark, L., & Harrision, J. (2001). Assessment instruments. In J. Livesley (Ed.), Handbook of 
personality disorders: Theory, research, and treatment (pp. 277-306). New York, NY: 
The Guilford Press. 
Clark, L., Livesley, W. J., & Morey, L. (1997). Personality disorder assessment: The 
challenge of construct validity. Journal of Personality Disorders, 11(3), 205-231. 
Clarkin, J., Hull, J., Cantor, J., & Sanderson, C. (1993), Borderline personality disorder and 
personality traits: A comparison of SCID-11 BPD and NEO-PI. Psychological 
Assessment, 5(4), 472-476. 
Cloniger, C., Przybeck, T., Svrakic, D., & Wetzel, R. (1994). 1iw Temperament and 
Character Inventory (TCI): A guide to its development and use. StLouis, MO: Center 
for Psychobiology of Personality, Washington University. 
Cloninger, C. R., Przybeck, T. R., & Svrakic, D. M. (1991). The Tridimensional Personality 
Questiom1aire: U.S. normative data. Psychological Reports, 69(3, Pt !), 1047-1057. 
Compton, W., Cottier, L., Jacobs,J., Ben-Abdallah, A., & Spitznagel, E. (2003). The role of 
psychiatric disorders in predicting drug dependence treatment outcomes. American 
Journal of Psychiatry, 160(5), 890-895. 
Conrod, P., Pihl, R., Stewart, S., & Dongier, M. (2000). Validation of a system of classifying 
female substance abusers on the basis of personality and motivational risk factors for 
substance abuse. Psychology of Addictive Behaviors, 14(3), 243-256. 
Conrod, P., Stewart, S., Pihl, R., Cote, S., Fontaine, V., & Congier, M. (2000). Efficacy of 
brief coping skills interventions that match different personality profiles of female 
substance abusers. Psychology ofAddictive Behaviors, 1 4(3), 231-242. 
PD Pre-Treatment Assessment 112 
Constantino, M., Castonguay, L., & Schut, A. (2002). The working alliance: A flagship for 
the "scientist-practitioner" model in psychotherapy. In G. Tyron (Ed.), Counseling based 
on process research, (pp. 81-131). New York, NY: Allyn & Bacon. 
Conte, H., Plutchik, R., Picard, S., & Karasu, B.T. (1991 ). Can personality traits predict 
psychotherapy outcome? Comprehensive Psychiatry,32(1), 66-72. 
Conte, H., Plutchik, R., Picard, S., Karasu, B.T., & Vaccaro, D. (1988). Self-report measures 
as predictors of psychotherapy outcome. Comprehensive Psychiatry, 29(4), 355-360. 
Costa Jr., P., & McCrae, R. (1992). NEO PI-Rprofessional manual. Odessa, FL: 
Psychological Assessment Resources. 
Costa Jr., P., McCrae, R., & PAR Staff. (2000). Revised NEO Personality Inventory 
interpretive report. Lutz, FL: PAR Psychological Assessment Resources, Inc. 
Cummings, N. (1977). Prolonged (ideal) versus short-term (realistic) psychotherapy. 
Professional Psychology: Research and Practice, 8, 491-501. 
Cummings, N., Budman, S., & Thomas, J. L. (1998). Efficient psychotherapy as a viable 
response to scarce resources and rationing of treatment. Professional Psychology: 
Research and Practice, 29(5), 460-469. 
Cummings, N., O'Donohue, W., & Cummings, J. (2009). The financial dimension of 
integrated behavioral/primary care. Journal of Clinical Psychology in Medical Settings, 
16,31-39. 
Cummings, N. A., & VandenBos, G. R. (1979). The general practice of psychology. 
Professional Psychology: Research and Practice, 10, 430--440. 
Cummings, N. A., & VandenBos, G. R. (1981). The twenty year Kaiser-Pennanente 
experience with psychotherapy and medical utilization: Implications for national health 
policy and national health insurance. Health Policy Quarterly, 1(2), 159-I 75. 
Derogatis, L. ( 1977). The SCL-90 manual: Scoring, administration and procedures for the 
SCL-90. Baltimore, ML: Johns Hopkins University School of Medicine, Clinical 
Psychometrics Unit. 
Dorfinan, W. (2000). Psychological assessment and testing under managed care. ln A. Kent, 
& M. Hersen (Eds.), A psychologist's proactive guide to managed mental health care 
(pp. 23-40). Mahwah, NJ: Lawrence Erlbaum Associates, Publishers. 
Dreessen, L., & Amtz, A. (1998). The impact of personality disorder on treatment outcome 
of anxiety disorders: Best-evidence synthesis. Behaviour Resesearch & Therapy, 36(5), 
483-504. 
PD Pre-Treatment Assessment 113 
Egger, J., De Mey, R., Derksen, J., & van der Staak, C. (2003). Cross-cultural replication of 
the five-factor model and comparison of the NEO-PI-R and MMPI-2 PSY-5 scales in a 
Dutch psychiatric sample. Psychological Assessment, 15(! ), 81-88. 
Eisman, E., Finn, S., Kay, G., Meyer, G., Dies, R., Eyde, L., eta!. (2000). Problems and 
limitations in using psychological assessment in the contemporary health care delivery 
system. Professional Psychology: Research and Practice, 31(2), 131-140. 
Ekselius, L., Lindstrom, E., von Knorring L., Bodlund, 0., & Kullgren, G. (1994). SCID II 
interviews and the SCID Screen questionnaire as diagnostic tools for personality 
disorders in DSM-III--R. Acta Psychiatrica Scandinavica, 90(2), 120-123. 
Ellis, B. B., Becker, P., & Kimmel, H. (1991). Measurement equivalence of an English 
translation of the Trierer Persiinlichkeitsfragebogen, InN. Bleichrodt, & P. Drenth, 
(Eds.), Contemporary issues in cross-cultural psychology (pp. 391-399). Lisse, 
Netherlands: Swets & Zeitlinger Publishers. 
English, J., Sharfstein, S., Scher!, D., Astrachan, B., & Muszynski, I. (1986). Diagnosis-
related groups and general hospital psychiatry: The AP A Study. American Journal of' 
Psychiatry, 143(2), 131-139. 
Erdberg, P. (2004). Assessing the dimensions of personality disorder. In J. Magna vita (Ed.), 
Handbook of personality disorders: Theory and practice, (pp. 78-91 ). Hoboken, NJ: 
John Wiley & Sons, Inc. 
Evans, D., Me11or-Ciark, J., Margison, F., Barkham, M., Audin, K., & Connell, J. (2000). 
CORE: Clinical outcomes in routine evaluation. Journal of' Mental Health, 9(3), 247-
255. 
Eysenck, H. (1994). Creativity and personality: Word association, origence, and 
psychoticism. Creativity Research Journal, 7(2), 209-216. 
Eysenck, H., & Eysenck, S. (1964). Manual of the Eysenck Personality Inventory. San 
Diego, CA: Educational and Industrial Testing Service. 
Fagan, P., Wise, T., Schmidt, C., Ponticas, Y., Marsha11, R., & Costa Jr., P. (1991). A 
comparison oftive-factor personality dimensions in males with sexual dysfunction and 
males with paraphilia. Journal of' Personality Assessment, 57, 434-448. 
Fahrenberg, J., Hampel, R., & Sclg, H. (1985). Die revidierte Fonn des Freiburger 
Persiinlichkeitsinventars FPI-R. Translated Title: A revised fom1 of the Freiburg 
Personality Inventory FPI-R. Diagnostica, 31(1), 1-21. 
Farmer, R., & Chapman, A (2002). Evaluation ofDSM-IV personality disorder criteria as 
assessed by the Structured Clinical Interview for DSM-!V personality disorders. 
Comprehensive Psychiatry, 43(4), 285-300. 
PD Pre-Treatment Assessment 114 
Fennig, S., Craig, T., Lavelle, J., Kovasznay, B., & Bromet, E. (1994). Best-estimate versus 
structured interview-based diagnosis in first-admission psychosis. Comprehensive 
Psychiatry, 35(5), 341-348. 
Fernandez-Ballesteros, R., De Bmyn, E., Godoy, A., Homke, L., Ter Laak, J., Vizcarra, C., 
eta!. (2001). Guidelines for the Assessment Process (GAP): A proposal for discussion. 
European Journal of Psychological Assessment, 17(3), 187-200. 
Finn, S., & Tonsager, M. (1992). Therapeutic effects of providing MMPI-2 test feedback to 
college students awaiting therapy. Psychological Assessment, 4(3), 278-287. 
Finn, S., & Tonsager, M. (1997). Information-gathering and therapeutic models of 
assessment: Complementary paradigms. Psychological Assessment, 9( 4), 374-385. 
First, M., Gibbon, M., Spitzer, R., Williams, J ., & Benjamin, L. ( 1997). User's guide/or the 
Structured Clinical Interview for the DSM-IV Axis Il Personality Disorders. 
Washington, DC: American Psychiatric Press. 
First, M., Spitzer, R., Gibbon, M., & Williams, J. (1995). The Structured Clinical Interview 
for DSM-III-R Personality Disorders (SCID-II): I. Description. Journal a/Personality 
Disorders, 9(2), 83-91. 
First, M., Bell, C., Cuthbert, B., Krystal, J., Malison, R., Offord, D., eta!. (2002). 
Personality disorders and relational disorders. In D. Kupfer, M. First, & D. Regier (Eds.), 
A research agenda for DSM-V(pp. 123-199). Washington, DC: American Psychiatric 
Association. 
Frank, R., & Garfield, R. (2007). Managed behavioral health care carve-outs: Past 
perfonnance and future perspectives. Annual Review ofPublic Health, 28, 303-320. 
Follette W., & Houts, A. (1996). Models of scientific progress and the role of theory in 
taxonomy development: A case study of the DSM. Journal of Consulting and Clinical 
Psychology, 64(6), 1120-1132. 
Gough, H. (1960). The adjective check list as a personality assessment research technique. 
Psychological Reports, 6, 107-122. 
Grilo, C., McGlashan, T., Morey, L., Gunderson, J., Skodol, A., Shea, M. T., eta!. (2001). 
Internal Consistency, intercriterion overlap and diagnostic efficiency of criteria sets for 
DSM-IV schizotypal, borderline, avoidant, and obsessive-compulsive personality 
disorders. Acta Psychiatrica Scandinavica, 104(4), 264-272. 
Gunderson, J., Kolb, J., & Austin, V. (1981). The Diagnostic Interview for Borderline 
Patients. The American Journal of Psychiatry, 138, 896-903. 
PD Pre-Treatment Assessment 115 
Guthrie, P., & Mobley, B. (1994). A comparison of the differential diagnostic efficiency of 
three personality disorder inventories. Journal of' Clinical Psychology, 50, 656-665. 
Hare, R. (1991). The Hare Psychopathy Checklist- Revised Manual. North Tonawanda, NY: 
Multi-Health Systems. 
Harkness, A., & Lilienfeld S. (1997). Individual differences science for treatment planning: 
Personality traits. Psychological Assessment, 9(4), 349-360. 
Harmon, S.C., Lambert, M., Smart, D., Hawkins, E., Nielsen, S. eta!. (2007). Enhancing 
outcome for potential treatment failures: Therapist-client feedback and clinical support 
tools. Psychotherapy Research, 17( 4), 379-392. 
Haynes, S., Leisen, M., & Blaine, D. (1997). Design of individualized behavioral treatment 
programs using functional analytic clinical case models. Psychological Assessment, 9( 4), 
334-348. 
Haynes, S., Spain, E. H., & Oliveira, J. (1993). Identifying causal relationships in clinical 
assessment. Psychological Assessment, 5(3), 281-291. 
Hennessy, K., & Hennessy-Green, S. (1997). An economic and clinical rationale for 
changing utilization review practices for outpatient psychotherapy. Journal of'Mental 
Health Administration, 24(3), 340-349. 
Hilsenroth, M., Peters, E., & Ackennan, S. (2004). The development of therapeutic alliance 
during psychological assessment: Patient and therapist perspectives across treatment. 
Journal of Personality Assessment. Special issue: Personality Assessment and 
Psychotherapy, 83(3), 332-344. 
Horowitz, L., Rosenberg, S., Baer, B., Ureno, G., & Villasenor, V. (1988). Inventory of 
interpersonal problems: Psychometric properties and clinical applications. Journal of 
Consulting and Clinical Psychology, 56, 885-892. 
Horvath, A., & Greenberg, L. (1989). Development and validation of the Working Alliance 
Inventory. Journal of' Counseling Psychology, 36, 223-233. 
Howard, R., & Bassos, C. (2000). The effect of screening versus nonscreening on treatment 
authorization in a managed care setting. Professional Psychology: Research and 
Practice, 31(5), 526-530. 
Huprich, S. (2003). Evaluating NEO Personality Inventory-Revised profiles in veterans with 
personality disorders. Journal ofPersonality Disorders, I 7(1 ), 33-44. 
Jackson, D. (1974). Personality Research Form Manual. Goshen, New York: Research 
Psychologists Press. 
PD Pre-Treatment Assessment 116 
Jackson, D. N. (1977). Reliability of the Jackson Personality Inventory. Psychological 
Reports, 40(2), 613-614. 
Jensen-Doss, A., & Weisz, J. (2008). Diagnostic agreement predicts treatment process and 
outcomes in youth mental health clinics. Journal of Consulting and Clinical Psychology, 
76(5), 711-722. 
Jones, J., Amaddeo, F., Barbui, C., & Tansella, M. (2007). Predicting costs of mental health 
care: A critical literature review. Psychological Medicine, 37, 467-477. 
Kamo, M., Beutler,L., & Harwood, T. M. (2002). Interactions between psychotherapy 
procedures and patient attributes that predict alcohol treatment effectiveness: A 
preliminary report. Addictive Behaviors, 27(5), 779-797. 
Kaye, A., & Shea, M. T. (2000). Personality disorders, personality traits, and defense 
mechanisms measures. In American Psychiatric Association (Ed.), Handbook of 
psychiatric measures, (pp. 713-749). Washington, D.C.: Author. 
Kivlighan, D., & Shaughnessy, P. (1995). Analysis of the development ofthe working 
alliance using hierarchical linear modeling. Journal of Counseling Psycho log, 42(3), 338-
349. 
Klein, D., Schwartz, J., Santiago, N., Vivian, D., Vocisano, C., Castonguay, L., et al. (2003). 
Therapeutic alliance in depression treatment: Controlling for prior change and patient 
characteristics. Journal of Consulting and Clinical Psychology, 71(6), 997-1006. 
Kokotovic, A., & Tracey, T. (1990). Working alliance in early phase of counseling. Journal 
of Counseling Pscyhology, 37, 16-21. 
Kopta, S.M., Lueger, R., Saunders, S., & Howard, K. (1999). Individual psychotherapy 
outcome and process research: Challenges leading to greater turmoil or a positive 
transition? Annual Review of Psychology, 50, 441-469. 
Kraus, D., Jordan, J., & Horan, F. (1996). Validation ofa treatment outcome and assessment 
tool: The Treatment Outcome Package. Ashland, MA: Access Measurement Systems, 
Inc. 
Krueger, R., Markon, K., Patrick, C., Benning, S., & Kramer, M. (2007). Linking antisocial 
behavior, substance use, and personality: An integrative quantitative model of the adult 
extemalizing spectrum. Journal of Abnormal Psychology, 116( 4), 645-666. 
Krupnick, J., Sotsky, S., Simmens, S., Moyer, J., Elkin, 1., Watkins, J., & Pilkonis, P. (1996). 
The role of the therapeutic alliance in psychotherapy ar1d pharmacotherapy outcome: 
Findings in the National Institute of Mental Health Treatment of Depression 
Collaborative Research Program. Journal of Consulting and Clinical Psychology, 64(3), 
532-539. 
PD Pre-Treatment Assessment 117 
Kubiszyn, T., Meyer, G., Finn, S., Eyde, L., Kay, G., Moreland, K., et al. (2000). Empirical 
support for psychological assessment in clinical health care settings. Professional 
Psychology: Research and Practice, 31(2), 119-130. 
Lambert, M., Burlingame, G., Umphress, V., Hansen, N., Vermeersch, D., Clouse, G., et al. 
(1996). The reliability and validity of the Outcome Questionnaire. Clinical Psychology 
and Psychotherapy, 3(4), 249-258. 
Lambert, M., Hansen, N., & Finch, A. (2001). Patient-focused research: Using patient 
outcome data to enhance treatment effects. Journal of Consulting and Clinical 
Psychology, 69(2), 159-172. 
Lambert, M., Hansen, N., Umpress, V., Lunnen, K., Okiishi, J., Burlingame, G., & Reisinger, 
C. (2001). Administration and scoring manualfor the OQ-45.2 (Outcome Questionnaire). 
Orem, UT: American Professional Credentialing Services LLC. 
Lambert, M., Whipple, J., Smati, D., Vermeersch, D., Nielsen, S., & Hawkins, E. (2001 ). 
The effects of providing therapists with feedback on patient progress during 
psychotherapy: Are outcomes enhanced? Psycotherapy Research, 11(1), 49-68. 
Lehman, A., Alexopoulos, G., Goldman, H., Jeste, D., & Ustin, B. (2002). Mental disorders 
and disability: Time to reevaluate the relationship? In D. Kupfer, M. First, & D. Regier 
(Eds.), A research agenda for DSM-V (pp. 201-218). Washington, DC: American 
Psychiatric Association. 
Lenzenweger, M., Lane, M., Loranger, A., & Kessler, R. (2007). DSM-IV personality 
disorders in the National Comorbidity Replication. Biological Psychiatry, 62, 553-564. 
Livesley, W. J. (2001). Conceptual and taxonomic issues. In Livesley, W. John (Ed.) 
Handbook of personality disorders: Theory, research, and treatment. (pp. 3-38). New 
York, NY, US: Guilford Press. 
Livesley, W. J. (2003). Diagnostic dilemmas in classifying personality disorder. In, K. 
Phillips, M. First, & Pincus, H. (Eds.), Advancing DSM: Dilemmas in Psychiatric 
Diagnosis (pp. 153-189). Washington, DC: American Psychiatric Association. 
Livesley, W., Jackson, D., & Schroeder, M. (1991). Dimensions of personality pathology. 
Canadian Journal of Psychiatry, 36(8), 557-562. 
Lutz, W. (2002). Patient-focused psychotherapy research and individual treatment progress 
as scientific groundwork lor an empi1ically based clinical practice. Psychotherapy 
Research, 12(3), 251-272. 
PD Pre-Treatment Assessment 118 
Lynam, D., & Widiger, T. (2001). Using the five-factor model to represent the DSM-IV 
personality disorders: An expert consensus approach. Journal ofAbnormal Psychology, 
I 10(3), 401-412. 
Martin, D., Garske, J., & Davis, M. (2000). Relation of the therapeutic alliance with outcome 
and other variables: A meta-analytic review. Journal ()(Consulting and Clinical 
Psychology, 68, 438-450. 
Maruish, M. (1999). Introduction. In M. Maruish (Ed.), The use of psychological testingfor 
treatment planning and outcomes assessment (211d Ed., pp. 1-39). Mahwah, NJ: Lawrence 
Erlbaum Associates, Publishers. 
Maruish, M. (2004). Introduction. In M. Maruish (Ed.), The use ofpsychological testingfor 
treatment planning and outcomes assessment: Volume 1: General Considerations (3'ct 
Ed., pp. 1-64). Mahwah, NJ: Lawrence Erlbaum Associates, Publishers. 
McCrae, R., & Costa Jr., P. (1997). Personality trait structure as a human universal. 
American Psychologist, 52(5), 509-516. 
McGlashan, T., Grilo, C., Skodol, A., Gunderson, J., Shea, M. T., Morey, L., et al. (2000). 
The collaborative longitudinal personality disorders study: Baseline axis III! and II/II 
diagnostic co-occunence. Acta Psychiatrica Scandinavica, I 02, 256-264. 
McKnight, D., Nelson, R., Hayes, S., & Janet!, R. (1984). Importance of treating 
individually assessed response classes in the amelioration of depression. Behavior 
Therapy, 15, 315-335. 
Meyer, G., Finn, S., Eyde, L., Kay, G., Moreland, K., Dies, R., et al. (200 I). Psychological 
testing and psychological assessment. American Psychologist, 56(2), 128-165. 
Miller, J., Reynolds, S., & Pilkonis, P. (2004). The validity of the five-factor model 
prototypes for personality disorders in two clinical samples. Psychological Assessment, 
16(3), 310-322. 
Millon, T. (1991 ). Classification in psychopathology: Rationale, alternatives, and standards. 
Journal ()/Abnormal Ps~vchology, I 00(3), 245-261. 
Millon, T., & Davis, R. (1995). Conceptions of personality disorders: Historical perspectives, 
the DSMs, and future directions. In W. J. Livesley (Ed.), The DSM-IV personality 
disorders (pp. 3-28). New York, NY: The Guilford Press. 
Millon, T., Millon, C., & Davis, R. (1994). The Millon Clinical Multiaxial Inventory-III, 
Third Edition (MCMI-Ul) manual. Minneapolis, MN: National Computer Systems. 
Mischel, W. (1968; 1996). Personality and assessment. Mahwah, NJ: Lawrence Erlbaum 
Associates, Publishers (1996 reprint). 
PD Pre-Treatment Assessment 119 
Morey, L. (1991 ). Personality Assessment Inventory: Professional manual. Odessa, FL: 
Psychological Assessment Resources. 
Morey, L. (1997). Personality diagnosis and personality disorders. In R. Hogan, J. Johnson, 
& S. Briggs (Eds.), Handbook of personality psychology (pp. 919-946). New York, NY: 
Academic Press. 
Newman, M., & Greenway, P. (1997). Therapeutic effects of providing MMPI-2 test 
feedback to clients at a university counseling service: A collaborative approach. 
Psychological Assessment, 9(2), 122-131. 
O'Connor, B. (2002). The search for dimensional structure differences between nonnality 
and abnormality: A statistical review of published data on personality and 
psychopathology. Journal of Personality and Social Psychology, 83( 4), 962-982. 
O'Connor, B., & Dyce, J. (1998). A test of models of personality disorder configuration. 
Journal of Abnormal Psychology, 107(1), 3-16. 
Oldham, J., Skodol, A., Kellman, H. D., Hyler, S., Doidge, N., Rosnick, L., eta!., (1995). 
Comorbidity of axis I and axis II disorders. American Journal ofPsychiatry, 152(4), 571-
578. 
Pcrepletchikova, F., Hilt, L., Chereju, E., & Kazdin, A. (2009). Baniers to implementing 
treatment integrity procedures: Survey of treatment outcome researchers. Journal of 
Consulting and Clinical Psychology, 77(2), 212-218. 
Perry, J. C., Banon, E., & Ianni, F. (1999). Effectiveness of psychotherapy for personality 
disorders. American Journal of Psychiatry, I 56, 1312-1321. 
Pettinati, H., Pierce Jr., J., Belden, P., & Meyers, K. (1999). The relationship of Axis II 
personality disorders to other known predictors of addition treatment outcome. The 
American Journal on Addictions, 8, 136-14 7. 
Piedmont, R., & Ciarrocchi, J. (1999). The utility of the Revised NEO Personality Inventory 
in an outpatient, dmg rehabilitation context. Psychology a/Addictive Behaviors, 13(3), 
213-226. 
Pilkonis, P. A., Kim, Y., Proietti, J. M., & Barkham, M. (1996). Scales for personality 
disorders developed from the inventory of interpersonal problems. Journal ofPersonality 
Disorders, 10(4), 355-369. 
Piper, W., Joyce, A., McCallum, M., Azim, H., & Ogrodniczuk, J. (2002).lnterpretive and 
supportive psychotherapies: Matching therapy and patient personality. Washington, 
D.C.: American Psychological Association. 
PD Pre-Treatment Assessment 120 
Quirk, M., Strosahl, K., Kreilkamp, T., & Erdberg, P. (1995). Personality feedback 
consultation to families in a managed mental health care practice. Professional 
Psychology: Research and Practice, 26(1), 27-32. 
Quirk, S., Christiansen, N., Wagner, S., & McNulty, J. (2003). On the usefulness of measure 
of normal personality for clinical assessment: Evidence of the incremental validity of the 
Revised NEO Personality Inventory. Psychological Assessment, 15(3), 311-325. 
Reynolds, S., & Clark, L. (2001). Predicting dimensions of personality disorder from 
domains and facets of the Five-Factor Model. Journal o/Personality. 69(2), 199-222. 
Rossier, J., de Stadelhofen, F., & Berthoud, S. (2004). The Hierarchical Structures of the 
NEO PI-Rand the 16PF5. European Journal ofPsychological Assessment, 20(1), 27-38. 
Rossier, J., & Rigozzi, C. (2008). Personality disorders and the Five-Factor Model among 
French speakers in Africa and Europe. Canadian Journal of Psychiatry, 53(8), 534-544. 
Rottman, B., Ahn, W-K., Sanislow, C., & Kim, N. (2009). Can clinicians recognize DSM-IV 
personality disorders from five-factor model descriptions of patient cases? American 
Journal of Psychiatry, 166(4), 427-433). 
Rubio-Stipec, M., Hicks, M., & Tsuang, M. (2000). Cultural factors influencing the selection, 
use, and interpretation of psychiatric measures. In Task Force for the Handbook of 
Psychiatric Measures (Eds.), Handbook of psychiatric measures (pp. 33-41). Washington, 
DC: American Psychiatric Association. 
Ryder, A., Costa Jr., P., & Bagby, R. M. (2007). Evaluation of the SCID-II personality 
disorder traits for DSM-IV: Coherence, discrimination, relations with general personality 
traits, and functional impairment. Journal ojPersonality Disorders, 21(6), 626-637. 
Samuel, D., & Widiger, T. (2008). A meta-analytic review ofthc relationships between the 
five-factor model and DSM-IV-TR personality disorders: A facet level analysis. Clinical 
Psychology Review, 28, 1326-1342. 
Sanislow, C., Grilo, C., Morey, L., Bender, D., Skodol, A., Gunderson, J., et al. (2002). 
Confirmatory factor analysis ofDSM-IV criteria for borderline personality disorder: 
Findings from the collaborative longitudinal personality disorder study. American 
Journal of Pc,ychiatry, 159(2), 284-290. 
Saulsman, L., & Page, A. (2003). The five-factor model and personality disorder empirical 
literature: A meta-analytic review. Clinical Psychology Review, 23(8), 1055-1085. 
Schwartz, S., & Wiedel, T. (198!).lncremental validity of the MMPI in neurological 
decision-making. Journal of Personality Assessment, 45, 424-426. 
PD Pre-Treatment Assessment 121 
Sharpe, J., & Desai, S. (2001). The revised Neo Personality Inventory and the MMPI-2 
Psychopathology Five in the prediction of aggression. Personality and Individual 
Differences, 31(4), 505-518. 
Shea, M. T., Stout, R., Yen, S., Pagano, M., Skodol, A., Morey, L., et al. (2004). 
Associations in the course of personality disorders and Axis I disorders over time. 
Journal of Abnormal Psychology, 113(4), 499-508. 
Shea, M. T., Widiger, T., & Klein, M. (1992). Comorbidity of personality disorders and 
depression: Implications for treatment. Journal of Consulting and Clinical Psychology, 
60(6), 857-868. 
Shear, M. K., Greeno, C., Kang, J., Ludewig, D., Frank, E., Swartz, A., et al. (2000). 
Diagnosis of nonpsychotic patients in community clinics. American Journal of 
Psychiatry, 157(4), 581-587. 
Sher. K., Bartholow, B., & Wood, M. (2000). Personality and substance use disorders: A 
prospective study. Journal of Consulting and Clinical Psychology, 68(5), 819-829. 
Skoda!, A., & Bender, D. (2009). The future of personality disorders in DSM-V? American 
Journal of Psychiatry, 166(4), 388-391. 
Soldz, S., & Vaillant, G. (1999). The big five personality traits and the life course: A 45-year 
longitudinal study. Journal ofResearch in Personality, 33(2), 208-232. 
Spielberger, C., Gorsuch, R., Lushene, R., Vagg, P., & Jacobs, G. (1983). Manual for the 
State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press. 
Stuart, G., Klimidis, S., & Minas, I. (1998). The treated prevalence of mental disorder 
amongst immigrants and the Australian-born community and primary-care rates. 
International Journal ofSocial Psychiatry, 44(1), 22-34. 
Tracy, T., & Kokotovic, A. (1989). Factor structure ofthc Working Alliance Inventory. 
Psychological Assessment, 1, 207-210. 
Trower, P., Yardley, K., Bryant, B., & Shaw, P. (1978). The treatment of social failure: A 
comparison of anxiety-reduction and skills acquisition procedures on two social 
problems. Behavior Modification, 2, 41-60. 
Trull, T., & Widiger, T. ( 1997). Structured Interview for the Five-Factor Model. Odessa, FL: 
Psychological Assessment Resources. 
Tyron, G., Blackwell, S., & Hammel E. (2007). A meta-analytic examination of client-
therapist perspectives of the working alliance. Psychotherapy Research, 17(6), 629-642. 
PD Pre-Treatment Assessment 122 
Tyrer, P., & Alexander, J. (1979). Classification of personality disorder. British Journal of 
Psychiatry, 135, 163-167. 
Tyrer, P., & Alexander, J. (1988). Personality assessment schedule. In P. Tyrer (Ed.), 
Personality disorders: Diagnosis, management and course, (pp. 43-62). Kent, England: 
Tyrer, P., Manley, C., Van Hom, E., Leddy, D., & Ukoumnnne, 0. (2000). Personality 
abnormality in severe mental illness and its inf1nence on outcome of intensive and 
standard case management: A randomised controlled trial. European Psychiatry, 
15(Suppll), 7-10. 
Viera, A., & Garrett, J. (2005). Understanding interobserver agreement: The kappa statistic. 
Research Series: Family Medicine, 37(5), 360-363. 
Walton, K, Roberts, B, Krueger, R., Blonigen, D., & Hicks, B. (2008). Capturing abnormal 
personality with normal personality inventories: An item response theory approach. 
Journal of Personality, 76(6), 1623-48. 
Weissman, M., & Bothwell, S. (1976). Assessment of social adjustment by patient self-
report. Archives of General Psychiatry, 33, 1111-1115. 
Westen, D., & Shedler, J. (1999). Revising and assessing axis II, Part I: Developing a 
clinically and empirically valid assessment method. American Journal of Psychiatry, 
156(2), 258-272. 
Westen, D., & Arkowitz-Westen, L. (1998). Limitations of axis II in diagnosing personality 
pathology in clinical practice. American Journal of Psychiatry, 155(12), 1767-1771. 
Whipple, J., Lambert, M., Venneersch, D., Smart, D., Nielsen, S., & Hawkins, E. (2003). 
Improving the effects of psychotherapy: The use of early identification of treatment 
failure and problem solving strategies in routine practice. Journal of Counseling 
Psychology, 50(1 ), 59-68. 
Widiger, T. (2001). Official classification systems. In W. J. Livesley (Ed.), Hanbook of 
personality disorders, (pp.60-83). New York, NY: The Guilford Press. 
Widiger, T., & Frances, A. (2002). Toward a dimensional model for the personality 
disorders. In P. Costa Jr., & T. Widiger (Eds.), Personality disorders and the five-factor 
model of personality (2"d Ed., pp. 23-44). Washington, DC: American Psychological 
Association, Publishers. 
Widiger, T., & Lowe. J. (2008). A dimensional model of personality disorder: proposal for 
DSM-V. The Psychiatric Clinics of North America, 31(3), 363-78. 
Widiger, T., & Mullins-Sweat!, S. (2009). Five-Factor Model of Personality Disorder: A 
Proposal for DSM-V. Annual Review of Clinical Psychology, 5, 197-220. 
PD Pre-Treatment Assessment 123 
Widiger, T., & Rogers, J. (1989). Prevalence and comorbidity of personality disorders. 
Psychiatric Annals, 19(3), 132-136. 
Widiger, T., & Sanderson, C. (1995). Toward a dimensional model of personality disorders. 
In J. Livesley (Ed.), The DSM-IV Personality Disorders, (pp. 433-458). New York, NY: 
The Guilford Press. 
Widiger, T., & Shea, T. (1991). Differentiation of axis I and axis II disorders. Journal of 
Abnormal Psychology, 100(3), 399-406. 
Wiggins, J. S., Trapnell, P., & Phillips, N. (1988). Psychometric and geometric 
characteristics of the Revised Interpersonal Adjective Scales (IAS--R). Multivariate 
Behavioral Research, 23( 4), 517-530. 
Wilson, S. (2003). Personality, insight, and compliance: A longitudinal study of treatment 
adherence in outpatients with schizophrenia and schizoaffective disorder. Dissertation 
Abstracts International: Section B: The Sciences and Engineering, 64(4-B), 1919. 
Wrig.'lt, R. H. (1991). Toward a national health plan. Advance Plan, I, 14--16. 
Wright, R. H. (1992). Toward a political solution to psychology's dilemmas: Managing 
managed care. Independent Practitioner, 12(3), 111-113. 
Zarin, D. (2000). Considerations in choosing, using, and interpreting a measure for a 
particular clinical context. In Task Force for the Handbook of Psychiatric Measures 
(Eds.), Handbook of psychiatric measures (pp. 15-22). Washington, DC: American 
Psychiatric Association. 
Zimmennan, M., Chelminski, 1., & Young D. (2008). The frequency of personality disorders 
in psychiatric patients. The Psychiatric Clinics o,{North America, 31(3), 405-20. 
PD Pre-Treatment Assessment 124 
Appendices 
A. Checklist for Personality Assessment Instruments 
B. Self-Repmi Personality Instruments Listed in Recent Compilations 
C. Comparison of Recommended Self Report Personality Assessment 
Instruments 
D. Working Alliance Inventory- Client Form 
E. Working Alliance Inventory- Therapist Form 
F. Client Demographics Questionnaire 
G. Therapist Demographics Questionnaire 
H. Therapist Questionnaire- E Form 
I. Therapist Questionnaire- C Fmm 
J. Supervisor Questionnaire 
K. NEO-PI-R Pre In-Service Questionnaire 
L. NEO-PI-R Post In-Service Questionnaire 
M. Therapist and Supervisor Recruitment Flier 
N. Therapist Consent Fonn for EMU PC and CAPS 
0. Therapist Consent Fmm for Wentworth and Associates 
P. Supervisor Consent Form for EMU PC and CAPS 
Q. Supervisor Consent Fonn for Wentworth and Associates 
R. Scripted Phone Contact Protocol 
S. Client Consent Fonn for EMU PC 
T. Client Consent Form for EMU CAPS 
U. Client Consent Fonn for Wentworth and Associates 
V. Study Follow-Up Cover Letter for Post-treatment Packets 
p. 126 
p. 127 
p. 128 
p. 129 
p. 130 
p. 131 
p. 132 
p. 133 
p. 134 
p. 135 
p. 136 
p. 137 
p. 138 
p. 139 
p. 141 
p. 143 
p. 145 
p. 147 
p. 149 
p. 151 
p. 153 
p. 155 
PD Pre-Treatment Assessment 125 
W. Results of Therapist and Supervisor Post Session 6 Questionnaires 
X. SCID-II-SR Questionnaire 
Y- AC. Human Subjects Review Board Approval Letters 
p. 156 
p. 157 
p. 163 
PD Pre-Treatment Assessment 126 
Appendix A: Checklist for Personality Assessment Instruments 
Consideration Comments 
What are the psychometric properties of the instmrnent? 
-
Reliability 
~ 
Construct Validity 
··-·-ON 
- -] Discriminant Validity 
- -------~ 
Positive Predictive Power 
-~··· 
Negative Predictive Power 
---
Is the reading level appropriate for clientele? 
----~ 
Is the instrument ethnically, culturally) or developmentally appropriate? 
·----
Is the length or level of comprehensiveness appropriate for diagnostic purposes? 
... ~ 
Is there a sufficient quantity of methodologically sound research studies available 
on the instrument? 
Does the instrument have impression management items or scales? 
Is the instrument appropriate in terms of cost and time commitment for the client? 
How much training is required to develop mastery with the instrument? 
How much will utilization of the instrument cost in terms of purchase price, time 
to administer, and time to score, interpret, and present results? 
Are important domains of assessment information omitted? 
Will administration or review of results facilitate rapport? 
Will instrument re~~lts improve diagnostic accuracy? 
Will instrument results facilitate detcnnining the appropriate treatment or level of 
care? 
Will use of the instrument foster a disregard of symptomology that may be difficult 
to objectively measure? 
Is the instrument used appropriately (e.g., as a screening device, diagnostic 
measure, prognostic measure, etc.)? 
------~ Is clinical decision-making enhanced due to use of the instrument? 
Is the administrative format the most appropriate means of gathering the desired 
information? ~ Will the results facilitate shorter treatment d~tration, with greater effectiveness? 
How will the results shorten the treatment protocol? 
---1 Can you substantiate your clinical assertions with empirical support? 
---
What is the potential emotional and psychological impact that completion of the 
instrument may evoke in the respondent? 
What are the consequences of true or false results? 
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Appendix B: Self-Report Personality Instruments Listed in Recent Compilations 
-Clark & Harrison, Kaye & Shea, Research Base for 
Measure 2001 2000 Measurec 
Compilation Compilation 
Diagnostically Based 
Coolidge Axis II Inventory -I 32 
Millon Clinical Multiaxial Inventory III -I -I 724 
Minnesota Multiphasic Personality 
Inventory ,j ,j 10,222/2 
MMPI Personality Disorder Scales 
.. 
Personality Assessment Inventoryo ~ -I 176 
---·· 
Personality Diagnostic Questionnaire 
,j ,j 126 IV 
Schedule for Nonadaptive and Adaptive 
,j 28 Personalitya 
- -·-·--·------
Wisconsin Personality Inventory ~ -I 9 
Trait Based . ·. 
Dimensional Assessment of Personality \ Pathology- Basic Questionnaire 17 
Extended Interpersonal Adjective 
,j 9 Scales 
Inventory of Interpersonal Problems-
,j ,j 137 Personality Disorder Scales 
NEO Personality Inventory-· Revised -I -I 601 
Personality Adjective Check List y 16 
Structural Analysis of Social Behavior 
-0 -0 144 lntrex Questiormairc 
Temperament- Character !nvent01y -I 41 
--
Tridimensional Personality 
,j 209 Questionnaire 
' Th1s self-report measure ts considered both a diagnostic mstrument and a trmt-based mstrument 
b Addresses major clinical constructs rather than specific diagnoses 
' Source: Psyehinfo Data Base 2003 
i 
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Appendix C: Comparison of Recommended Self-Rep01i Personality Assessment Instruments 
Instrument 
ITP-PD 
SASBQ-IQ 
TPVTCI 
NEO-PI-R 
#of ltems 
127 
108 
240 
240 
f·ormat ol hems 
5~pt response 
11 ~pt response 
yes/no 
5-pt response 
I line to complete Cost to Hand Score Cost to Computer Score 
NA outofprint out of print 
NA cost prohibitive $2.00+ 
30-40 min NA $4.50 
20-40 min $3.00 S I 3.00 
PD Pre-Treatment Assessment 129 
Appendix D: Working Alliance Inventory- Client Fonn 
Working Alliance Inventory 12 -- Client Fonn 
Study ID #: ----~--~~----­
Date: ------~ 
Below is a list of statements about your relationship with your therapist Please consider each item carefully and indicate 
your level of agreement with each by circling the appropriate number. 
1_ My therapist and I agree about the things I will need to do in therapy to help improve my situation_ 
Not at all 0-------1-------2-------3-------4-------5-------6-------7-------8-------9-------1 0 Always 
2_ What I am doing in therapy gives me new ways of looking at my problem_ 
Not at all 0------1-------2-------3-------4-------5-------6-------7-------8-------9-------1 0 Always 
3_ I believe my therapist likes me_ 
Not at all 0-------1------2-------3-------4-------5-------6-------7-------8-------9-------10 Always 
4_ My therapist does not understand what I am trying to accomplish in therapy_ 
Always 0-------1-------2-------3-------4-------5-------6-------7-------8-------9-------10 Not at all 
5- I am confident in my therapist's ability to help me_ 
Not at all 0-------1------2-------3-------4-------5-------6-------7------8-------9-------1 0 Always 
6_ My therapist and I are working towards mutually agreed upon goals_ 
Not at all 0-------1-------2-------3------4------5-------6-------7-------8-------9-------1 0 Always 
7_ I feel my therapist appreciates me. 
Not at all 0-------1-------2-------3------4------5-----6------7-------8-------9-------10 Always 
8. We agree on what is important for me to work on. 
Not at all 0-------1-------2-------3-------4-------5-------6-------7-------8-------9-------1 0 Always 
9. My therapist and I trust one another. 
Not at all 0------1-------2------3-------4-------5-------6------7-------8-------9-------10 Always 
10. My therapist and I have different ideas on what my problems are. 
Always 0-------1-------2-------3-------4-------5-------6-------7-------8-------9-------10 Not at all 
11. We have established a good understanding of the kind of changes that would be good for me. 
Not at all 0------1-------2------3-------4------5-------6-------7------8-------9-------1 0 Always 
12. I believe the way we are working with my problem is correct. 
Not at all 0-------1-------2-------3-------4-------5-------6-------7-------8-------9-------10 Always 
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Appendix E: Working Alliance Inventory- Therapist Form 
Client: ____ _ 
Date: 
Working Alliance Inventory 12 -~Therapist Form 
Below is a list of statements about your relationship with your client Please consider each item carefully and indicate your 
level of agreement for each by circling the appropriate number. 
1. My client and I agree about the things he/she will need to do in therapy to help improve his/her situation. 
Not at all 0----1-----2-------3------4-------5-------6-------7-------8------9-------1 0 Always 
2. What my client is doing in therapy gives him/her new ways of looking at his/her problem. 
Not at all 0-------1-------2-------3-------4-------5-------6-------7-------8-------9-------10 Always 
3. I believe my client likes me. 
Not at all 0-------1-------2-------3-------4-------5-------6-------7-------8-------9-------1 0 Always 
4. My client does not understand what I am trying to accomplish in therapy. 
Always 0-------1-------2------3-------4-------5-------6-------7-------8-------9-------1 0 Not at all 
5. I am confident in my client's ability to help him/herself. 
Not at all 0-------1-------2-------3-------4-------5-------6-------7-------8-------9-------10 Always 
6. My client and I are working towards mutually agreed upon goals. 
Not at all 0-------1-------2-------3-------4-------5-------6-------7-------8-------9-------1 0 Always 
7. I feel my client appreciates me. 
Not at all 0-------1-------2-------3-------4-------5-------6-------7------8-------9-------10 Always 
8. We agree on what is important for my client to work on. 
Not at all 0-------1-------2-------3-------4-------5-------6------7------8-------9-------1 0 Always 
9. My client and I trust one another. 
Not at all 0------1-------2-------3-------4-------5-------6-------7-------8-------9-------10 Always 
10. My client and I have different ideas on what his/her problems are. 
Always 0-------1-------2-------3-------4------5------6-------7------8-------9-------10 Not at all 
11. We have established a good understanding of the kind of changes that would be good for him/her. 
Not at all 0-------1-------2-------3-------4-------5-------6-------7-------8-------9-------1 0 Always 
12. I believe the way we are working with my client's problem is correct 
Not at all 0-------1-------2-------3-------4-------5-------6-------7-------8-------9-------10 Always 
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Appendix F: Client Demographics Fonn 
DEMOGRAPHICS 
Please first provide us with some background information: 
Your age: years Your sex: o Male o Female 
Some people identify themselves as belonging to one or several racial or ethnic group(s). Please check which group(s) you 
identify most strongly with: 
o European-American o Black or African-American o Hispanic/Latino-American o Asian-American 
o American Native or Alaskan Native o Pacific Islander-American o Middle Eastern-American 
o Mixed o Other- please list ~~~~ 
Number of years of college completed: ___ years 
Marital status: 
o Married o Live with partner o Single [J Scparated/Di vorccd 
o Widowed o Other--· please list ~--- .. ~-~- .. ·-~-
Employment (please check all that apply): 
o Employed o Unemployed 
o Studento Homemaker 
LJ Retired o Disability 
o Military Service 
Annual household income: Are you a dependent on your parents' tax return? D Y cs o No 
If yes, please indicate his/her/their income level; if no, please indicate your income !eve!: 
0 2:$150,000 0$100,000-$149,999 0$75,000-$99,999 0$50,000-$74,999 
o $25,000-$49,999 o $10,000-$24,999 o :S$9,999 o Don't know, or prefer notto say 
How would you describe the economic situation of your family as you were growing up? (Check one) 
We had barely enough to get by 
We had enough to get by, but no more 
We were solidly middle class 
We had plenty of"extras" 
We had plenty of"luxuries" 
Don't know/unsure/prefer not to say 
Which of the following is most true for you? 
o I do not have any friends or relatives that I can talk to about my troubles and sorrows. 
o I have one or two friends or family members that I can talk to about my troubles and sorrows. 
o I have a f"Cw friends or fi:uni!y members that I can talk to about my troubles and sorrows. 
o I have many friends or family members that I can talk to about my troubles and sorrows. 
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Appendix G: Therapist Demographics Questionnaire 
Therapist Demographics 
Thank you for agreeing to participate in this study. Please complete the following and return to the 
research coordinator. 
Date: 
Your age: ___ years Your sex: o Male o Female 
Some people identify themselves as belonging to one or several racial or etlmic group(s). Please check which 
group(s) you identify most strongly with: 
o White or Caucasian o Black or African-American o Hispanic or Latino o Asian 
o American Native or Alaskan Native o Pacific Islandero Middle Eastern o Mixed 
o Other - please list 
1, What is your primary theoretical orientation? 
o Behavioral o Biological o Cognitive 
o Cognitive-Behavioral o Ecosystems o Family 
o Humanistic o Pragmatic o Psychodynamic 
o Other: 
2. Please indicate the number of clients you have seen for the following: 
Therapy: _________________ (approximate total number) 
Assessment: 
Personality _______ (approximate total number) 
LD ---"~" ____ " ___ " __ (approximate total number) 
ADHD _________ (approximate total number) 
Functional Analysis ______ " ___ (approximate total number) 
Other _" ______ Type: 
3. Please indicate the number of assessment feedback sessions you have conducted: 
Therapy: ____________ (approximate total number) 
Assessment: ________ (approximate total number) 
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Appendix H: Therapist Questionnaire- E Form 
Therapist Questionnaire~ E Form 
After your sixth session with c-;-;c---:---:;~-----c---cc--c--cc---c-·' please answer the following questions. Thank 
you for returning your completed form to the research assistant. Your participation in this study is appreciated more than 
you know! 
Date: 
! . How helpful was the NEO-PI-R mmativc report in the development of your case formulation? 
Not at all O-------l-------2-------3-------4-------5-------6-------7 -------8-------9-------1 0 Very 
2. Did you share the NEO-PI-R results with your client? o Yes o No 
3. If you shared the results with your client, how did you present them? 
o Per in-service training 
o Slight modification to in-service training. Please explain: -:;c-e----
o Considerable modification to in-service training. Please explain: ___ _ 
o Gave the client the report with minima! or no discussion of results. 
o Other. Please explain: 
~~--------~~~-
If you did not share the results with your client, what influenced your decision? 
o No time o Clinically contraindicated o Forgot 
o Inconsistent attendance by client o Irrelevant to case conccptuulization 
o Other. Please explain: 
4. How has the narrative influenced your conceptualization of your client's personality strengths and weaknesses? 
V cry negatively -5 -4 -3 -2 -I 0 2 3 4 5 Very positively 
Comment: 
5. How has the narrative influenced your interaction with your client? 
Very negatively -5 -4 -3 -2 -I 0 2 3 4 5 Very positively 
Comment (i.e., you became more conservative, more empathic, less empathic, reconsidered your intervention stnltegy, etc.): 
6. If you shared the results with your client, how did they influence your client's response to therapeutic interventions? 
Very negatively -5 -4 -3 -2 -I 0 2 3 4 5 Very positively 
Comment 
7. Other than the OQ 45.2, please list all assessment instruments you have given to your client to complete or your client 
has received during the course of therapy, including any form of questionnaire, rapid assessment inventories, personality 
inventories, intelligence testing, etc: 
D MMPI D TAT D MCMI-lll o 16PF 
o Beck Depression Inventory (BDJ) 
o WISC-IV o WAIS-lll o WIATII 
o Rorschach 
D State Trait Anxiety Scale (STAI) 
D WMS D CPT 
Any other assessment instruments (i.e., gambling, assertiveness, structured interviews, etc.)? 
o Other: 
--~~--------------------~~-----~~~~~ 
o Other: 
o Other: 
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Appendix I: Therapist Questionnaire - C F onn 
Therapist Questionnaire-" C Fonn 
After your sixth session with -· , please answer the following 
questions. Thank you fOr returning your completed form to the research assistant. Your participation in this 
study is appreciated more than you know! 
Date: 
1. How much has the NEO-PI-R training/intervention influenced your attention to the impact of this client's 
personality traits on therapeutic interactions? 
Not at all 0-------1-------2-------3-------4-------5-------6-------7-------8-------9-------1 0 Very 
2. How has the training/intervention influenced your conceptualization of your client's personality strengths 
and weaknesses? 
Very negatively -5 -4 -3 -2 -1 0 2 3 4 5 Very positively 
Comments: 
3. How has the training/intervention influenced your interaction with your client? 
Very negatively -5 -4 -3 -2 -l 0 2 3 4 5 Very positively 
Comment (i.e., you became more conservative, more empathic, less empathic, reconsidered your intervention 
strategy, etc.): 
4. Other than the OQ 45.2, please list all assessment instruments you have given to your client to complete or 
your client has received during the course of therapy, including any form of questionnaire, rapid assessment 
inventories, personality inventories, intelligence testing, etc: 
o MMPI o TAT o MCMI-Ill o 16PF o Rorschach 
o Beck Depression Inventory (BDI) o State Trait Anxiety Scale (ST AI) 
o WISC-IV o WAlS-III o WIATII o WMSo CPT 
Any other assessment instruments (i.e., gambJing, assertiveness, structured interviews, etc.)? 
o Other: 
o Other: 
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Appendix J: Supervisor Questionnaire 
For your supervisee,----~-"----~---·· seeing__ , would you please answer the 
following questions? Thank you for placing your completed fonn in Shauncie's mailbox. Your pmiicipation in this study is 
appreciated more than you know! 
1. How much has the NEO~PI~R training/intervention influenced your attention to the impact of this client's personality 
traits on therapeutic interventions? 
Not at all 0-------1-------2-------3-------4-------5-------6-------7-------8-------9-------1 0 Very 
2. How has the training/intervention influenced your conceptualization of this client's personality strengths and 
weaknesses? 
Very negatively -5 -4 -3 -2 -1 0 2 3 4 5 Very Positively 
Comment:.~--------- ~~~~-----······ 
3. How has the training/intervention in1luenced your recommendation/suggestions regarding therapeutic interventions 
with this client? 
Very negatively -5 -4 -3 -2 -1 0 2 3 4 5 Very Positively 
4. If your supervisee received NEO-PI-R results for this client, did you encourage your supervisee to share the results with 
the client? 
o Yes o No o Not Applicable 
If yes, which of the following best describes your suggestions about the feedback? 
o No specific feedback suggestions were given 
o As suggested in the in-service training 
o Slight modification to in-service training. Please explain:--~-~-...... --.. ~·~··---------- ----·------~"-· 
o Considerable modification to in-service training. Please explain: ·------ --------~-·-
0 Gave the client the report with minimal or no discussion of results. 
o Other. Please explain: ---------------------------~~- .. ~----··-~-----~ .. ~··-------~-----------~------
If not, what influenced you decision? 
o Notime o Clinically contraindicated o Forgot 
o Inconsistent attendance by client o Inelevant to case conceptualization 
o Other. Please explain: ___ _ 
5. Other than the OQ 45.2, please list a!! assessment instruments you have recommended that your supervisee administer to 
this client, including any form of questionnaire, rapid assessment inventory, personality inventory, intelligence testing, 
etc.: 
o Not Applicable 
o MMPI o TAT o MCMI-111 o 16PF o Rorschach 
o Beck Depression Inventory (BDI) o State Trait Anxiety Scale (STAI) 
o WISC-IV o W AIS-111 o WIA T 11 o WMS o CPT 
Any other assessment instruments (i.e., gambling, assertiveness, structured interviews, etc.)? 
o Other: 
o Other: ----------------------------------------~-----------
II 
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Appendix K: NEO-Pl-R Pre In-Service Questionnaire 
NEO-PI-R In-Service Pre-Q 
Thank you for choosing to participate in this in-service. Thank you, also, for taking the time to complete this 
questionnaire. 
1. How many years of clinical psychology experience/education do you have? 
2. How would you rate your level of expertise with assessment feedback to clients? 
No Expertise 0-----1-----2-----3-----4-----5-----6-----7-----8-----9-----10 Expert 
3. How would you rate your level of expertise with the NEO-PI-R? 
No Expertise 0-----1-----2-----3-----4-----5-----6-----7-----8-----9-----10 Expert 
4. How would you rate your level of expertise regarding utilization of the NEO-PI-R with a clinical 
population? 
No Expertise 0-----1-----2-----3-----4-----5-----6-----7-----8-----9-----10 Expert 
5. Did you have any specific expectation regarding this in-service? Is yes, please explain: 
6. Any additional comments: 
·-~----~---------
II 
II 
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Appendix L: NEO-Pl-R Post In-Service Questionnaire 
NEO-Pl-R In-Service Post-Q 
Thank you again for choosing to participate in this in-service. Thank you, also, for taking the time to complete 
this questi01maire. 
1. How many years of clinical psychology experience/education do you have? 
2. How useful was the information presented today? 
Not at all Useful 0-----1-----2-----3-----4-----5-----6-----7-----8-----9-----10 Very Useful 
3. Do you feel you received enough information about the NEO-PI-R? 
oYES oNO oDON'TKNOW 
3. How confident do you feel about giving clients feedback regarding their NEO-PI-R results? 
Not at all Confident O-----l-----2-----3-----4-----5-----6-----7-----8-----9-----l 0 Extremely Confident 
4. How confident do you feel about the clinical utility of the NEO-PI-R results? 
Not at all Confident O-----l-----2-----3-----4-----5-----6-----7-----8-----9-----l 0 Extremely Confident 
5. Do you feel you given enough opporlunity to discuss the issues you wanted to discuss? 
oYES o NO oDON'TKNOW 
6. Comments: 
····---··-·----
II 
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Appendix M: Therapist and Supervisor Recruitment Flier 
Dear Fellow Therapists & Supervisors 
Your Participation Will Be Greatly Appreciated!!!! 
Shauncie' s dissertation, a study investigating the usefulness of administering a personality assessment to clients 
before they are seen for therapy, will begin the next week. The success o(tlte study is dependent on therapist 
and supervisor participation. Tit ere (ore. vour help would be greatly appreciated, 
The details of the study are listed in the attached consent form. Note: This applies to new clients only, and the 
NEO-PI-R will be administered, by a research assistant, before the client is seen for therapy. The table below 
indicates the time line and needed paperwork for each client. 
Therapist Tasks: 
I) a one-time completion of a 6-item demographics questionnaire, 
2) if you receive a copy of the NEO-Pl-R, discuss/review the results with your supervisor, 
3) if your supervisor agrees, give the results ofNEO-Pl-R report to the client, 
4) completion of a 12-item Working Alliance Inventory for each client, and 
5) completion of a 4 or 8-item, post-treatment-plan questionnaire for each client. 
Supervisor Tasks: 
1) if the therapist is given the NEO-PI-R for a client, discuss/review the results with the therapist, and 
2) completion of 4-item, post-treatment-plan questionnaire. 
-·-
Measure Time of Assessment 
Pre-Tx 21w Session 3ru Session ln Session 611 Session Post-Tx 
Client Demographics Client Q 
SCID-II PQ Client Client 
NEO-Pl-R Client 
NEO Nan-alive Therapist Report to Therapist 
Working Alliance Therapist & 
Inventory Client 
Therapist 
Demographics Therapist 
Questionnaire 
Post Treatment Plan Therapist & 
Questionnaire Supervisor 
OQ45.2 Client Client Client Client Client Client 
If you have any questions or would like additional information, please feel free to contact me or Dr. Saulcs 
(sskidmor@cmich.edu or 734-255-7691; ksaules@cmich.edu or 734-487-4988). 
lfvou would like to participate. please complete the in(ormed consent and place it in mv mailbox. 
Thanks so much for your time and consideration of this request. 
' 
~ 
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Appendix N: Therapist Consent Fmm for EMU PC & CAPS 
Therapist Informed Consent 
Project Title: The Effect of Pre-Treatment Assessment on Therapy Outcome 
Investigator: Shauncie Skidmore, M.S., Eastern Michigan University 
Co-Investigator: Karen Saules, PhD., EMU Psychology Clinic Director 
PURPOSE OF THIS RESEARCH STUDY: To evaluate factors that may influence the course of 
individual psychotherapy. 
PROCEDURE: Please read this consent form. If you have any questions about the study, please 
contact either Shauncie Skidmore (487-4987; sskidmor@emich.edu) or Karen Saules (487-4988; 
ksaules@emich.edu), 
Your clients, who consent to participate in this study, will be asked to complete five questionnaires: a 
demographics questionnaire, the NEO-PI-R, which is a measure of personality, the SCID II 
Questionnaire, which is a measure of personality patterns, the Outcome Questionnaire 45.2, which is 
a measure of symptomology, and the Working Alliance Inventory 12- Client Version, which is a 
measure of the quality of the relationship with the therapist The first four measures will be 
administered before your client sees you for the first time. The fifth measure will be administered just 
prior to the fourth session. In addition, your client will be asked to complete an Outcome 
Questionnaire (OQ 45.2) just prior to their first six sessions. 
For this study, each client participant will be randomly assigned to one of two conditions, either to a 
group in which the therapist will be given a report describing the results of the NEO-PI-R 
questionnaire data (results condition), or to a group in which the therapist is not given any information 
about the NEO-PI-R questionnaire results (no results condition). Therapists will not be given 
feedback on the results of the SCID II Questionnaire or Working Alliance Inventory for either 
condition. 
If you consent to participate in this study, you will be asked to complete a demographics 
questionnaire (one time only) and a Working Alliance Inventory 12- Therapist Version just prior to 
the fourth session with each client In addition, if your client has been assigned to the results 
condition, you will be given a narrative report of the NEO-PI-R results (to use at your discretion) prior 
to the second session with your client Also, you will be asked to complete a therapist questionnaire 
(containing 6 items) after the 6th session with your client The approximate total time to complete the 
questionnaires should be about 15 minutes. 
Also, you will be given a duplicate copy of this informed consent, which includes follow-up contact 
information, if needed. 
CONFIDENTIALITY: All study data will be kept in a locked file cabinet at the EMU Psychology Clinic, 
separate from your client's clinic chart 
EXPECTED RISKS: There are no known risks or side effects associated with participation in this 
study, 
EXPECTED BENEFITS: All participants will receive educational benefits concerning the nature of 
psychological research. In addition, you might be given information that may influence the course of 
therapy with your client 
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VOLUNTARY PARTICIPATION: Participation in this study is voluntary. You may choose not to 
participate. If you do decide to participate, you can change your mind at any time and withdraw from 
the study without negative consequences. 
USE OF RESEARCH RESULTS: The results of this study may be included in the principal 
investigator's dissertation, may be included in a research publication, and/or may be presented at 
conferences. You will not be identified in any publication or report of this study. 
If the results of this study indicate that the course of treatment is improved with the therapist's 
knowledge of the questionnaire results, for any of your clients that may have been assigned to the no-
results-to-therapist group, a description of their questionnaire responses will be provided to you upon 
request after, but not before, the 6th session or upon completion of the study. 
FUTURE QUESTIONS: If, at any time, you have questions about study procedures or your 
participation in the study, please contact the principal investigator, Shauncie Skidmore, at 734-487-
4987. 
EMERGENCY CONTACT INFORMATION: If you feel the need to consult with someone regarding 
your reactions to participating in this study, the following agencies offer services: 
Snow Counseling Services: (734) 487-1118 (services are for EMU students only) 
EMU Psychology Clinic: (734) 487-4987 
University of Michigan 24-Hour Psychiatric Emergency Services: (734) 996-4747 
HUMAN SUBJECTS REVIEW BOARD: This research protocol and informed consent document 
have been reviewed and approved by the Eastern M'tchigan University Human Subjects Review 
Committee for use from 15 June 07 to 15 June 08. If you have any questions about the approval 
process, please contact Dr. Deb de Laski-Smith (734.487.0042, Interim Dean of the Graduate School 
and Administrative Co-chair of UHSRC, human.subjects@emich.edu). 
CONSENT TO PARTICIPATE: I have read or had read to me all the above information about this 
research study, including the research procedures, possible risks, side effects, and the likelihood of 
any benefit to me. The content and meaning of this information has been explained and I 
understand. All my questions, at this time, have been answered. I hereby consent and do voluntarily 
offer to follow the study requirements and take part in the study. 
PRINT NAME: ------·----------
Signatures: 
Participant (your signature) Date 
Witness: 
Investigator or Specified Designee Date 
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Appendix 0: Therapist Consent Form for Wentworth and Associates 
THERAPIST INFORMED CONSENT 
Project Title: The Effect of Pre-Treatment Assessment on Therapy Outcome 
Investigator: Shauncie Skidmore, M. S., Eastern Michigan University 
Co-Investigator: Karen Saules, Ph.D., EMU Psychology Clinic Director 
PURPOSE OF THIS RESEARCH STUDY: To evaluate factors that may influence the course of 
individual psychotherapy. 
PROCEDURE: Please read this consent form. If you have any questions about the study, please 
contact either Shauncie Skidmore (487-4987; sskidmor@emich.edu) or Karen Saules (487-4988; 
ksaules@emich.edu). 
Your clients, who consent to participate in this study, will be asked to complete five questionnaires: a 
demographics questionnaire, the NEO-PJ-R, which is a measure of personality, the SCID II 
Questionnaire, which is a measure of personality patterns, the Outcome Questionnaire 45.2, which is 
a measure of symptomology, and the Working Alliance Inventory 12- Client Version, which is a 
measure of the quality of the relationship with the therapist. The first four measures will be 
administered before your client sees you for the first time. The fifth measure will be administered just 
prior to the fourth session. In addition, your client will be asked to complete an Outcome 
Questionnaire (OQ 45.2) just prior to their first six sessions. 
For this study, each client participant will be randomly assigned to one of two conditions, either to a 
group in which the therapist will be given a report describing the results of the NEO-PI-R 
questionnaire data (results condition), or to a group in which the therapist is not given any information 
about the NEO-PI-R questionnaire results (no results condition). Therapists will not be given 
feedback on the results of the SCID II Questionnaire or Working Alliance Inventory for either 
condition. 
If you consent to participate in this study, you will be asked to complete a demographics 
questionnaire (one time only) and a Working Alliance Inventory 12- Therapist Version just prior to 
the fourth session with each client. In addition, if your client has been assigned to the results 
condition, you will be given a narrative report of the NEO-PI-R results (to use at your discretion) prior 
to the second session with your client. Also, you will be asked to complete a therapist questionnaire 
(containing 6 items) after the 61h session with your client. The approximate total time to complete the 
questionnaires should be about 15 minutes. 
Also, you will be given a duplicate copy of this informed consent, which includes follow-up contact 
information, if needed. 
CONFIDENTIALITY: All study data will be kept in a locked file cabinet at the EMU Psychology Clinic, 
separate from your client's clinic chart. 
EXPECTED RISKS: There are no known risks or side effects associated with participation in this 
study. 
EXPECTED BENEFITS: All participants will receive educational benefits concerning the nature of 
psychological research. In addition, you might be given information that may influence the course of 
therapy with your client. 
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VOLUNTARY PARTICIPATION: Participation in this study is voluntary. You may choose not to 
participate. If you do decide to participate, you can change your mind at any time and withdraw from 
the study without negative consequences. 
USE OF RESEARCH RESULTS: The results of this study may be included in the principal 
investigator's dissertation, may be included in a research publication, and/or may be presented at 
conferences. You will not be identified in any publication or report of this study. 
If the results of this study indicate that the course of treatment is improved with the therapist's 
knowledge of the questionnaire results, for any of your clients that may have been assigned to the no-
results-to-therapist group, a description of their questionnaire responses will be provided to you upon 
request after, but not before, the sixth session or upon completion of the study. 
FUTURE QUESTIONS: If, at any time, you have questions about study procedures or your 
participation in the study, please contact the principal investigator, Shauncie Skidmore, at 734-487-
4987. 
EMERGENCY CONTACT INFORMATION: If you feel the need to consult with someone regarding 
your reactions to participating in this study, the following agencies offer services: 
Wentworth and Associates: 
Harbor Oaks: 
StJohn's Oakland Hospital: 
(586) 997-3153 
(586) 725-5777 
(248) 997-3153 
HUMAN SUBJECTS REVIEW BOARD: This research protocol and informed consent document 
have been reviewed and approved by the Eastern Michigan U n·1versity Human Subjects Review 
Committee for use from 15 June 07 to 15 June 08. If you have any questions about the approval 
process, please contact Dr. Deb de Laski-Smith (734.487.0042, Interim Dean of the Graduate School 
and Administrative Co-chair of UHSRC, human.subjects@emich.edu). 
CONSENT TO PARTICIPATE: I have read or had read to me all the above information about this 
research study, including the research procedures, possible risks, side effects, and the likelihood of 
any benefit to me. The content and meaning of this information has been explained and I 
understand. All my questions, at this time, have been answered. I hereby consent and do voluntarily 
offer to follow the study requirements and take part in the study. 
PRINT NAME: ---------------
Signatures: 
Participant (your signature) Date 
Witness: 
-·----
Investigator or Specified Designee Date 
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Appendix P: Supervisor Informed Consent for EMU PC and CAPS 
SUPERVISOR INFORMED CONSENT 
Project Title: The Effect of Pre-Treatment Assessment on Therapy Outcome 
Investigator: Shauncie Skidmore, M.S., Eastern Michigan University 
Co-Investigator: Karen Sautes, Ph.D., EMU Psychology Clinic Director 
Please read this consent form in its entirety. If you have any questions about the study, please 
contact either Shauncie Skidmore (487-4987; sskidmor@emich.edu) or Karen Sautes (487-4988; 
ksaules@emich.edu). 
PURPOSE OF THIS RESEARCH STUDY: To evaluate factors that may influence the course of 
individual psychotherapy. 
PROCEDURE: Your supervisees' clients, who consent to participate in this study, will be asked to 
complete five questionnaires: a demographics questionnaire, the NEO-PI-R, which is a measure of 
personality, the SCID II Questionnaire, which is a measure of personality patterns, the Outcome 
Questionnaire 45.2, which is a measure of distress symptomology, and the Working Alliance 
Inventory 12- Client Version, which is a measure of the quality of the relationship with the therapist. 
The first four measures will be administered before your supervisees' clients are seen by the 
supervisees for the first time. The fifth measure will be administered just prior to the fourth session. 
In addition, your supervisees' clients will be asked an Outcome Questionnaire (OQ 45.2) before each 
of their first six sessions. 
For this study, each client participant will be randomly assigned to one of two conditions, either to a 
group in which your supervisees will be given a report describing the results of the NEO-PI-R 
questionnaire data (results condition), or to a group in which they are not given any information about 
the NEO-PI-R questionnaire results (no results condition). They will not be given feedback on the 
results of the SCID II Questionnaire or Working Alliance Inventory for either condition. If your 
supervisee's client has been assigned to the results condition, they will be given a narrative report of 
the NEO-PI-R results (to use at your and their discretion) prior to the second session with the client. 
If you consent to participate in this study, you will be asked to complete a Supervisor's Questionnaire 
after your supervisee has had time to refine the case conceptualization and treatment plan for their 
study-participating client (typically following the 6'h session). The approximate total time to complete 
the questionnaires should be about 15 minutes. 
Also, you will be given a duplicate copy of this informed consent, which includes follow-up contact 
information, if needed. 
CONFIDENTIALITY: All study data will be kept in a locked file cabinet at the EMU Psychology Clinic, 
separate from the client's clinic chart 
EXPECTED RISKS: There are no known risks or side effects associated with participation in this 
study. 
EXPECTED BENEFITS: All participants will receive educational benefits concerning the nature of 
psychological research. In addition, you might be given information that may influence the course of 
therapy with the client. 
VOLUNTARY PARTICIPATION: Participation in this study is voluntary. You may choose not to 
participate. If you do decide to participate, you can change your mind at any time and withdraw from 
the study without negative consequences. 
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USE OF RESEARCH RESULTS: The results of this study may be Included In the principal 
Investigator's dissertation, may be included in a research publication, and/or may be presented at 
conferences. You will not be identified in any publication or report of this study. 
If the results of this study indicate that the course of treatment is improved with the therapist's 
knowledge of the questionnaire results, for any of the clients that may have been assigned to the no-
results-to-therapist group, a description of their questionnaire responses will be provided to your 
supervlsees upon request after, but not before, the 61h session or upon completion of the study. 
FUTURE QUESTIONS: If, at any time, you have questions about study procedures or your 
participation in the study, please contact the principal investigator, Shauncie Skidmore, at 734-487-
4987. 
EMERGENCY CONTACT INFORMATION: If you feel the need to consult with someone regarding 
your reactions to participating in this study, the following agencies offer services: 
Snow Counseling Services: (734) 487-1118 (services are for EMU students only) 
EMU Psychology Clinic: (734) 487-4987 
University of Michigan 24-Hour Psychiatric Emergency Services: (734) 996-47 47 
HUMAN SUBJECTS REVIEW BOARD: This research protocol and informed consent document 
have been reviewed and approved by the Eastern Michigan University Human Subjects Review 
Committee for use from 15 June 07 to 15 June 08. If you have any questions about the approval 
process, please contact Dr. Deb de Laski-Smith (734.487.0042, Interim Dean of the Graduate School 
and Administrative Co-chair of UHSRC, human.subjects@emich.edu). 
CONSENT TO PARTICIPATE: I have read or had read to me all the above information about this 
research study, including the research procedures, possible risks, side effects, and the likelihood of 
any benefit to me. The content and meaning of this information has been explained and I 
understand. All my questions, at this time, have been answered. I hereby consent and do voluntarily 
offer to follow the study requirements and take part in the study. 
PRINTNAME: --------------------------------
Signatures: 
Participant (your signature) Date 
Witness: 
Investigator or Specified Designee Date 
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Appendix Q: Supervisor Informed Consent for Wentworth and Associates 
SUPERVISOR INFORMED CONSENT 
Project Title: The Effect of Pre-Treatment Assessment on Therapy Outcome 
Investigator: Shauncie Skidmore, M. S., Eastern Michigan University 
Co-Investigator: Karen Sautes, Ph.D., EMU Psychology Clinic Director 
Please read this consent form in its entirety. If you have any questions about the study, please 
contact either Shauncie Skidmore (487-4987; sskidmor@emich.edu) or Karen Sautes (487-4988; 
ksaules@emich.edu). 
PURPOSE OF THIS RESEARCH STUDY: To evaluate factors that may influence the course of 
individual psychotherapy. 
PROCEDURE: Your supervisees' clients, who consent to participate in this study, will be asked to 
complete five questionnaires: a demographics questionnaire, the NEO-PI-R, which is a measure of 
personality, the SCID II Questionnaire, which is a measure of personality patterns, the Outcome 
Questionnaire 45.2, which is a measure of distress symptomology, and the Working Alliance 
Inventory 12- Client Version, which is a measure of the quality of the relationship with the therapist. 
The first four measures will be administered before your supervisees' clients are seen by the 
supervisees for the first time. The fifth measure will be administered just prior to the fourth session. 
In addition, your supervisees' clients will be asked an Outcome Questionnaire (OQ 45.2) before each 
of their first six sessions. 
For this study, each client participant will be randomly assigned to one of two conditions, either to a 
group in which your supervisees will be given a report describing the results of the NEO-Pl-R 
questionnaire data (results condition), or to a group in which they are not given any information about 
the NEO-PI-R questionnaire results (no results condition). They will not be given feedback on the 
results of the SCID II Questionnaire or Working Alliance Inventory for either condition. If your 
supervisee's client has been assigned to the results condition, they will be given a narrative report of 
the NEO-PI-R results (to use at your and their discretion) prior to the second session with the client. 
If you consent to participate in this study, you will be asked to complete a Supervisor's Questionnaire 
after your supervisee has had time to refine the case conceptualization and treatment plan for their 
study-participating client (typically following the 61h session). The approximate total time to complete 
the questionnaires should be about 15 minutes. 
Also, you will be given a duplicate copy of this informed consent, which includes follow-up contact 
information, if needed. 
CONFIDENTIALITY: All study data will be kept in a locked file cabinet at the EMU Psychology Clinic, 
separate from the crtent's c!fnlc chart. 
EXPECTED RISKS: There are no known risks or side effects associated with participation in this 
study. 
EXPECTED BENEFITS: All participants will receive educational benefits concerning the nature of 
psychological research. In addition, you m·tght be g'tven ·Information that may influence the course of 
therapy with the client. 
VOLUNTARY PARTICIPATION: Participation in this study is voluntary. You may choose not to 
participate. If you do decide to participate, you can change your mind at any time and withdraw from 
the study without negative consequences. 
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USE OF RESEARCH RESULTS: The results of this study may be included in the principal 
investigator's dissertation, may be included in a research publication, and/or may be presented at 
conferences. You will not be identified in any publication or report of this study. 
If the results of this study indicate that the course of treatment is improved with the therapist's 
knowledge of the questionnaire results, for any of the clients that may have been assigned to the no-
results-to-therapist group, a description of their questionnaire responses will be provided to your 
supervisees upon request after, but not before, the 6"' session or upon completion of the study. 
FUTURE QUESTIONS: If, at any time, you have questions about study procedures or your 
participation in the study, please contact the principal investigator, Shauncie Skidmore, at 734-487-
4987. 
EMERGENCY CONTACT INFORMATION: If you feel the need to consult with someone regarding 
your reactions to participating in this study, the following agencies offer services: 
Wentworth and Associates: 
Harbor Oaks: 
StJohn's Oakland Hospital: 
(586) 997-3153 
(586) 725-5777 
(248) 997-3153 
HUMAN SUBJECTS REVIEW BOARD: This research protocol and informed consent document 
have been reviewed and approved by the Eastern Michigan University Human Subjects Review 
Committee for use from 15 June 07 to 15 June 08. if you have any questions about the approval 
process, please contact Dr. Deb de laski-Smith (734.487.0042, Interim Dean of the Graduate School 
and Administrative Co-chair of UHSRC, human.subjects@emich.edu). 
CONSENT TO PARTICIPATE: I have read or had read to me all the above information about this 
research study, including the research procedures, possible risks, side effects, and the likelihood of 
any benefit to me. The content and meaning of this information has been explained and I 
understand. All my questions, at th:s time, have been answered. I hereby consent and do voluntarily 
offer to follow the study requirements and take part in the study. 
PRINTNAME: --------------------------------
Signatures: 
Participant (your signature) Date 
Witness: 
Investigator or Specified Designee Date 
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Appendix R: Scripted Phone Contact Protocol 
i---------- ------------- r;t;;;;e-c~;:;t;;ct r·r;;t~~i ·i;;; oci -45~2/ NEo-ri:Iz ~;t;;-ci;----------------------- i 
·~-~·-~------------------------------------------------------------------------------------· 
Hi, May I speak to ----··------------
If individual is not home, do not leave a message. 
If answering machine response, just hang up. 
If someone else answers phone, just say you will call back at another time. 
If individual is available: 
I am calling from the ___ _ Psychology Clinic. 
My name is 
I am calling to find out if you would be willing to participate in a study. 
If you choose to participate, you will receive ($1 0 or $10 credit toward account). 
At this point, the callee will probably ask what the study is about. 
The purpose of the study is to determine if it would be useful to administer questionnaires to 
clients before they see their therapist for the first time. 
If you choose to participate in the study, you will be asked to come to the clinic sometime 
BEFORE your first scheduled appointment with a therapist. You will not see a therapist at this 
lime. 
When you come to the clinic to participate in the study, a research assistant will explain the 
purpose of the study to you, review a consent form with you, ask you to sign the consent 
form, and have you complete four questionnaires about personality characteristics. 
The benefit to you for participating in this study will be educational benefits concerning the 
nature of psychological research and the monetary award previously mentioned. Would you 
be willing to participate in this study? 
If they say !!Q: Thank you for your time. 
If they say YES: II takes about 1 hour to complete the questionnaires. When would be a 
convenient time for you to come to the clinic to complete this paperwork? 
After a time has been scheduled: When you come to the clinic, please tell the receptionist you are 
here to participate in the study. 
After a time has been agreed upon: Do,you need directions to the clinic?- see attached for directions. 
Do you have any questions? 
See list ofF AQs. 
______ ·" , thank you very much for being willing to participate in our 
(name) 
study. 
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We will see you (scheduled dole and time). 
Thanks again. Bye 
Frequently Asked Questions (FAQs) 
Will my name be on the paperwork? 
No, each person that participates in the study is assigned a number. Only the number is on the questionnaires. 
The list of names and numbers is kept under lock and key in a separate place from the rest of the questionnaires. 
1Vltat kind of personality information is being asked in the questionnaires? 
The questions concern aspects of personality, such as openness, extraversion, agreeableness, etc. 
What happens to the results of the questionnaires I answer? 
Because the purpose of the study is to determine if it is useful to give questionnaires to clients before they are 
seen by a therapist, some participants' results will be given to the therapist to discuss with the client, some will 
not. We cannot determine at this time whether your results will be given to your therapist 
Can I get a copy of the questionnaire results? 
If you would like a written narrative of your questiormaire results, we will have you complete a form at the time 
of your appointment that requests permission to mail the results to you at the end of the study. 
Project Title: 
Investigator: 
Co-Investigator: 
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Appendix S: Client lnfonned Consent for EMU PC 
Participant lnf(>rmed Consent 
The Effect of Pre-Treatment Assessment on Therapy Outcome 
Shauncie Skidmore, M.S., Eastern Michigan University 
Karen Saules, Ph.D., EMU Psychology Clinic Director 
PURPOSE OF THIS RESEARCH STUDY: To evaluate factors that may influence the course of individual 
psychotherapy. 
PROCEDURE: A research assistant will explain the study to you, answer any questions you may have, and 
witness your signature to this consent form. 
Participation tasks include: completion of 4 questionnaires pre-treatment, completion of the OQ45.2 prior to 
each therapy session for six consecutive sessions, completion of the Working Alliance Inventory before the 4111 
session of therapy, and possible completion of a follow-up questionnaire packet. Total time commitment is 
approximately 4 hours over the course of 2 to 8 months. 
In particular, you will be asked to complete four questionnaires before your first session of therapy: the NEO-PI-
R, which is a measure of personality, the SCID II Questionnaire, which is a measure of personality patterns, the 
OQ 45.2, which is a measure of every cay functioning, and a brief demographics questionnaire that asks age, 
gender, etc. Upon completing the questionnaires, you will be given a duplicate copy of this informed consent, 
which includes follow-up contact information, if needed. The approximate total time to complete the 
questionnaires should be about 1 hour. 
Before the 4th session of therapy. you will be asked to complete the Working Alliance Inventory 12- Client 
Version, which is a measure of the quality of the relationship with your therapist. You will also be asked to 
complete an OQ 45.2 before each session of therapy. Each should only take 5 to 10 minutes to complete. 
For this study, each participant will be randomly assigned to one of two conditions, either to a group in which the 
therapist will be given a report describing the results of your NEO-PI-R questionnaire data, or to a group in which 
the therapist is not given any information about your questionnaire results. If you are assigned to the "no results" 
condition, your therapist may request a NEO-PI-R report after the sixth session of therapy. 
Also, participants may be contacted 3 months after they finish therapy. If contacted, you will be asked to 
complete an Outcome Questionnaire (OQ45.2) and a SCID II SR Questionnaire, total completion time 
approximately 30 minutes. A return envelope with postage will be provided at that time. 
CONFIDENTIALITY: All study data will be kept in a locked file cabinet at the EMU Psychology Clinic, separated 
from your clinic chart. As mentioned previously, your therapist may or may not have access to your 
questionnaire results. 
EXPECTED RISKS: There are no known risks or side effects associated with participation in this study. 
However, the questionnaires contain items about symptoms that may be troubling to you. You may experience 
some emotional discomfort when answering these items, but it is not expected to last longer than it takes you to 
complete the questionnaires. If, however, you experience emotional reactions that are difficult for you to 
manage, please mention your reactions to your therapist or contact the principal investigator of this research 
study. It is expected that your therapist will be able to address any concerns you have regarding your reactions 
to the questionnaires. However, you will·be provided referral information for additional appropriate services, if 
needed. 
EXPECTED BENEFITS: All participants will receive educational benefits concerning the nature of psychological 
research. In addition, each participant will be given a $10 credit to their clinic account upon completion of the 
questionnaires, to compensate for their time. Likewise, if you are contacted to complete the follow-up 
questionnaires, upon receipt (at the EMU Psychology Clinic) of your completed questionnaires, you will be 
forwarded a monetary compensation of $10 for your time and effort. 
VOLUNTARY PARTICIPATION: Participation in this study is voluntary. You may choose not to participate. If 
you do decide to participate, you can change your mind at any time and withdraw from the study without negative 
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consequences. Regardless of whether you decide to participate or not to participate, your decision will not affect 
your course of treatment or eligibility for services at the clinic in any way. 
USE OF RESEARCH RESULTS: The results of this study may be included in the principal investigator's 
dissertation, may be included in a research publication, and/or may be presented at conferences. You will not be 
identified in any publication or report of this study. 
If the results of this study indicate that the course of treatment is improved with the therapist's knowledge of the 
questionnaire results, therapists will be given a description of questionnaire responses, upon completion of the 
study (or upon request after, but not before, the sixth session as mentioned previously), for any clients that may 
have been assigned to the no-results-to-therapist group. 
FUTURE QUESTIONS: If, at any time, you have questions about study procedures or your participation in the 
study, please contact the principal investigator, Shauncie Skidmore, at 734-487-4987. 
EMERGENCY CONTACT INFORMATION: If you feel the need to consult with someone regarding your 
reactions to participating in this study, the following agencies offer services: 
Snow Counseling Services: (734) 487-1118 (services are for EMU students only) 
EMU Psychology Clinic: (734) 487-4987 
University of Michigan 24-Hour Psychiatric Emergency Services: (734) 996-4747 
HUMAN SUBJECTS REVIEW BOARD: This research protocol and informed consent document have been 
reviewed and approved by the Eastern Michigan University Human Subjects Review Committee for use from 15 
June 07 to 15 June 08. If you have any questions about the approval process, please contact Dr. Deb de Laski-
Smith (734.487.0042, Interim Dean of the Graduate School and Administrative Co-chair of UHSRC, 
human.subjects@emich.edu). 
CONSENT TO PARTICIPATE: I have read or had read to me all the above information about this research 
study, including the research procedures, possible risks, side effects, and the likelihood of any benefit to me. 
The content and meaning of this information has been explained, and I understand. All my questions, at this 
time, have been answered. I hereby consent and do voluntarily offer to follow the study requirements and take 
part in the study. 
PRINT NAME: 
Signatures: 
Participant (your signature) Date 
Also, I consent to participate in the follow-up mailing 3 months after my last session or at the end of the study, 
whichever comes first. 
Signature Date 
Witness: 
Investigator or Specified Designee Date 
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Appendix T: Client Informed Consent EMU CAPS 
PAR71CIPANT INFORMED CONSENT 
Project Title: The Effect of Pre-Treatment Assessment on Therapy Outcome 
Investigator: Shauncie Skidmore, M.S., Eastern Michigan University 
Co-Investigator: Karen Saules, Ph.D., EMU Psychology Clinic Director 
PURPOSE OF THIS RESEARCH STUDY: To evaluate factors that may influence the course of individual 
psychotherapy. 
PROCEDURE: A research assistant will explain the study to you, answer any questions you may have, and 
witness your signature to this consent form. 
Participation tasks include: completion of 4 questionnaires pre-treatment, completion of the 0045.2 prior to 
each therapy session for six consecutive sessions, completion of the Working Alliance Inventory before the 41h 
session of therapy, and possible completion of a follow-up questionnaire packet. Total time commitment is 
approximately 4 hours over the course of 2 to 8 months. 
In particular, you will be asked to complete four questionnaires before your first session of therapy: the NEO-PI-
R, which is a measure of personality, the SCID !I Questionnaire, which is a measure of personality patterns, the 
OQ 45.2, which is a measure of every day functioning, and a brief demographics questionnaire that asks age, 
gender, etc. Upon completing the questionnaires, you will be given a duplicate copy of this informed consent, 
which includes follow-up contact information, if needed. The approximate total time to complete the 
questionnaires should be about 1 hour. 
Before the 41h session of therapy, you will be asked to complete the Working Alliance Inventory 12- Client 
Version, which is a measure of the quality of the relationship with your therapist. You will also be asked to 
complete an 00 45.2 before each session of therapy. Each should only take 5 to 10 minutes to complete. 
For this study, each participant will be randomly assigned to one of two conditions, either to a group in which the 
therapist will be given a report describing the results of your NEO-PI-R questionnaire data, or to a group in which 
the therapist is not given any information about your questionnaire results. If you are assigned to the "no results" 
condition, your therapist may request a NEO-PI-R report after the sixth session of therapy. 
Also, participants may be contacted 3 months after they finish therapy. If contacted, you will be asked to 
complete an Outcome Questionnaire (0045.2) and a SCID II SR Questionnaire, total completion time 
approximately 30 minutes. A return envelope with postage will be provided at that time. 
CONFIDENTIALITY: All study data will be kept in a locked file cabinet at the EMU Psychology Clinic, separated 
from your clinic chart. As mentioned previously, your therapist may or may not have access to your 
questionnaire results. 
EXPECTED RISKS: There are no known risks or side effects associated with participation in this study. 
However, the questionnaires contain items about symptoms that may be troubling to you. You may experience 
some emotional discomfort when answering these items, but it is not expected to last longer than it takes you to 
complete the questionnaires. If, however, you experience emotional reactions that are difficult for you to 
manage, please mention your reactions to your therapist or contact the principal investigator of this research 
study. It is expected that your therapist will be able to address any concerns you have regarding your reactions 
to the questionnaires. However, you will be provided referral information for additional appropriate services, if 
needed. 
EXPECTED BENEFITS: All participants will receive educational benefits concerning the nature of psychological 
research. In addition, each participant will be given $10 upon completion of the questionnaires, to compensate 
for their time. Likewise, if you are contacted to complete the follow-up questionnaires, upon receipt (at the EMU 
Psychology Clinic) of your completed questionnaires, you will be forwarded a monetary compensation of $10 for 
your time and effort. 
VOLUNTARY PARTICIPATION: Participation in this study is voluntary. You may choose not to participate. If 
you do decide to participate, you can change your mind at any time and withdraw from the study without negative 
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consequences. Regardless of whether you decide to participate or not to participate, your decision will not affect 
your course of treatment or eligibility for services at the clinic in any way. 
USE OF RESEARCH RESULTS: The results of this study may be included in the principal investigator's 
dissertation, may be included in a research publication, and/or may be presented at conferences. You will not be 
identified in any publication or report of this study. 
If the results of this study indicate that the course of treatment is improved with the therapist's knowledge of the 
questionnaire results, therapists will be given a description of questionnaire responses, upon completion of the 
study (or upon request after, but not before, the sixth session as mentioned previously), for any clients that may 
have been assigned to the no-results-to-therapist group. 
FUTURE QUESTIONS: If, at any time, you have questions about study procedures or your participation in the 
study, please contact the principal investigator, Shauncie Skidmore, at 734-487-4987. 
EMERGENCY CONTACT INFORMATION: If you feel the need to consult with someone regarding your 
reactions to participating in this study, the following agencies offer services: 
Snow Counseling Services: (734) 487-1118 (services are for EMU students only) 
EMU Psychology Clinic: (734) 487-4987 
University of Michigan 24-Hour Psychiatric Emergency Services: (734) 996-4747 
HUMAN SUBJECTS REVIEW BOARD: This research protocol and informed consent document have been 
reviewed and approved by the Eastern Michigan University Human Subjects Review Committee for use from 15 
June 07 to 15 June 08. If you have any questions about the approval process, please contact Dr. Deb de Laski-
Smith (734.487.0042, Interim Dean of the Graduate School and Administrative Co-chair of UHSRC, 
human.subjects@emich.edu). 
CONSENT TO PARTICIPATE: I have read or had read to me all the above information about this research 
study, including the research procedures, possible risks, side effects, and the likelihood of any benefit to me. 
The content and meaning of this information has been explained, and I understand. All my questions, at this 
time, have been answered. I hereby consent and do voluntarily offer to follow the study requirements and take 
part in the study. 
PRINT NAME: ___________ _ 
Signatures: 
Participant (your signature) Date 
Also, I consent to participate in the follow-up mailing 3 months after my last session or at the end of the study, 
whichever comes first. 
Signature Date 
Witness: 
Investigator or Specified Designee Date 
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Appendix U: Client Infonned Consent for Wentworth and Associates 
PARTIC1PANT INFORMED COiVSENT 
Project Title: The Effect of Pre-Treatment Assessment on Therapy Outcome 
Investigator: Shauncie Skidmore, M.S., Eastern Michigan University 
Co-Investigator: Karen Saules, Ph.D., EMU Psychology Clinic Director 
PURPOSE OF THIS RESEARCH STUDY: To evaluate factors that may influence the course of individual 
psychotherapy. 
PROCEDURE: A research assistant will explain the study to you, answer any questions you may have, and 
witness your signature to this consent form. 
Participation tasks include: completion of 4 questionnaires pre-treatment, completion of the OQ45.2 prior to 
each therapy session for six consecutive sessions, completion of the Working Alliance Inventory before the 41h 
session of therapy, and possible completion of a follow-up questionnaire packet. Total time commitment is 
approximately 4 hours over the course of 2 to 8 months. 
In particular, you will be asked to complete four questionnaires before your first session of therapy: the NEO-PI-
R, which is a measure of personality, the SCID II Questionnaire, which is a measure of personality patterns, the 
00 45.2, which is a measure of every day functioning, and a brief demographics questionnaire that asks age, 
gender, etc. Upon completing the questionnaires, you will be given a duplicate copy of this informed consent, 
which includes follow-up contact information, if needed. The approximate total time to complete the 
questionnaires should be about 1 hour. 
Before the 4th session of therapy, you will be asked to complete the Working Alliance Inventory 12- Client 
Version, which is a measure of the quality of the relationship with your therapist. You will also be asked to 
complete an OQ 45.2 before each session of therapy. Each should only take 5 to 10 minutes to complete. 
For this study, each participant will be randomly assigned to one of two conditions, either to a group in which the 
therapist will be given a report describing the results of your NEO-PI-R questionnaire data, or to a group in which 
the therapist is not given any information about your questionnaire results. If you are assigned to the "no results" 
condition, your therapist may request a NEO-PI-R report after the sixth session of therapy. 
Also, participants may be contacted 3 months after they finish therapy. If contacted, you will be asked to 
complete an Outcome Questionnaire (OQ45.2) and a SCID II Questionnaire, total completion time approximately 
30 minutes. A return envelope with postage will be provided at that time. 
CONFIDENTIALITY: All study data will be kept in a locked file cabinet at the EMU Psychology Clinic, separated 
from your clinic chart. As mentioned previously, your therapist may or may not have access to your 
questionnaire results. 
EXPECTED RISKS: There are no known risks or side effects associated with participation in this study. 
However, the questionnaires contain items about symptoms that may be troubling to you. You may experience 
some emotional discomfort when answering these items, but it is not expected to last longer than it takes you to 
complete the questionnaires. If, however, you experience emotional reactions that are difficult for you to 
manage, please mention your reactions to your therapist or contact the principal investigator of this research 
study. It is expected that your therapist will be able to address any concerns you have regarding your reactions 
to the questionnaires. However, you will be provided referral information for additional appropriate services, if 
needed. 
EXPECTED BENEFITS: All participants will receive educational benefits concerning the nature of psychological 
research. In addition, each participant will be given $10 upon completion of the questionnaires, to compensate 
for their time. Likewise, if you are contacted to complete the follow-up questionnaires, upon receipt (at the EMU 
Psychology Clinic) of your completed questionnaires, you will be forwarded a monetary compensation of $1 0 for 
your time and effort. 
VOLUNTARY PARTICIPATION: Participation in this study is voluntary. You may choose not to participate. If 
you do decide to participate, you can change your mind at any time and withdraw from the study without negative 
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consequences. Regardless of whether you decide to participate or not to participate, your decision will not affect 
your course of treatment or eligibility for services at the clinic in any way. 
USE OF RESEARCH RESULTS: The results of this study may be included in the principal investigator's 
dissertation, may be included in a research publication, and/or may be presented at conferences. You will not be 
identified in any publication or report of this study. 
If the results of this study indicate that the course of treatment is improved with the therapist's knowledge of the 
questionnaire results, therapists will be given a description of questionnaire responses, upon completion of the 
study (or upon request after the sixth session as mentioned previously), for any clients that may have been 
assigned to the no-results-to-therapist group. 
FUTURE QUESTIONS: If, at any time, you have questions about study procedures or your participation in the 
study, please contact the principal investigator, Shauncie Skidmore, at 734-487-4987. 
EMERGENCY CONTACT INFORMATION: If you feel the need to consult with someone regarding your 
reactions to participating in this study, the following agencies offer services: 
Wentworth and Associates: (586) 997-3153 
Harbor Oaks: (586) 725-5777 
StJohn's Oakland Hospital: (248) 997-3153 
HUMAN SUBJECTS REVIEW BOARD: This research protocol and informed consent document have been 
reviewed and approved by the Eastern Michigan University Human Subjects Review Committee for use from 15 
June 07 to 15 June 08. If you have any questions about the approval process, please contact Dr. Deb de Laski-
Smith (734.487.0042, Interim Dean of the Graduate School and Administrative Co-chair of UHSRC, 
human.subjects@emich.edu). 
CONSENT TO PARTICIPATE: I have read or had read to me all the above information about this research 
study, including the research procedures, possible risks, side effects, and the likelihood of any benefit to me. 
The content and meaning of this information has been explained, and I understand. All my questions, at this 
time, have been answered. I hereby consent and do voluntarily offer to follow the study requirements and take 
part in the study. 
PRINTNAME: --------------------------------
Signatures: 
Participant (your signature) Date 
Also, I consent to participate in the follow-up mailing 3 months after my last session or at the end of the study, 
whichever comes first. 
Signature Date 
Witness: 
Investigator or Specified Designee Date 
PD Pre-Treatment Assessment !55 
Appendix V: Study Follow-Up Cover Letter for Post Treatment Questionnaire Packets 
(Date) 
(Addressee Information) 
Subject: Pruticipation in Personality Study 
Dear~~~~~~~-" _, 
Thank you so much tOr agreeing to participate in our post-treatment personality assessment study. Enclosed you will find a 
copy of the consent fonn you signed at the beginning of the study, one personality questionnaire, and an OQ 45.2. 
Please remember, your name will not be listed on the questionnaires (a number will used to track questionnaire return) and 
will not be included in any data analyses. Your answers arc completely confidential. 
Pmticipation in this study is completely vo!untmy. You may choose not to participate. Your decision will not affect your 
eligibility for any future services in any way. 
Please complete both questionnaires. Also, please check to make sure you did not skip any pages. If you have any 
questions regarding the questionnaires, please call the EMU Psychology Clinic, 734~487A987, and ask for Shauncie 
Skidmore or her research assistant. 
After you complete the questionnaires, please mail them in the stamped, addressed envelope provided. 
Once the completed fonns are received by a research assistant, you will be sent a check for $10 for you participation. 
If you would prefer, you can deliver the completed questionnaires to the EMU Psychology Clinic and receive your $10 
check at that time. If you choose this option, we request that you call and make prior arrangements with a research assistant 
so that we can make sure your money is available at the front desk. 
Again, thank you so much for participating in our study. We look forward to receiving your responses. 
Sincerely, 
Shauncie Skidmore, MS, LLP, PhD Candidate 
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Appendix W: Results ofTherapist and Supervisor Post Session 6 Questionnaires 
Question 
17terapisl C Form (No Results Group) 
Q I. NEO-PI-R training inllucnce on attention to impact 
of client's personality on therapeutic interaction 
Q2. NEO-Pl-R training influence on conceptualization 
of client's personality strengths and weaknesses 
Q3. NEO-PI-R training influence interaction with 
the client 
Therapist E Form (Results to Therapist Group} 
Ql. Usefulness ofNEO-PI-R report in development 
of case fOnnulation 
Q5. NEO-Pl-R influence on conceptualization 
of client's personality strengths and weaknesses 
Q6. NEO-PI-R int1uence interaction with client 
Supervisor Form 
Ql, NEO-PI-R int1uence on attention to impact of 
client's personality on therapeutic interaction 
Q2. NEO-Pl-R int1ucncc on conceptualization 
of client's personality strengths and weaknesses 
QJ. NEO-PI-R int1uence on recommendations 
Mean (SD) Median 
1.67(SD~2.1) 2.0 
1.00 (SD = 1.6) 0.0 
0.67 (SD = 1.0) 0.0 
5.83 (SD = 1.7) 6.0 
1.00 (SD = L7) l.5 
1.67 (SD = l.O) 2.0 
3.90(SD=2.1) 4.0 
1.70 (SD = 1.5) 2.5 
1.40 (SD = l.O) 2.0 
Mode Actual Range [Range Choices] 
0 0 to 3 [0 (not at all) to 10 (very)] 
0 Oto3 [-5(veryneg)to-t-5(verypos)"j 
0 0 to 2 f-5 (very neg) to +5 (very pos)] 
6 lto8 [O(notatall)to10(vcry)J 
-1, 2 -1 to3 [-5(veryneg)to+5(verypos)] 
2 0 to 3 [-5 (very neg) to +5 (very pos)] 
3, 5 0 to 7 [0 (not at all) to 10 (vety)] 
3 0 to 3 [-5 (very neg) to +5 (vel)' pos)] 
2 0 to 2 [-5 (vety neg) to +5 (vety pos)] 
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Appendix X: SCID-II-SR Questionnaire 
STUDYID#: --------------· 
SCID -II QUESTIONNAIRE 
These questions are about the kind of person you generally are, that is, how you have usually 
felt or behaved over the past several years. Check "no" or "yes" if the question completely 
or mostly applies to you. If you do not understand a question, leave it blank. 
STATEMENT RESPONSE 
I Have you avoided jobs or tasks that involved having to deal with a lot of No o 
people? Yes o 
2 Do you avoid getting involved with people unless you are certain they will like No cJ 
you? Yes CJ 
3 Do you find it hard to be "open" even with people you are close to? No n 
·-··--t 
Yes o 
·j 4 Do you often worry about being criticized or rejected in social situations? No CJ I Yes o I 5 Are you usualiy quiet when you meet new people? No cJ 
Yes o 
6 Do you need a lot of advice or reassurance from others before you can make No D 
everyday decisions -like what to wear or what to order at a restaurant? Yes o 
7 Do you believe that you arc not as good, as smart, or as attractive as most No o 
people? Yes tJ 
8 Are you afraid to try new things? No o 
Yes o 
9 Do you depend on other people to handle important areas in your life such as No o 
finances, childcarc, or living arrangements? Yes o 
10 Do you find it hard to disagree with people even when you think they are No o 
wrong? Yes o 
11 Do you find it hard to start or work on tasks when there is no one to help you? No o 
Yes o 
12 Have you often volunteered to do things that are unpleasant? No o 
Yes o 
13 Do you usually feel uncomfortable when you are by yourself? No cJ 
Yes !J 
14 When a close relationship ends, do you feel you immediately have to find No [] 
someone else to take care of you? Yes ,-, 
15 Do you worry a lot about being left alone to take care of yourselfJ No u 
Yes u 
16 Are you the kind of person who focuses on details, order, and organization or No o 
likes to make lists and schedules? Yes o 
17 Do you have trouble finishing jobs because you spend so much time trying to No o 
get things exactly right? Yes o 
18 Do you or other people feel that you are so devoted to work (or school) that you No o 
have no time left for anyone else or for just having fun? Yes o 
1 19 Do you have very high standards about what is right and what is wrong? No o 
i Yes o 
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20 Do you have trouble throwing things out because they might come in handy No o 
some day? Yes o 
21 Is it hard for you to let other people help you of they don't agree to do things No o 
exactly the way you want? Yes rJ ' 
22 Is it hard for you to spend money on yourself and other people even when you No o 
have enough? Yes o 
--
23 Are you often so sure you are right that it doesn't matter what other people say? No o 
Yes o 
24 Have other people told you that you are stubborn or rigid? No D 
Yes o 
""" 
25 When someone asks yon to do something that yon don't want to do, do you say No o 
"yes" but then work slowly or do a bad job? Yes o 
26 If you don't want to do something, do you often just "forget" to do it? No o 
Yes o 
27 Do you often feel that other people don't understand you, or don't appreciate No o 
how much you do? Yes o 
28 Are you often grumpy and likely to get into arguments? No o 
Yes o 
29 Have you found that most of your bosses, teachers, supervisors, doctors, and No o 
others who are supposed to know what they are doing really don't? Yes o 
30 Do you think that it's not fair that other people have more than you do? No o 
Yes o 
31 Do you often complain that more than your share of bad things have happened No o 
to you? Yes o 
32 Do you often angrily ref-use to do what others want and then later feel bad and No o 
apologize? I Yes '" l 33 Do you usually feel unhappy or feel like life is no fun? I No u 
Yes rJ 
__ .J 
34 Do you believe that you are basically an inadequate person and don't feel good No u 
about yourself? Yes rJ 
35 Do you often put yourself down? No u 
Yes 0 
36 Do you keep thinking about bad things that have happened in the past or worry No o 
about bad things that might happen in the future? Yes o 
37 Do you often judge others harshly and easily find fault with them? No o 
Yes o 
38 Do you think that most people are basically no good? No o 
Yes o 
39 Do you almost always expect things to turn out badly? No o 
Yes o 
40 Do you often feel t,'llilty about things you have or haven't done? No o 
Yes o 
41 Do you often have to keep an eye out to stop people from using you or hurting No o 
you? Yes o 
1 
42 Do you spend a lot of time wondering if you can trust your friends or the people No o 
you work with? Yes o 
43 Do you find that it is best not to let other people know much about you because No D 
they will use it against you? Yes c i 
44 Do you often detect hidden threats or insults in things people say or do? No n ""] Yes u 
--·--
45 Are you the kind of person who holds grudges or takes a long time to forgive No u 
i people who have insulted or slighted you? Yes c1 
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46 Are there many people you can't forgive hecause they did or said something to No o 
you a long time ago? Yes o 
47 Do you often get angry or lash out when someone criticizes or insults you in No 0 
someway? Yes o 
48 Have you often suspected that your spouse or partner has been unfaithful? No o 
Yes o 
49 When you are out in public and see people talking, do you often feel that they No o 
are talking about you? Yes o 
-
50 Do you often get the feeling that things that have no special meaning to most No n 
people arc really meant to give you a message? Yes o 
. ---
51 When you are around people, do you often get the feeling that you are being No u 
watched or stared at? Yes o 
52 Have you ever felt that you could make things happen just by making a wish or No o 
thinking about them? Yes o 
··-
53 Have you had personal experiences with the supernatural? No c1 
Yes 0 
54 Do you believe that you have a "sixth sense" that allows you to know and No o 
predict things that others can't? Yes "' 
55 Do you often think that objects or shadows are really people or animals or that No ["j 
noises are actually people's voices? Yes o 
56 Have you had the sense that some person or force is around you, even though No o 
you cannot see anyone? Yes o 
57 Do you often see auras or energy fields around people? No c 
Yes o 
58 Are there very few people that you're really close to outside of your innnediate No o 
family? Yes o 
59 Do you often feel nervous when you are with other people? No o 
Yes o 
60 Is it NOT important to you whether you have any close relationships? No o 
Yes o 
61 Would you almost always rather do things alone than with other people? No o 
Yes 0 
62 Could you be content without ever being sexually involved with anyone? No lJ 
Yes o 
63 Are there really very few things that give you pleasure? No cJ 
' Yes LJ 
·----
64 Does it not matter to you what people think of you? No o 
Yes '" 
···-
65 Do you find that nothing makes you very happy or very sad? No cJ 
Yes 0 
-·-
66 Do you like to be the center of attention? No o 
Yes D 
67 Do you flirt a lot? No o 
Yes o 
68 Do you often find yourself"coming on" to people? No o 
Yes o 
69 Do you try to draw attention to yourself by the way you dress or look? No o 
Yes o 
70 Do you often make a point of being dramatic and colorful? No o 
Yes o 
71 Do you often change your mind about things depending on the people you're No o 
with or what you have just read or seen on TV? Yes o 
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72 Do you have Jots of friends that you arc very close to? No o 
Yes o 
73 Do people often fail to appreciate your very special talents or No o 
accomplishments? Yes o 
74 Have people told you that you have too high an opinion of yourself? No rJ 
Yes :::: j 
75 Do you think a lot about power, fame, or recognition that will be yours No u 
someday? Yes o 
76 Do you think a Jot about the perfect romance that will yours someday? No o 
Yes o 
77 When you have a problem, do you almost always insist on seeing tbe top No o 
person? Yes o 
78 Do you feel it is important to spend time with people who are special or No o 
influential? Yes o 
79 Is it very important to you that people pay attention to you or admire you in No o 
some way? Yes o 
80 Do you think that it's not necessary to follow certain rules or social conventions No lJ 
when they get in your way? Yes o 
81 Do you feel that you are the kind of person who deserves special treatment? No o 
Yes o 
82 Do you often find it necessary to step on a few toes to get what you want? No o I Yes c 
83 Do you often have to put your needs above other people's? No o 
Yes o 
84 Do you often expect other people to do what you ask without question because No 0 
of who you are? Yes o 
85 Are you not really interested in other people's problems or feelings? No cr 
Yes u 
86 Have people complained to you that you don't listen to them or care about their No '' 
feelings? Yes rJ 
87 Are you often envious of others? No [) 
' Yes o 
88 Do you feel that others are often envious of you? No o 
Yes r·1 
89 Do you find that there are very few people that are worth your time aud No o 
attention? Yes o 
90 Have you often become frantic when you thought that someone your really No o 
cared about was going to leave you? Yes o 
91 Do your relationships with people you really care about have lots of extreme No o 
ups and downs? Yes o 
92 Have you all of a sudden changed your sense of who you are and where you are No o 
headed? Yes o 
93 Does your sense of who you are often change dramatically? No c1 
Yes cr 
94 Are you different with different people or in different situations so that you No u 
sometimes don't know who you really are? Yes o 
95 Have there been lots of sudden changes in your goals, career plans, religious No '. ,_, 
beliefs, and so on? Yes r:::-J 
96 Have you often done things impulsively? No u 
Yes o 
97 Have you tried to hurt or kill yourself or threatened to do so? No o 
Yes u 
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98 Have you ever cut, burned, or scratched yourself on purpose? No o 
Yes o 
99 Do you have a lot of sudden mood changes? No o 
Yes o 
100 Do you ofteu feel empty iuside? No o 
Yes o 
101 Do you often have temper outbursts or get so angry that you lose control? No o 
Yes o 
102 Do you hit people or throw things when you get angry? No o 
Yes o 
103 Do even little things get you very angry? No o 
Yes o 
104 When you are under a lot of stress, do you get suspicious of other people or feel No o 
especial! y spaced out? Yes o 
Note: Questions 105 through 119 are age specific. Some pertain to your 
behavior before age 15, others to your behavior before age 13. 
105 Before you were 15, would you bully or threaten other kids? No 'J 
Yes 'l 
106 Before you were 15, would you start fights? No c1 I 
'Yes o I 
107 Before you were 15, did you hmt or threaten someone with a weapon, like a No o 
bat, brick, broken bottle, knife, or gun? Yes o 
108 Before you were 15, did you deliberately torture someone or cause someone No o 
physical pain and suffering? Yes o 
109 Before you were 15, did you torture or hurt animals on purpose? No o 
Yes o 
110 Before you were 15, did you rob, mug, or forcibly take something from No c 
someone by threatening him or her? Yes o 
111 Before you were 15, did you force someone to have sex with you, get No o 
undressed, or touch you sexually? Yes c1 
112 Before you were 15, did you set fires? No o 
Yes o 
113 Before you were 15, did you deliberately destroy things that weren't yours? No o 
Yes o 
114 Before you were 15, did yom break into houses, other buildings, or cars? No o 
Yes o 
115 Before you were 15, did you lie a lot or con other people? No o I 
Yes CJ i 
116 Before you were 15, did you sometimes steal or shoplift things or forge No :.1 
I someone's signature? Yes u 
117 Before you were 15, did you run away and stay away ovemight? No u 
Yes cJ 
118 Before you were 13, did you often stay out very late, long after the time you No o 
were supposed to be home? Yes o 
119 Before you were 13, did you often skip school? No o 
Yes o 
NOTE: The following questions pertain to your behavior FROM age 15 
until NOW, 
120 Since you were 15, have you done things that are against the law - even if you No c 
weren't caught - like stealing, using or selling drugs, writing bad checks, Yes o 
numing number, having sex for money, etc.? 
121 Since you were 15, have you ever been arrested for anything? No o 
Yes o 
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122 Since you were 15, have you been in more than one physical fight, attacked No !] 
someone, or hit someone? Yes u 
123 Since you were 15, have you ever been so angry that you have thrown things at No e; 
your spouse/partner more than once? Yes c 
124 Since you were 15, have you ever hit a child, yours or someone else's, so hard No o 
that he or she had bruises or had to stay in bed or see a doctor? Yes o 
125 Since you were 15, have you sometimes not paid bills or other financial No o 
obligations? Yes o 
126 Since you were 15, have you sometimes been unable to pay for household No o 
necessities such as food, rent, or the electric bill because you spent so much Yes o 
money on things you could have done without? 
127 Since you were 15, have you ever failed to make court ordered payments such No 0 
as child support, alimony, or a lawsuit settlement? Yes o 
128 Since you were 15 and when you have been working, have you ever gotten into No o 
trouble for not aniving on time, missing too many days, not doing your work, Yes o 
or not following the rules? 
129 Since you were 15, did you ever walk off a job without having another one to No o 
go to? Yes o 
130 Since you were 15, have you impulsively picked up and moved around from No o 
place to place without any idea of how long you were going to stay or where Yes o 
you would go next? 
131 Since you were 15, do you regularly spend money impulsively on things you do No c1 
not need or can not afford? Yes o 
132 Since you were 15, do you often get into trouble because you don't plan ahead? No [J 
Yes 'J 
' - -133 Since you were 15, do you often find that you have to lie to get what you want? No ,, i 
Yes CJ i 
-
134 Since you were 15, have you ever used an alias or pretended you were someone No c 
else or developed a scheme to con people into giving you what you want? Yes o 
135 Since you were 15, did you ever drive a car when you were drunk or high? No o 
Yes o 
136 Since you were 15, have you received an above average nwnber of speeding No o 
tickets or been in several car accidents? Yes o 
137 Since you were 15, have others often said that you tend to be a reckless or No o 
dangerous driver? Yes o 
138 Since you were 15, have you been known as someone who risks life and limb in No o 
recreational activities? Yes o 
139 Since you were 15, did you ever get into trouble at work for doing things that No o 
could be dangerous to you or others? Yes o 
140 If you answered yes to any item between 120 and 139, do you think what you No o 
did was wrong in any way? Yes CJ 
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Appendix Y: Human Subjects Review Board Approval Letter 1 
EASTERN .MICHIGAN UNIVERSITY 
September 27, 2004 
Shauncie Weber 
Department of Psychology 
RE: "The impact of identifYing personality style and personality disorder symptoms on 
outcomes in a training clinic." 
The Human Subjects Institutional Review Board (JRB) ofEastem Michigan University 
has granted approval to your proposal: "The impact of identifying personality style and 
personality disorder symptoms on outcomes in a training clinic~'. 
After careful review of your application, the IRB determined that the rights andwelfare 
of the individual subjects involved in this research are carefully guarded. Additionally, 
the methods used to obtain informed consent are appropriate, and the individuals are not 
at a risk. 
You are reminded of your obligation to advise the IRB of any change in the protocol that 
might alter your research in any manner that differs from that upon which this approval is 
based. Approval of this project applies for one year from the date of this letter. If your 
data collection continues beyond the one-year period, you must apply for a renewal. 
On behalf of the Human Subjects Committee, I wish you success in conducting your 
research. 
Sincerely, 
 
Administrative Co-Chair 
Human Subjects Committee 
CC: Dr. Steve Pernecky, Faculty Co-Chair 
Dr. Karen Saules 
--~~-~~~~· 
Graduate Studies & Research • Office of the Associate Vice President • Starkweather Hall • Ypsilan.ti, Michigan 48197 
Phone: 734.487.0042 FAX: 734.487.0050 
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Appendix Z: Human Subjects Review Board Approval Letter 2 
EASTERN MICHIGAN UNIVERSITY 
July 22, 2005 
Ms. Shauncie Skidmore 
Department of Psychology 
RE: "The impact of identifying personality style and personality disorder symptoms on 
outcomes in a training clinic" 
The Human Subjects Institutional Review Board (IRB) of Eastern Michigan University 
has granted approval to your modified proposal: "The impact of identifying personality 
style ~d personality disorder symptoms on outcomes in a training clinic". 
After careful review of your application, the IRB determined that the rights and welfare 
of the individual subjects involved in this research are carefully guarded. Additionally, 
the methods used to obtain informed consent are appropriate, and the individuals are not 
at a risk. 
You are reminded of your obligation to advise the IRB of any change in the protocol that 
might alter your research in any marmer that differs from that upon which this approval is 
based. Approval of this project applies for one year from the date of this letter. If your 
data collection continues beyond the one-year period, you must apply for a renewal. 
On behalf of the Human Subjects Conunittee, I wish you success in conducting your 
research. 
Sincerely, 
 
Dr. Patrick Melia 
Administrative Co,Chair 
Human Subjects Committee 
CC: Dr. Steve Pernecky, Faculty Co-Chair 
Dr. Karen Saules 
Graduate Studies & Research • Office of the Associate Vice President • Stnkweather Hall ~ Ypsilanti, Michigan 48197 
Ph...-.,,. 7'<4 4~7 nn4? FAX: 734.487.0050 
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Appendix AA: Human Subjects Review Board Approval Letter 3 
From Robgx:Ltl_glkebo~_L <robert. holkeboer@emk:_h&~d-~ 
Sent Wednesday, July 26, 2006 10:58 am 
To S ha u ncie f':1 .. 9I.~_ . .S_f.;l9 mp re~-~~l<;lcLmo [@_~mJs;:Jl,_§9J!2': 
Cc .'J($ .. 91J.!£?@_~m ich__,_~@~!§.illJ_lQ~@_e m ich. edu > , ~tr£~_LT~.Lk < M qr_y_,_~(:JLrrLCJlt;s.@__s:_mJ~)ld~_Q_lJ2:_ 
Bee 
Subject Re: UHSRC Renewal Request 
Shauncie: 
Thanks for your renewal request (revised protocol) for "Personality Disorder 
Identification and the Subsequent Impact on Treatment Outcomes in a Training 
Clinic Setting." Your request is approved. 
You are reminded of your obligation to advise the IRB of any change in the 
protocol that might alter your research in any manner that differs from that 
upon which this approval is based. Reapproval of this project applies for 
one year from the date of this letter. If your data collection continues 
beyond the additional one-year period, you must apply for an additional, and 
final, renewal. 
On behalf of the Human Subjects Committee, I wish you success in conducting 
your research. 
Bob Holkeboer 
Robert Holkeboer, Ph.D. 
Associate Vice President 
Graduate Studies and Research 
Eastern Michigan University 
Ypsilanti, MI 48197 
Phone (734) 487-0042 
Fax (734) 487-0050 
robert.holkeboer@emich.edu 
On 07/19/2006 6:20PM, "Shauncie Marie Skidmore" <sskidmor@emich.edu> wrote: 
> Dr. Holkeboer, 
> 
>Attached please find a UHSRC Research Approval renewal request. This 
> request includes a few minor modifications. A modified Summary of 
> Research and modified forms, as listed in the renewal request, have 
> been attached for your review. 
> 
> H you require a paper version with an original signature, please let 
>me know. 
> 
> Thank you for your time and consideration. I look forward to hearing 
>from you. 
> 
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Appendix AB: Human Subjects Review Board Approval Letter 4 
EASTERN MICHIGAN UNIVERSITY 
July 17, 2007 
Shauncie Skidmore 
P.O. Box 971512 
Ypsilanti, MI 48197 
Dear Shauncie Skidmore: 
The Human Subjects Jnstitntional Review Board (IRB) of Eastern Michigan Un.iversity 
has granted approval to your proposal, "The Impact of IdentifYing Personality Style and 
Personality Disorder Symptoms on Outcomes in a Training Clin.ic." 
After careful review of your completion application, the IRB determined that the rights 
and welfare of the individual subjects involved in this research are carefully guarded. 
Additionally, the methods used to obtain informed consent are appropriate, and the 
individuals participating in your stndy are not at risk. 
You are reminded of your obligation to advise the IRB of any change in the protocol that 
might alter your research in any manner that differs from that upon which tills approval is 
based. Approval of this project applies for one year from the date of this letter. If your 
data collection continues beyond the one-year period, you must apply for a renewal. 
On behalf of the Human Subjects Committee, I wish you success in conducting your 
research. 
Sincerely, 
Deb de Laski-Smith, Ph.D. 
Interim Dean 
Graduate School 
Administrative Co-Chair 
University Human Subjects Review Committee 
Note: If project continues beyond the length of one year, please submit a continuation 
request form by 7/17/08. 
Reference# 070615 
Graduate Studies & Research • Office of the Dean • Starlwveather Hall • Ypsilanti, Michigan 48197 
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Appendix AC: Human Subjects Review Board Approval Letter 5 
EASTERN MICHIGAN UNIVERSITY 
October 22, 2007 
Shauncie Skidmore 
P.O. Box 971512 
Ypoilanti, MI 48197 
Dear Shauncie Skidmore: 
Education First . 
The Human Subjects Institutional Review Board (IRB) of Eastern Michigan University 
has granted approval to your modified proposal, "The Impact of Identifying Personality 
Style and Personality Disorder Symptoms on Outcomes in a Training Clinic." 
After careful riOView of your completed application, the IRB determined that the rights 
and welfare of tile' illilividual subjects involved in this research are carefully guarded. 
_Ac[ditiona1Iy,(he methogsused to obtain informed consent are ~ppropriatc0 _a_nciJ11" 
individuals participating in your study are not at risk. 
You are reminded of your obligation to advise the IRB of any change in the protocol that 
-might alter yourresearch·in·any·marmer-thatdiffers·from·that-Bponwhich· this· approval i-s 
based. Approval of this project applies for one year from the date ofthis letter. If your 
data collection continues beyond the one-year period, you must apply for a renewal. 
On behalf of the Human Subjects Committee, I wish you success in conducting your 
research. 
 
-Smith, Ph.D. 
Interim Dean 
Graduate School 
Administrative Co-Chair 
University Human Subjects Review Committee 
Note: If project continues beyond the length of one year, please submit a continuation 
request form by 10/23/08. 
Reference# 071013M 
University Human Subjects Revie-w Committee· Eastern Michigan University· Starklnnrther Hall 
Ypsilanti, Michigan 4-8197 
Phone: 734.487.0042 Fa:x: 734.487.0050 
E·mail: human.subjects@emich.edu 
www.ord.emich.edu/ 
